<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="review-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">62420</article-id><article-id pub-id-type="doi">10.7554/eLife.62420</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>The effects of age and systemic metabolism on anti-tumor T cell responses</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-212612"><name><surname>Drijvers</surname><given-names>Jefte M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5675-5643</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-23024"><name><surname>Sharpe</surname><given-names>Arlene H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-15286"><name><surname>Haigis</surname><given-names>Marcia C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2530-2681</contrib-id><email>marcia_haigis@hms.harvard.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><label>1</label><institution>Department of Immunology, Blavatnik Institute and Ludwig Center at Harvard, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Cell Biology, Blavatnik Institute and Ludwig Center at Harvard, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kaeberlein</surname><given-names>Matt</given-names></name><role>Reviewing Editor</role><aff><institution>University of Washington</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Tyler</surname><given-names>Jessica K</given-names></name><role>Senior Editor</role><aff><institution>Weill Cornell Medicine</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Third Rock Ventures, Boston, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e62420</elocation-id><history><date date-type="received" iso-8601-date="2020-08-26"><day>26</day><month>08</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-10-29"><day>29</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Drijvers et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Drijvers et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-62420-v2.pdf"/><abstract><p>Average age and obesity prevalence are increasing globally. Both aging and obesity are characterized by profound systemic metabolic and immunologic changes and are cancer risk factors. The mechanisms linking age and body weight to cancer are incompletely understood, but recent studies have provided evidence that the anti-tumor immune response is reduced in both conditions, while responsiveness to immune checkpoint blockade, a form of cancer immunotherapy, is paradoxically intact. Dietary restriction, which promotes health and lifespan, may enhance cancer immunity. These findings illustrate that the systemic context can impact anti-tumor immunity and immunotherapy responsiveness. Here, we review the current knowledge of how age and systemic metabolic state affect the anti-tumor immune response, with an emphasis on CD8<sup>+</sup> T cells, which are key players in anti-tumor immunity. A better understanding of the underlying mechanisms may lead to novel therapies enhancing anti-tumor immunity in the context of aging or metabolic dysfunction.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>immunity</kwd><kwd>metabolism</kwd><kwd>cancer metabolism</kwd><kwd>obesity</kwd><kwd>aging</kwd></kwd-group><funding-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5F31CA224601</award-id><principal-award-recipient><name><surname>Drijvers</surname><given-names>Jefte M</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009729</institution-id><institution>Ludwig Cancer Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sharpe</surname><given-names>Arlene H</given-names></name><name><surname>Haigis</surname><given-names>Marcia C</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>U54-CA225088</award-id><principal-award-recipient><name><surname>Sharpe</surname><given-names>Arlene H</given-names></name><name><surname>Haigis</surname><given-names>Marcia C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A comprehensive literature review delineates the current knowledge of how systemic context, such as age and obesity, can impact CD8<sup>+</sup> T cell function, anti-tumor immunity, and immunotherapy responsiveness.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Average human lifespan has dramatically increased across the globe. For example, life expectancy in the United States (U.S.) has risen by more than 30 years since the beginning of the 20<sup>th</sup> century, from 47 to 79 years (<xref ref-type="bibr" rid="bib7">Arias and Xu, 2019</xref>). More recently, many parts of the world have seen a sharp increase in obesity rates, with now over 40% of adults in the U.S. being obese (defined as a body mass index (BMI) ≥30 kg/m<sup>2</sup>). These profound demographic changes are also reflected in the diseases that impose the largest burden on present-day societies. Notably, cancer is the leading cause of death in the U.S. for individuals between 55 and 74 years of age and the second leading cause of death overall, behind only cardiovascular disease (<xref ref-type="bibr" rid="bib102">Kochanek et al., 2019</xref>).</p><p>Age is among the most well-known cancer risk factors, and the incidence of most cancer types increases with age (<xref ref-type="bibr" rid="bib210">Siegel et al., 2019</xref>). Illustratively, the chance for an individual in the U.S. to develop any cancer in the first 50 years of life is 4–5%, whereas this is close to 30% over the age of 70 (<xref ref-type="bibr" rid="bib210">Siegel et al., 2019</xref>). Similarly, obesity is a risk factor for at least 13 cancer types, including common cancers like colorectal and postmenopausal breast cancer (<xref ref-type="bibr" rid="bib111">Lauby-Secretan et al., 2016</xref>). Due to the increasingly high prevalence of obesity in the western world, obesity-related cancers constitute a significant health problem: between 2011 and 2015, almost 5% and almost 10% of cancer cases in men and women respectively of 30 years and older in the U.S. were attributable to excess body weight (<xref ref-type="bibr" rid="bib88">Islami et al., 2018</xref>). In contrast to aging and obesity, dietary restriction is thought to provide widespread health benefits and increased lifespan (<xref ref-type="bibr" rid="bib67">Fontana and Partridge, 2015</xref>; <xref ref-type="bibr" rid="bib123">López-Otín et al., 2016</xref>; <xref ref-type="bibr" rid="bib135">McCay et al., 1935</xref>), and the limited evidence available, largely derived from animal studies, suggests that cancer incidence may also be lowered with dietary restriction (<xref ref-type="bibr" rid="bib42">Colman et al., 2009</xref>; <xref ref-type="bibr" rid="bib140">Michels and Ekbom, 2004</xref>; <xref ref-type="bibr" rid="bib193">Ross and Bras, 1965</xref>; <xref ref-type="bibr" rid="bib195">Rous, 1914</xref>; <xref ref-type="bibr" rid="bib232">Weindruch and Walford, 1982</xref>).</p><p>For both aging and obesity, a plethora of systemic and local factors have been suggested to directly promote cancer incidence and growth (<xref ref-type="bibr" rid="bib60">Fane and Weeraratna, 2020</xref>; <xref ref-type="bibr" rid="bib101">Khandekar et al., 2011</xref>). Although aging and excess body weight are distinct physiological entities, both conditions are also associated with reduced immune function, as evidenced by increased susceptibility to infections and suboptimal antibody titers following vaccination (<xref ref-type="bibr" rid="bib155">Nikolich-Žugich et al., 2012</xref>; <xref ref-type="bibr" rid="bib166">Painter et al., 2015</xref>; <xref ref-type="bibr" rid="bib208">Sheridan et al., 2012</xref>), and both are among the main risk factors for a severe disease course in the ongoing COVID-19 pandemic, which is characterized by immune dysregulation and dysfunction (<xref ref-type="bibr" rid="bib119">Lighter et al., 2020</xref>; <xref ref-type="bibr" rid="bib223">Vabret et al., 2020</xref>; <xref ref-type="bibr" rid="bib235">Wu and McGoogan, 2020</xref>). Given the recent appreciation of the importance of anti-cancer immune responses, this poses the question whether altered immunity may impact cancer rates and outcomes in systemic conditions like aging, obesity, and dietary restriction.</p><p>The first evidence for cancer immunotherapy was provided by the American surgeon William Coley in the late 19<sup>th</sup> century (<xref ref-type="bibr" rid="bib134">McCarthy, 2006</xref>). Dr. Coley injected sarcoma patients with streptococcal bacteria or bacterial products, inducing an immune response and, in some cases, tumor regressions. Not much later, the notion that defense mechanisms must exist in the body to limit the frequency of malignancies was first suggested by <xref ref-type="bibr" rid="bib57">Ehrlich, 1909</xref>. However, Coley’s approach fell out of favor, and it was not until the second half of the 20<sup>th</sup> century that experimentation with immune-mediated cancer therapies, including the first cancer vaccines, resumed (<xref ref-type="bibr" rid="bib47">Decker et al., 2017</xref>; <xref ref-type="bibr" rid="bib72">Graham and Graham, 1959</xref>). Around the same time, the concept of cancer immunosurveillance was described by Burnet and Thomas but could not yet be experimentally proven given the limited understanding of the immune system and the tools available at the time (<xref ref-type="bibr" rid="bib27">Burnet, 1957</xref>; <xref ref-type="bibr" rid="bib55">Dunn et al., 2002</xref>). The field of immunology was then propelled by several seminal discoveries, including the existence of distinct T and B lymphocyte populations (<xref ref-type="bibr" rid="bib43">Cooper et al., 1965</xref>; <xref ref-type="bibr" rid="bib141">Miller et al., 1967</xref>) as well as the concept of major histocompatibility complex (MHC) restriction in T cell-mediated immunity (<xref ref-type="bibr" rid="bib243">Zinkernagel and Doherty, 1974</xref>). Definitive evidence for a role of immune cells in suppressing malignant tumors was provided by the laboratory of Robert Schreiber, who observed that tumors generated in immunodeficient mice could be cleared upon transplantation into immunocompetent animals (<xref ref-type="bibr" rid="bib206">Shankaran et al., 2001</xref>), confirming the existence of cancer immunosurveillance and immunoediting (<xref ref-type="bibr" rid="bib55">Dunn et al., 2002</xref>). These findings led to a renewed interest and confidence in the field of cancer immunotherapy, which would ultimately revolutionize cancer care (see ‘Cancer immunotherapies’ section below).</p><p>CD8<sup>+</sup> T cells play a central role in anti-tumor immune responses by recognizing tumor cell antigens that differ from normal tissue and deploying cytolytic machinery to kill cancer cells directly. However, CD8<sup>+</sup> T cell functions are often suppressed in the context of anti-tumor immunity. One reason for reduced T cell function in this context is the potently immunosuppressive nature of the tumor microenvironment (TME), where inhibitory signaling pathways are activated and immunosuppressive cell populations are present (<xref ref-type="bibr" rid="bib152">Nakamura and Smyth, 2020</xref>). Moreover, extensive research has highlighted the importance of cell-intrinsic metabolic pathways for T cell activation, differentiation, and function (<xref ref-type="bibr" rid="bib26">Buck et al., 2017</xref>). Since the TME is often depleted of nutrients, due to limited blood supply and competition with metabolically active tumor cells, nutrient unavailability provides another layer of immunosuppression (<xref ref-type="bibr" rid="bib120">Lim et al., 2020</xref>).</p><p>In addition to local factors, the macroenvironment in which anti-tumor T cell responses take place also warrants consideration. Interestingly, aging and obesity both induce metabolic (e.g. insulin resistance) and immunologic (e.g. chronic inflammation) systemic alterations (<xref ref-type="bibr" rid="bib81">Hotamisligil, 2017</xref>; <xref ref-type="bibr" rid="bib122">López-Otín et al., 2013</xref>). However, how these organism-level changes are reflected in the TME and impact the anti-tumor immune response both systemically and locally are incompletely understood. Given that average age and obesity prevalence are rising in many parts of the world, a better understanding of these mechanisms is important to inform therapeutic strategies aiming to enhance the anti-tumor immune response in patients of any age and body composition. Here, we review the current knowledge of the shared and distinct effects of age, obesity, and various forms of dietary restriction on anti-tumor T cell responses with an emphasis on the metabolic pathways involved and the CD8<sup>+</sup> T cell compartment. For each of these conditions, we will address alterations in (1) the anti-tumor T cell response, (2) metabolism and signaling, (3) TME-specific immunosuppression, and (4) cancer immunotherapy responsiveness.</p><sec id="s1-1"><title>Anti-tumor T cell responses</title><p>T lymphocytes are a part of the adaptive immune system, which is characterized by the ability to mount immune responses that are highly specific to certain antigens and result in the formation of immunological memory (<xref ref-type="bibr" rid="bib34">Chaplin, 2010</xref>). To facilitate the recognition of any pathogenic antigen, T cells are endowed with unique antigen receptors known as T cell receptors (TCRs). Since TCRs recognize antigenic peptides in the context of MHC molecules, they rely on other cells to take up, process, and present antigens to them. To facilitate the interaction of the TCR with peptide-MHC complexes, T cells express a coreceptor, CD8 or CD4, which binds to MHC class I (MHC-I) or MHC class II (MHC-II) respectively (<xref ref-type="bibr" rid="bib194">Rossjohn et al., 2015</xref>).</p><p>Naïve CD8<sup>+</sup> and CD4<sup>+</sup> T cells are generated from bone marrow-derived progenitor cells in the thymus and circulate through secondary lymphoid organs in the body, such as lymph nodes and spleen, until they encounter their cognate antigen. For initial T cell activation, an antigen needs to be presented by a professional antigen-presenting cell (APC), usually a cell of the myeloid lineage like a dendritic cell or macrophage, in the context of the appropriate costimulatory signals, most importantly ligation of the costimulatory receptor CD28 (<xref ref-type="bibr" rid="bib59">Esensten et al., 2016</xref>; <xref ref-type="bibr" rid="bib171">Pennock et al., 2013</xref>). Upon activation, a T cell undergoes clonal expansion, differentiates into an effector cell, and migrates toward the relevant peripheral tissue, for example a site of infection or a tumor (<xref ref-type="bibr" rid="bib211">Smith-Garvin et al., 2009</xref>). Cytotoxic effector CD8<sup>+</sup> T cells can directly kill cells that present their cognate antigen through cytotoxic molecules, like granzyme B (GzmB) and perforin, and also secrete pro-inflammatory cytokines, like interferon (IFN)-γ and tumor necrosis factor (TNF)-α (<xref ref-type="bibr" rid="bib62">Farhood et al., 2019</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>). CD8<sup>+</sup> T cells therefore play a central role in the effectuation of immune responses against intracellular pathogens and cancer. Activated CD4<sup>+</sup> T cells take on more diverse roles. Conventional CD4<sup>+</sup> T cells (Tconvs) can differentiate into various types of immune helper T cells that support an immune response. A distinct lineage of CD4<sup>+</sup> T cells, so-called regulatory T cells (Tregs), suppresses immune responses and is important for preventing autoimmunity (<xref ref-type="bibr" rid="bib224">van der Vliet and Nieuwenhuis, 2007</xref>). After a successful immune response, most effector T cells undergo apoptosis, while some remain as memory T cells, which are poised to be reactivated more quickly than naïve T cells (<xref ref-type="bibr" rid="bib171">Pennock et al., 2013</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>CD8<sup>+</sup> T cells are key effectors of the anti-tumor immune response.</title><p>Naïve CD8<sup>+</sup> T cells circulate through the body, until their cognate antigen is presented to them by an antigen-presenting cell, for example a dendritic cell, in a secondary lymphoid organ, for example a lymph node. T cells then become activated, proliferate, differentiate, and migrate to the tumor. Upon entering the TME, they can mediate an effective anti-tumor response through direct cytolytic activity, mediated by perforin and granzymes, and the secretion of cytokines like IFNγ and TNFα. IFNγ, interferon γ. MHC-I, major histocompatibility complex I. TCR, T cell receptor. TME, tumor microenvironment. TNFα, tumor necrosis factor α.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62420-fig1-v2.tif"/></fig><p>In addition to the TCR and costimulatory receptors such as CD28, which promote T cell activation, T cells also express co-inhibitory receptors, including cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed death-1 (PD-1). Inhibitory signaling through these receptors is important to maintain tolerance to self-antigens and for the resolution of immune responses (<xref ref-type="bibr" rid="bib156">Nishimura et al., 1999</xref>; <xref ref-type="bibr" rid="bib218">Tivol et al., 1995</xref>). However, enhanced expression of co-inhibitory receptors develops when T cells are exposed to persistent antigen stimulation (e.g. during chronic viral infection or in tumors) and correlates with an exhausted, dysfunctional state in T cells (<xref ref-type="bibr" rid="bib10">Barber et al., 2006</xref>; <xref ref-type="bibr" rid="bib19">Blackburn et al., 2009</xref>). Moreover, tumor cells and other cell populations in the TME suppress T cell function by expressing ligands of these receptors, such as PD-L1 (<xref ref-type="bibr" rid="bib54">Dong et al., 2002</xref>).</p><p>Several other immune cell types can also play important roles in anti-tumor immunity. Natural killer (NK) lymphocytes, like CD8<sup>+</sup> T cells, can acquire a cytotoxic phenotype and kill cancer cells (<xref ref-type="bibr" rid="bib144">Miller and Lanier, 2019</xref>). Some myeloid cells in the TME can promote the anti-tumor immune response, for example macrophages with a pro-inflammatory phenotype often referred to as ‘M1’, but many tumor-associated macrophages have an ‘M2’-like phenotype and have pro-tumor effects, including suppression of anti-tumor immunity (<xref ref-type="bibr" rid="bib242">Zhou et al., 2020</xref>). Importantly, the M1 and M2 designations do not describe distinct populations, but rather reflect opposite ends of the wide spectrum of functional states that macrophages can assume (<xref ref-type="bibr" rid="bib150">Murray, 2017</xref>). Additionally, myeloid-derived suppressor cells (MDSCs), a heterogenous population of immature myeloid cells, inhibit T cell function in the TME through a variety of mechanisms, including depletion of extracellular arginine, expression of PD-L1, and recruitment of Tregs (<xref ref-type="bibr" rid="bib106">Kumar et al., 2016</xref>).</p></sec><sec id="s1-2"><title>Anti-tumor T cell responses with aging</title><p>Aging negatively impacts CD8<sup>+</sup> T cell immunity, in cancer and other contexts, through a combination of T cell-intrinsic and -extrinsic mechanisms. First, the generation of new naïve T cells declines with age, as the thymus involutes and produces fewer naïve CD4<sup>+</sup> and CD8<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib8">Bains et al., 2009</xref>). Maintenance of the naïve T cell pool, both in terms of numbers and TCR diversity, thus becomes dependent on homeostatic proliferation of existing T cells, which leads to a reduction in naïve T cell numbers, especially of CD8<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib71">Goronzy and Weyand, 2019</xref>). In addition, aging-associated adipocyte accumulation in the bone marrow also contributes to reduced hematopoiesis with age (<xref ref-type="bibr" rid="bib3">Ambrosi et al., 2017</xref>), and hematopoiesis becomes skewed toward myeloid and away from lymphoid lineages with age (<xref ref-type="bibr" rid="bib13">Beerman et al., 2010</xref>).</p><p>While the number of naïve T cells decreases with age, there are increased numbers of circulating T cells that express markers of antigen experience, for example CD45RO in humans or CD44 in mice (<xref ref-type="bibr" rid="bib108">Lages et al., 2010</xref>; <xref ref-type="bibr" rid="bib116">Li et al., 2019</xref>). Adoptive transfer experiments in mice have shown that these cells are dysfunctional (<xref ref-type="bibr" rid="bib48">Decman et al., 2010</xref>). Some antigen-experienced cells express co-inhibitory receptors, including PD-1, and have been likened to exhausted T cells (<xref ref-type="bibr" rid="bib49">Decman et al., 2012</xref>; <xref ref-type="bibr" rid="bib108">Lages et al., 2010</xref>), whereas others are virtual memory T cells (Tvm), which develop from naïve T cells without full antigenic stimulation, and display some features of cellular senescence – an aging-associated phenotype of growth arrest (<xref ref-type="bibr" rid="bib37">Chiu et al., 2013</xref>; <xref ref-type="bibr" rid="bib180">Quinn et al., 2018</xref>; <xref ref-type="bibr" rid="bib186">Renkema et al., 2014</xref>). However, although Tvm cells display a strongly reduced proliferation capacity, especially after TCR stimulation, they can still proliferate after stimulation with interleukin (IL)−15 (<xref ref-type="bibr" rid="bib180">Quinn et al., 2018</xref>; <xref ref-type="bibr" rid="bib186">Renkema et al., 2014</xref>), and thus do not have the irreversible cell cycle block that is characteristic of true cellular senescence (<xref ref-type="bibr" rid="bib71">Goronzy and Weyand, 2019</xref>). In humans the number of T effector memory CD45RA (T<sub>EMRA</sub>) cells increases with age (<xref ref-type="bibr" rid="bib180">Quinn et al., 2018</xref>). T<sub>EMRA</sub> cells develop upon viral infections and display some, but not all, properties of cellular senescence (<xref ref-type="bibr" rid="bib71">Goronzy and Weyand, 2019</xref>). Finally, a loss of the co-stimulatory receptor CD28, which is essential for normal T cell activation, has been observed on CD8<sup>+</sup> T cells during aging (<xref ref-type="bibr" rid="bib108">Lages et al., 2010</xref>), and CD8<sup>+</sup> CD28<sup>–</sup> T cells may even play an immunosuppressive role in tumors (<xref ref-type="bibr" rid="bib65">Filaci et al., 2007</xref>).</p><p>T cells rely on antigen-presenting cells, especially dendritic cells, to display antigens and provide costimulatory signals to drive T cell activation in secondary lymphoid organs. In addition to the described changes in the T cell compartment itself, dendritic cells also have reduced functionality with aging, including in the context of murine cancer models (<xref ref-type="bibr" rid="bib75">Grolleau-Julius et al., 2008</xref>; <xref ref-type="bibr" rid="bib74">Grolleau-Julius et al., 2006</xref>). Overall, a reduction in the naïve CD8<sup>+</sup> T cell compartment, the existence of multiple dysfunctional T cell populations and reduced antigen presentation by dendritic cells likely all contribute to reduced T cell-mediated immunity in aging (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Systemic changes in the immune system with aging, obesity, and dietary restriction.</title><p>T cell progenitors arise in the bone marrow and travel to the thymus where they develop into mature naïve T lymphocytes. Naïve T cells circulate through the bloodstream and secondary lymphoid organs. Systemic conditions like aging, obesity, and dietary restriction affect the immune system at each of these levels, impacting both anti-tumor and other immune responses. Aging- and obesity-associated changes lead to reduced T cell immunity, while dietary restriction-associated changes promote T cell responses. CLP, common lymphoid progenitor. SLO, secondary lymphoid organs. TCR, T cell receptor.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62420-fig2-v2.tif"/></fig><p>Few studies have analyzed the anti-tumor T cell response without any immune-boosting therapies in aged animals, but the existing studies predominantly show reduced T cell function in this context. For example, anti-tumor T cell responses are decreased with age in a mouse model of oral cancer, and this is accompanied by increased numbers of MDSCs (<xref ref-type="bibr" rid="bib205">Sekido et al., 2019</xref>). Similarly, MDSCs inhibit anti-tumor T cell function with age in a murine breast cancer model (<xref ref-type="bibr" rid="bib73">Grizzle et al., 2007</xref>). Defects in anti-tumor CD8<sup>+</sup> T cell responses were also observed in a hematological cancer model as well as a mesothelioma model (<xref ref-type="bibr" rid="bib91">Jackaman et al., 2019</xref>; <xref ref-type="bibr" rid="bib125">Lustgarten et al., 2004</xref>). Paradoxically, one study found that the growth of several tumor types was slower in aged mice, and this difference in growth rate was CD8<sup>+</sup> T cell-dependent (<xref ref-type="bibr" rid="bib163">Oh et al., 2018</xref>). It is not clear what explains this discrepancy, but differences in experimental setup (e.g. mouse strain, tumor model, duration of aging) and environmental factors (e.g. microbiome) between studies could play a role. More research carefully examining the anti-tumor immune response in aged animals and humans is thus needed. At this point, most of the available evidence points toward a reduction of anti-tumor immunity with advanced age.</p></sec><sec id="s1-3"><title>Anti-tumor T cell responses with obesity</title><p>In addition to other systemic changes, including metabolic alterations and inflammation, obesity has been associated with reduced immune function (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Some of the mechanisms impairing systemic CD8<sup>+</sup> T cell function with age are promoted by obesity. For example, diet-induced obesity accelerates the age-associated decline of thymic function, resulting in reduced output of naïve T cells and TCR diversity (<xref ref-type="bibr" rid="bib238">Yang et al., 2009b</xref>). Just like aging, diet-induced obesity induces the accumulation of adipocytes in the bone marrow (<xref ref-type="bibr" rid="bib3">Ambrosi et al., 2017</xref>), which impairs hematopoiesis (<xref ref-type="bibr" rid="bib153">Naveiras et al., 2009</xref>). Secondary lymphoid organ function is also affected by obesity: lymphatic transport, dendritic cell migration, and lymph node structure are reduced (<xref ref-type="bibr" rid="bib233">Weitman et al., 2013</xref>), and murine dendritic cells stimulate T cell responses less effectively in obesity (<xref ref-type="bibr" rid="bib93">James et al., 2012</xref>; <xref ref-type="bibr" rid="bib133">Mauro et al., 2017</xref>). In addition, the prevalence of dysfunctional T cell populations is increased in obesity (<xref ref-type="bibr" rid="bib209">Shirakawa et al., 2016</xref>; <xref ref-type="bibr" rid="bib212">Spielmann et al., 2014</xref>; <xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>) and higher frequencies of T cells expressing markers of antigen experience are present in the circulation of obese humans and animals (<xref ref-type="bibr" rid="bib133">Mauro et al., 2017</xref>; <xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>), similar to aged individuals. Despite these challenges, effective antigen-specific CD8<sup>+</sup> T cell responses can be generated in obesity in certain contexts, such as infection of mice with lymphocytic choriomeningitis virus (LCMV) (<xref ref-type="bibr" rid="bib100">Khan et al., 2014</xref>). Thus, disease context is a factor that affects CD8<sup>+</sup> T cell-intrinsic function with obesity.</p><p>Recent studies have demonstrated that CD8<sup>+</sup> T cell responses are impaired in the context of cancer with obesity. The growth of syngeneic subcutaneous B16 melanoma, 4T1 breast, and 3LL lung carcinoma tumors is accelerated in C57BL/6 mice fed a high-fat diet (HFD) for 4–5 months (<xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>). This is associated with a dysfunctional CD8<sup>+</sup> T cell phenotype, characterized by enhanced expression of co-inhibitory receptors and reduced expression of cytokines and the proliferation marker Ki-67. Although the interpretation of co-inhibitory receptor expression can be complicated, given that these receptors can be upregulated following T cell activation as well as during T cell exhaustion, the decreased expression of cytokines and Ki-67 points to a dysfunctional state. This defect is CD8<sup>+</sup> T cell-intrinsic, as it is also present with ex vivo T cell activation. Another study also found a reduced anti-tumor CD8<sup>+</sup> T cell response with diet-induced obesity in a murine breast cancer model (<xref ref-type="bibr" rid="bib241">Zhang et al., 2020</xref>). There is some evidence, albeit limited, to suggest that the anti-tumor immune response is reduced in obese human patients with cancer. For example, reduced T cell infiltration was described in obese colorectal cancer patients, and increased expression of markers of T cell exhaustion, including co-inhibitory receptor PD-1, was seen in tumor-infiltrating T cells in obese melanoma patients (<xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>).</p></sec><sec id="s1-4"><title>Anti-tumor T cell responses with dietary restriction</title><p>Dietary restriction has long been suggested to enhance anti-tumor immune function (<xref ref-type="bibr" rid="bib63">Fernandes et al., 1976</xref>), and this may occur through both systemic and tumor-specific mechanisms. Dietary restriction encompasses various interventions, ranging from a reduction of caloric intake, for example by starvation or a fasting-mimicking diet (FMD), to a diet lacking in specific components, such as a low-protein diet (<xref ref-type="bibr" rid="bib97">Katewa and Kapahi, 2010</xref>), or intermittent fasting (<xref ref-type="bibr" rid="bib46">de Cabo and Mattson, 2019</xref>). Some of the metabolic consequences of dietary restriction can be induced pharmacologically by agents known as caloric restriction mimetics (CRMs). It is important to distinguish relatively mild dietary restriction regimens often used in studies of anti-tumor immunity from severely reduced dietary intake leading to malnutrition and lack of necessary nutrients. Malnutrition negatively impacts the immune system, including CD8<sup>+</sup> T cells, in both animals and humans (<xref ref-type="bibr" rid="bib89">Iyer et al., 2012</xref>; <xref ref-type="bibr" rid="bib199">Rytter et al., 2014</xref>; <xref ref-type="bibr" rid="bib216">Taylor et al., 2013</xref>).</p><p>Dietary restriction may improve T cell responses through several systemic mechanisms and can delay or prevent the decline in T cell immunity induced by aging (<xref ref-type="fig" rid="fig2">Figure 2</xref>). First, age-induced thymic involution can be decreased by long-term dietary restriction, thereby enhancing thymic output in aged mice (<xref ref-type="bibr" rid="bib237">Yang et al., 2009a</xref>). Second, feeding of a calorically restricted diet for 13 to 18 years leads to preservation of T cell functions with age in non-human primates, in addition to increased naïve T cell numbers and TCR repertoire (<xref ref-type="bibr" rid="bib137">Messaoudi et al., 2006</xref>). Finally, dietary restriction induces a reduction of memory T cells in secondary lymphoid organs and circulation but an accumulation in the bone marrow, resulting in increased protection from both infectious and tumor challenges (<xref ref-type="bibr" rid="bib41">Collins et al., 2019</xref>).</p><p>In addition to systemic effects on T cell immunity in general, anti-tumor immunity is specifically improved with dietary restriction. For example, a short-term (48 hr) fast enhances the efficacy of chemotherapy in the murine fibrosarcoma model MCA205 in a T cell-dependent manner (<xref ref-type="bibr" rid="bib172">Pietrocola et al., 2016</xref>). CRMs, including ATP citrate lyase inhibitor hydroxycitrate, reduce tumor growth in chemotherapy-treated mice similarly to short-term fasting, in a manner dependent on CD8<sup>+</sup> T cells. These effects extend to murine breast, colorectal and lung cancer models (<xref ref-type="bibr" rid="bib172">Pietrocola et al., 2016</xref>). Notably, there is little to no effect of fasting or CRM alone in this setting, implying that cell death induced by chemotherapy is needed to induce the anti-tumor immune response, which can then be boosted by dietary restriction. Another study demonstrated similar findings with the 4T1 breast cancer and B16 melanoma models, using a low calorie FMD in combination with chemotherapy (<xref ref-type="bibr" rid="bib52">Di Biase et al., 2016</xref>). However, in contrast to the Pietrocola et al. study, they observed a significant benefit of FMD alone as well, albeit less pronounced than in combination with chemotherapy. Systemically, the numbers of common lymphoid progenitors (CLPs) in the bone marrow as well as circulating CD8<sup>+</sup> T cells are increased by FMD (<xref ref-type="bibr" rid="bib52">Di Biase et al., 2016</xref>). Another CRM, glycolysis inhibitor 2-deoxyglucose (2-DG), also promotes an anti-tumor T cell response in combination with chemotherapy, although this is likely primarily caused by an effect on the tumor cells themselves, since the combination of 2-DG and chemotherapy also enhances tumor cell death in vitro (<xref ref-type="bibr" rid="bib16">Bénéteau et al., 2012</xref>). The fact that CRMs can replicate the benefits of dietary restriction suggests that the therapeutic targeting of these pathways to promote anti-tumor immunity may be feasible.</p><p>Finally, reducing dietary protein may also enhance anti-tumor immunity. Rubio-Patiño et al. found that a low-protein diet reduced tumor progression in murine lymphoma, colorectal adenocarcinoma and melanoma models in a CD8<sup>+</sup> T cell-dependent manner (<xref ref-type="bibr" rid="bib196">Rubio-Patiño et al., 2018</xref>). Restriction of specific amino acids may also impact anti-tumor immunity. For example, dietary methionine restriction, which promotes lifespan and metabolic health in mice (<xref ref-type="bibr" rid="bib1">Ables et al., 2012</xref>; <xref ref-type="bibr" rid="bib142">Miller et al., 2005</xref>), can have anti-cancer effects (<xref ref-type="bibr" rid="bib68">Gao et al., 2019</xref>; <xref ref-type="bibr" rid="bib228">Wanders et al., 2020</xref>) and impacts helper T cell responses (<xref ref-type="bibr" rid="bib231">Wang et al., 2020</xref>). Accordingly, a shift in macrophage polarization accompanied by increased intratumoral CD8<sup>+</sup> T cell numbers and GzmB expression occurs in mice fed a methionine-restricted diet (<xref ref-type="bibr" rid="bib164">Orillion et al., 2018</xref>). The extent to which reduced intake of particular amino acids may affect the anti-tumor T cell response is an interesting topic for future investigations.</p></sec><sec id="s1-5"><title>Metabolism and signaling</title><p>Metabolism plays crucial roles in regulating T cell activation, differentiation, and function (<xref ref-type="bibr" rid="bib26">Buck et al., 2017</xref>; <xref ref-type="bibr" rid="bib120">Lim et al., 2020</xref>; <xref ref-type="bibr" rid="bib162">O'Sullivan et al., 2019</xref>). When naïve T cells are activated by ligation of the TCR and costimulatory signals, they initiate a phase of rapid growth, differentiation, and proliferation (<xref ref-type="bibr" rid="bib211">Smith-Garvin et al., 2009</xref>). This transition is accompanied by a switch from a quiescent metabolic state, characterized by mostly oxidative metabolism, to a highly metabolically active state, characterized by the use of anabolic pathways such as anaerobic glycolysis, glutaminolysis, and one-carbon metabolism (<xref ref-type="bibr" rid="bib31">Chang et al., 2013</xref>; <xref ref-type="bibr" rid="bib80">Ho et al., 2015</xref>; <xref ref-type="bibr" rid="bib190">Ron-Harel et al., 2016</xref>; <xref ref-type="bibr" rid="bib229">Wang et al., 2011</xref>). These pathways not only provide the molecules necessary for cell growth and proliferation, but also support activation and differentiation in different ways. For example, glycolysis directly impacts translation of IFN-γ mRNA (<xref ref-type="bibr" rid="bib31">Chang et al., 2013</xref>), calcium signaling (<xref ref-type="bibr" rid="bib80">Ho et al., 2015</xref>) and epigenetic state (<xref ref-type="bibr" rid="bib170">Peng et al., 2016</xref>) in activated T cells.</p><p>In contrast to effector T cells, memory T cells and Tregs rely on oxidative metabolic pathways, including fatty acid oxidation (FAO) (<xref ref-type="bibr" rid="bib138">Michalek et al., 2011</xref>; <xref ref-type="bibr" rid="bib169">Pearce et al., 2009</xref>; <xref ref-type="bibr" rid="bib225">van der Windt et al., 2012</xref>). In many cases, manipulating metabolism is sufficient to change the differentiation of T cells toward distinct phenotypes, indicating that certain metabolic pathways lie upstream of fate decisions in T cells (<xref ref-type="bibr" rid="bib25">Buck et al., 2016</xref>; <xref ref-type="bibr" rid="bib138">Michalek et al., 2011</xref>; <xref ref-type="bibr" rid="bib169">Pearce et al., 2009</xref>; <xref ref-type="bibr" rid="bib174">Pollizzi et al., 2016</xref>; <xref ref-type="bibr" rid="bib226">Verbist et al., 2016</xref>).</p><p>Several transcription factors and nutrient-sensitive signaling pathways coordinate the metabolic profiles of distinct T cell subsets. The anabolic metabolic program characteristic of effector T cells is orchestrated by mammalian target of rapamycin (mTOR), Myc, and hypoxia-inducible factor (HIF)−1α, which are engaged during T cell activation (<xref ref-type="bibr" rid="bib175">Pollizzi and Powell, 2014</xref>). In contrast, memory T cell metabolism is promoted by AMP-activated protein kinase (AMPK) – a nutrient sensor that is activated during low energy conditions and opposes signaling through mTOR, which is activated by high nutrient levels (<xref ref-type="bibr" rid="bib175">Pollizzi and Powell, 2014</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>). Accordingly, memory T cell generation is promoted by metformin-induced AMPK activation as well as rapamycin-mediated mTOR inhibition (<xref ref-type="bibr" rid="bib6">Araki et al., 2009</xref>; <xref ref-type="bibr" rid="bib169">Pearce et al., 2009</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The balance between mTOR and AMPK signaling impacts anti-tumor immunity.</title><p>High nutrient states induce mTOR signaling, which promotes anabolic metabolism and reduces lifespan. Conversely, low energy states induce AMPK signaling, which promotes oxidative metabolism and extends lifespan. While mTOR signaling is important for effector T cell responses, there is evidence to suggest that memory T cell-like oxidative metabolism may be more beneficial for the anti-tumor T cell response. Since mTOR signaling is enhanced with obesity while AMPK signaling is promoted by dietary restriction, altering the mTOR-AMPK balance may one way by which systemic metabolic state can affect CD8<sup>+</sup> T cell function in cancer. AMPK, AMP-activated protein kinase. mTOR, mammalian target of rapamycin.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62420-fig3-v2.tif"/></fig><p>Although effector T cell responses have predominantly been associated with a shift toward anabolic metabolic pathways, a more oxidative metabolic profile may be beneficial for T cell survival and functionality in the context of a nutrient-depleted TME (see section on ‘Immune regulation in the tumor microenvironment’). Various interventions that promote oxidative, mitochondrial metabolic pathways in T cells enhance their anti-tumor function, for example promoting mitochondrial fusion, enhancing mitochondrial biogenesis, supplementing arginine, inducing fatty acid metabolism, and inhibiting glutamine metabolism (<xref ref-type="bibr" rid="bib25">Buck et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Chowdhury et al., 2018</xref>; <xref ref-type="bibr" rid="bib69">Geiger et al., 2016</xref>; <xref ref-type="bibr" rid="bib114">Leone et al., 2019</xref>; <xref ref-type="bibr" rid="bib203">Scharping et al., 2016</xref>; <xref ref-type="bibr" rid="bib240">Zhang et al., 2017</xref>).</p><p>Since the nutrient sensors mTOR and AMPK are affected by systemic metabolic state, an interesting question is how the balance between mTOR- and AMPK-mediated metabolism may impact anti-tumor T cell function downstream of systemic metabolism. While mTOR and AMPK are generally activated in different energy conditions, both signaling pathways are engaged during T cell activation (<xref ref-type="bibr" rid="bib175">Pollizzi and Powell, 2014</xref>). Given the importance of mTOR signaling in T cell activation and acquisition of effector functions, the mTOR inhibitor rapamycin is generally viewed as immunosuppressive, and mTOR signaling has indeed been shown to support anti-tumor T cell responses (<xref ref-type="bibr" rid="bib33">Chaoul et al., 2015</xref>; <xref ref-type="bibr" rid="bib173">Pollizzi et al., 2015</xref>). However, rapamycin can also promote anti-tumor immunity in certain contexts, such as the MOC1 oral cancer model (<xref ref-type="bibr" rid="bib28">Cash et al., 2015</xref>; <xref ref-type="bibr" rid="bib147">Moore et al., 2016</xref>). On the other hand, T cell-intrinsic AMPK signaling is also required for T cell responses, including anti-tumor immunity, by promoting metabolic fitness and survival (<xref ref-type="bibr" rid="bib20">Blagih et al., 2015</xref>; <xref ref-type="bibr" rid="bib183">Rao et al., 2015</xref>), which may be of particular relevance in the context of a nutrient-depleted TME. Indeed, the AMPK activator metformin promotes anti-tumor T cell responses through several mechanisms, including AMPK activation in T cells (<xref ref-type="bibr" rid="bib58">Eikawa et al., 2015</xref>), AMPK-dependent degradation of inhibitory ligand PD-L1 (<xref ref-type="bibr" rid="bib30">Cha et al., 2018</xref>), and reduced oxygen consumption in tumor cells, likely resulting from AMPK-independent inhibition of the electron transport chain by metformin (<xref ref-type="bibr" rid="bib204">Scharping et al., 2017</xref>). These findings show that the net result of the balance between effector function-promoting mTOR and metabolic fitness-promoting AMPK is context-dependent and can affect CD8<sup>+</sup> T cell function both directly through T cell-intrinsic metabolic effects and indirectly through other cell types. Cellular nutrient sensors like mTOR and AMPK thus provide an example of how organismal metabolic state may interact with cellular metabolism and T cell function.</p></sec><sec id="s1-6"><title>Metabolism and signaling with aging</title><p>Aging is a process characterized by widespread metabolic and signaling changes impacting many of the pathways highlighted above (<xref ref-type="bibr" rid="bib11">Barzilai et al., 2012</xref>), which may affect anti-tumor T cell responses. Specific metabolic changes considered hallmarks of aging are mitochondrial dysfunction and dysregulation of nutrient sensing (<xref ref-type="bibr" rid="bib122">López-Otín et al., 2013</xref>). Underscoring the importance of metabolism in regulating lifespan and aging, inhibition of insulin, insulin-like growth factor (IGF)−1, or mTOR signaling increases lifespan, and so does enhancing AMPK signaling (<xref ref-type="bibr" rid="bib123">López-Otín et al., 2016</xref>; <xref ref-type="bibr" rid="bib122">López-Otín et al., 2013</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>). mTOR signaling also impacts immunity in aging: inhibition of mTOR signaling improves hematopoiesis in aged mice as well as immune function in the contexts of vaccination and infection in elderly humans (<xref ref-type="bibr" rid="bib36">Chen et al., 2009</xref>; <xref ref-type="bibr" rid="bib129">Mannick et al., 2018</xref>; <xref ref-type="bibr" rid="bib128">Mannick et al., 2014</xref>). Systemic inflammation is similarly associated with aging – often referred to as ‘inflammaging’ (<xref ref-type="bibr" rid="bib122">López-Otín et al., 2013</xref>), and this contributes to aging-related decline, as evidenced for example by the observation that inhibition of pro-inflammatory NF-κB signaling can reduce aging phenotypes (<xref ref-type="bibr" rid="bib217">Tilstra et al., 2012</xref>). Interestingly, recent research demonstrated that T cells may contribute to age-related inflammation and its metabolic complications, such as hyperglycemia (<xref ref-type="bibr" rid="bib18">Bharath et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Desdín-Micó et al., 2020</xref>; <xref ref-type="bibr" rid="bib113">Lee et al., 2019</xref>), and engineered T cells can prevent pathology by clearing senescent cells (<xref ref-type="bibr" rid="bib4">Amor et al., 2020</xref>). However, here we will focus on the inverse relationship: how do systemic changes associated with aging impact T cell responses, particularly in the context of cancer?</p><p>Cellular metabolic changes contribute to age-associated T cell dysfunction (<xref ref-type="bibr" rid="bib181">Quinn et al., 2019</xref>; <xref ref-type="bibr" rid="bib189">Ron-Harel et al., 2015</xref>). For example, aged T cells are characterized by mitochondrial dysfunction (<xref ref-type="bibr" rid="bib191">Ron-Harel et al., 2018</xref>). This results in defective respiratory capacity and one-carbon metabolism, and supplementation with one-carbon metabolites, like formate and glycine, can improve aged T cell activation and survival (<xref ref-type="bibr" rid="bib191">Ron-Harel et al., 2018</xref>). Both mitochondrial dysfunction and autophagy contribute to inflammatory phenotypes in aged T cells, and this can be improved by the AMPK activator metformin (<xref ref-type="bibr" rid="bib18">Bharath et al., 2020</xref>). Mitogen-activated protein kinase (MAPK) signaling, through complex formation with a class of stress response proteins known as sestrins, directly contribute to aged T cell dysfunction (<xref ref-type="bibr" rid="bib109">Lanna et al., 2017</xref>). It should be noted that the aforementioned studies were conducted in CD4<sup>+</sup> T cells, and the effects in CD8<sup>+</sup> T cells could thus be different, although signs of mitochondrial dysfunction have been seen in aged human CD8<sup>+</sup> T cells as well (<xref ref-type="bibr" rid="bib148">Moskowitz et al., 2017</xref>).</p><p>In some cases, different T cell subsets can display distinct metabolic phenotypes with age. For example, aged CD8<sup>+</sup> Tvm cell were recently shown to have enhanced respiratory capacity despite being dysfunctional (<xref ref-type="bibr" rid="bib182">Quinn et al., 2020</xref>). Furthermore, aged memory CD8<sup>+</sup> T cells may have increased mTOR activity and glycolysis well as a reduced ability to engage in autophagy (<xref ref-type="bibr" rid="bib45">Davenport et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Henson et al., 2014</xref>), while newly activated aged CD4<sup>+</sup> T cells fail to induce glycolysis as robustly as younger counterparts (<xref ref-type="bibr" rid="bib191">Ron-Harel et al., 2018</xref>). Thus, while the exact metabolic properties of distinct T cell subsets in aging need to be further delineated, there is substantial evidence that metabolic dysregulation contributes to T cell dysfunction in aging.</p></sec><sec id="s1-7"><title>Metabolism and signaling with obesity</title><p>Like aging, obesity is characterized by profound systemic changes in both humans and animal models, including insulin resistance, dyslipidemia, and inflammation, collectively leading to the so-called metabolic syndrome (<xref ref-type="bibr" rid="bib11">Barzilai et al., 2012</xref>; <xref ref-type="bibr" rid="bib82">Huang, 2009</xref>). Adipose tissue inflammation plays a key role in the pathophysiology of metabolic syndrome, and adipose tissue secretion of adipokines, such as the satiety regulator leptin, and inflammatory cytokines into the circulation contributes to systemic inflammatory and metabolic dysregulation (<xref ref-type="bibr" rid="bib24">Bremer and Jialal, 2013</xref>). While not the focus of this review, it is noteworthy that T cells also play an important role in the development of adipose tissue inflammation and its systemic sequelae. Specifically, infiltration of CD8<sup>+</sup> and inflammatory CD4<sup>+</sup> T cells into adipose tissue is increased with obesity, while CD4<sup>+</sup> Tregs are reduced, contributing to adipose tissue inflammation and insulin resistance (<xref ref-type="bibr" rid="bib64">Feuerer et al., 2009</xref>; <xref ref-type="bibr" rid="bib157">Nishimura et al., 2009</xref>; <xref ref-type="bibr" rid="bib234">Winer et al., 2009</xref>).</p><p>Obesity and metabolic syndrome are characterized by mTOR activation (<xref ref-type="bibr" rid="bib121">Liu and Sabatini, 2020</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>). mTOR hyperactivation contributes to development of the metabolic syndrome, including insulin resistance, as well as chronic inflammation, for example by promoting inflammatory cytokine secretion by cells of the innate immune system in the liver and adipose tissue (<xref ref-type="bibr" rid="bib95">Jiang et al., 2014</xref>; <xref ref-type="bibr" rid="bib121">Liu and Sabatini, 2020</xref>). In turn, chronic inflammation associated with obesity is thought to promote the dysfunctional T cell states described above (<xref ref-type="bibr" rid="bib209">Shirakawa et al., 2016</xref>; <xref ref-type="bibr" rid="bib212">Spielmann et al., 2014</xref>; <xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>).</p><p>Given the importance of metabolism in regulating T cell fate and function, it is likely that the vast metabolic changes observed with obesity also affect T cell metabolism and function (<xref ref-type="bibr" rid="bib56">Dyck and Lynch, 2018</xref>; <xref ref-type="bibr" rid="bib221">Turbitt et al., 2020</xref>). Indeed, in the context of influenza infection with HFD feeding, C57BL/6 mouse CD8<sup>+</sup> T cells display a shift toward oxidative metabolism accompanied by defective memory T cell responses (<xref ref-type="bibr" rid="bib184">Rebeles et al., 2019</xref>). This finding highlights the complex context-dependent interactions between T cell metabolism, fate, and function, given that oxidative metabolism is generally thought to promote memory T cell development (<xref ref-type="bibr" rid="bib169">Pearce et al., 2009</xref>; <xref ref-type="bibr" rid="bib225">van der Windt et al., 2012</xref>). CD8<sup>+</sup> T cells from obese BALB/c mice have increases in both spare respiratory capacity and glycolytic reserve, indicating a more general metabolic dysfunction (<xref ref-type="bibr" rid="bib221">Turbitt et al., 2020</xref>). These findings contrast with the observed mitochondrial dysfunction in aged CD8<sup>+</sup> T cells.</p><p>Increased circulating levels of the adipokine leptin with diet-induced obesity contribute to the observed dysfunction in CD8<sup>+</sup> T cells in the context of cancer, as leptin receptor-deficient T cells mount a more effective anti-tumor response after adoptive transfer into HFD-fed recipients (<xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>). This is an interesting finding, given that the roles of leptin, while complex and incompletely understood, are predominantly thought to promote T cell responses (<xref ref-type="bibr" rid="bib154">Naylor and Petri, 2016</xref>). For example, leptin promotes proliferation, function, and glycolytic metabolism in CD4<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib70">Gerriets et al., 2016</xref>; <xref ref-type="bibr" rid="bib124">Lord et al., 1998</xref>; <xref ref-type="bibr" rid="bib201">Saucillo et al., 2014</xref>). Leptin also enhances mitochondrial metabolism in CD8<sup>+</sup> T cells, and oncolytic virus-mediated expression of leptin in the TME improved CD8<sup>+ </sup>T cell function in a mouse model of melanoma (<xref ref-type="bibr" rid="bib187">Rivadeneira et al., 2019</xref>). One potential explanation for this discrepancy is that leptin may have different effects in the context of lean compared to obese organisms due to chronic exposure to elevated leptin levels with obesity. This hypothesis is supported by the observations that intratumoral leptin delivery provides no benefit in obese mice, in contrast to controls (<xref ref-type="bibr" rid="bib187">Rivadeneira et al., 2019</xref>), and that neutralization of leptin improves immunotherapy responsiveness in mice with diet-induced obesity (<xref ref-type="bibr" rid="bib149">Murphy et al., 2018</xref>). Further supporting the notion that leptin may reduce CD8<sup>+</sup> T cell anti-tumor function in the context of obesity, a recent study found that leptin contributes to CD8<sup>+</sup> tumor-infiltrating lymphocyte (TIL) dysfunction in a spontaneous breast cancer model (<xref ref-type="bibr" rid="bib241">Zhang et al., 2020</xref>). This occurs through a STAT3-mediated increase in FAO in CD8<sup>+</sup> TILs, suggesting that FAO is harmful for the anti-tumor T cell response. Like for leptin, different studies have yielded opposing results regarding the impact of FAO on CD8<sup>+</sup> TIL functionality. CD8<sup>+</sup> T cells upregulate FAO in oxygen- and glucose-poor environments, like the TME, and promoting FAO through PPARα activation enhances CD8<sup>+</sup> TIL function in melanoma models (<xref ref-type="bibr" rid="bib240">Zhang et al., 2017</xref>) and murine colorectal adenocarcinoma models (<xref ref-type="bibr" rid="bib38">Chowdhury et al., 2018</xref>). In all, the effects of FAO and leptin on anti-tumor CD8<sup>+</sup> T cell function are complex and likely dependent on many environmental factors, and further studies are needed to delineate these.</p><p>In addition to leptin, circulating levels of free fatty acids and cholesterol are increased with obesity, and these too may impact CD8<sup>+</sup> T cell function, although there is currently only circumstantial evidence to support this. Elevated fatty acid levels promote the differentiation of CD4<sup>+</sup> T cells toward an effector-memory-like phenotype in obesity (<xref ref-type="bibr" rid="bib133">Mauro et al., 2017</xref>) and suppress the NK cell-mediated anti-tumor response through the accumulation of intracellular lipids (<xref ref-type="bibr" rid="bib139">Michelet et al., 2018</xref>). Lipid accumulation in the TME of a pancreatic cancer model led to intracellular lipid accumulation in CD8<sup>+</sup> T cells, reducing their functionality (<xref ref-type="bibr" rid="bib130">Manzo et al., 2020</xref>). Enabling the T cells to use these lipids for oxidation restored T cell function. Therefore, how CD8<sup>+</sup> T cells handle the lipids in a particular context, i.e. intracellular accumulation versus use for FAO, may be a factor that determines how environmental lipids affect T cell function. Moreover, the cholesterol content of the cell membrane modulates CD8<sup>+</sup> T cell function in tumors (<xref ref-type="bibr" rid="bib239">Yang et al., 2016</xref>), but it is unclear whether this is significantly impacted by increased cholesterol levels in the circulation with obesity.</p><p>Another metabolic feature often associated with obesity is insulin resistance, which leads to increased plasma levels of both glucose and insulin. Hyperglycemia does not appear to affect CD8<sup>+</sup> T cell function (<xref ref-type="bibr" rid="bib185">Recino et al., 2017</xref>), but the effects of hyperinsulinemia on CD8<sup>+</sup> T cells are not well-understood. T cells do express the insulin receptor and insulin signaling in T cells is required for their metabolic reprogramming upon activation and optimal anti-viral responsiveness (<xref ref-type="bibr" rid="bib66">Fischer et al., 2017</xref>; <xref ref-type="bibr" rid="bib219">Tsai et al., 2018</xref>), suggesting that T cells could be sensitive to systemic alterations in insulin signaling. Moreover, obesity-associated hyperinsulinemia inhibits IL-10-mediated immunosuppression by Tregs (<xref ref-type="bibr" rid="bib77">Han et al., 2014</xref>). Activated T cells from obese human subjects bind less insulin, suggesting reduced expression of the insulin receptor in this condition (<xref ref-type="bibr" rid="bib78">Helderman and Raskin, 1980</xref>). However, the functional consequences of obesity-associated alterations in insulin signaling on the anti-tumor CD8<sup>+</sup> T cell response are currently unknown.</p></sec><sec id="s1-8"><title>Metabolism and signaling with dietary restriction</title><p>The biological effects of dietary restriction are in many ways, perhaps expectedly, opposite to those seen in obesity. Although human data are scarcer for dietary restriction than obesity, animal studies have suggested that dietary restriction may provide widespread benefits, including protection from various pathologies and increased lifespan (<xref ref-type="bibr" rid="bib67">Fontana and Partridge, 2015</xref>; <xref ref-type="bibr" rid="bib123">López-Otín et al., 2016</xref>; <xref ref-type="bibr" rid="bib132">Mattison et al., 2017</xref>; <xref ref-type="bibr" rid="bib135">McCay et al., 1935</xref>). Dietary restriction also reduces cancer incidence in animal studies (<xref ref-type="bibr" rid="bib42">Colman et al., 2009</xref>; <xref ref-type="bibr" rid="bib140">Michels and Ekbom, 2004</xref>; <xref ref-type="bibr" rid="bib193">Ross and Bras, 1965</xref>; <xref ref-type="bibr" rid="bib195">Rous, 1914</xref>; <xref ref-type="bibr" rid="bib232">Weindruch and Walford, 1982</xref>) and may improve the efficacy of cancer therapies, including chemotherapy, radiotherapy and targeted therapies (<xref ref-type="bibr" rid="bib103">Kopeina et al., 2017</xref>; <xref ref-type="bibr" rid="bib160">O'Flanagan et al., 2017</xref>).</p><p>Prominent systemic metabolic consequences of dietary restriction include activation of AMPK and PPARα signaling as well as a reduction of mTOR signaling, due to low insulin, IGF-1 and glucose levels, together resulting in an increase in catabolic and mitochondrial metabolism (<xref ref-type="bibr" rid="bib103">Kopeina et al., 2017</xref>; <xref ref-type="bibr" rid="bib131">Martin-Montalvo and de Cabo, 2013</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>). These metabolic changes are important, as reduced IGF-1 levels contribute to the anti-cancer effects of caloric restriction in mice (<xref ref-type="bibr" rid="bib158">Nogueira et al., 2012</xref>). AMPK-mediated metabolism also counteracts inflammatory pathways, thus dampening age-related systemic inflammation and its consequences (<xref ref-type="bibr" rid="bib161">O'Neill and Hardie, 2013</xref>).</p><p>As described above, effector T cell responses are associated with mTOR-mediated anabolic metabolism, whereas memory T cell development is supported by AMPK-promoted oxidative pathways. However, in many instances, interventions that induce oxidative, mitochondrial metabolism result in enhanced anti-tumor T cell function (<xref ref-type="bibr" rid="bib25">Buck et al., 2016</xref>; <xref ref-type="bibr" rid="bib69">Geiger et al., 2016</xref>; <xref ref-type="bibr" rid="bib114">Leone et al., 2019</xref>; <xref ref-type="bibr" rid="bib203">Scharping et al., 2016</xref>), and AMPK signaling can promote anti-tumor immunity (<xref ref-type="bibr" rid="bib30">Cha et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Eikawa et al., 2015</xref>; <xref ref-type="bibr" rid="bib183">Rao et al., 2015</xref>). Dietary restriction also induces sirtuin 1 activity (<xref ref-type="bibr" rid="bib40">Cohen et al., 2004</xref>), which can support anti-tumor function in CD4<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib35">Chatterjee et al., 2018</xref>). Effector and memory T cell subsets may respond differently to such systemic metabolic alterations given their distinct metabolic dependencies. Indeed, memory T cells assume a metabolically quiescent state with reduced mTOR signaling during dietary restriction, resulting in increased protection in infection and tumors (<xref ref-type="bibr" rid="bib41">Collins et al., 2019</xref>). Further work is needed to understand how systemic metabolic alterations with dietary restriction, shifting toward catabolic, AMPK-induced metabolism, may contribute to enhanced CD8<sup>+</sup> T cell responses against tumors.</p></sec><sec id="s1-9"><title>Immune modulation in the tumor microenvironment</title><p>Both cellular and metabolic factors contribute to the immunosuppressive nature of the TME. Cancer cells, Tregs, macrophages, MDSCs, and fibroblasts cultivate a highly immunosuppressive microenvironment, where CD8<sup>+</sup> T cell responses are impaired by signaling through inhibitory receptors, suppressive cytokines, and reduced antigen presentation (<xref ref-type="bibr" rid="bib5">Anderson et al., 2017</xref>; <xref ref-type="fig" rid="fig4">Figure 4</xref>). Metabolic challenges in the TME constitute another layer of immunosuppression (<xref ref-type="bibr" rid="bib120">Lim et al., 2020</xref>). For example, T cells compete with tumor cells and other intratumoral cell populations for nutrients, which are limited by the tumor vasculature and high density of metabolically active tumor cells. This has been shown most specifically for glucose (<xref ref-type="bibr" rid="bib32">Chang et al., 2015</xref>; <xref ref-type="bibr" rid="bib80">Ho et al., 2015</xref>), but may apply to other nutrients as well. Accordingly, immunosuppressive cells in the TME express the enzymes arginase and indoleamine 2,3-dioxygenase, which degrade the amino acids arginine and tryptophan respectively, resulting in suppression of T cell responses (<xref ref-type="bibr" rid="bib188">Rodriguez et al., 2004</xref>; <xref ref-type="bibr" rid="bib222">Uyttenhove et al., 2003</xref>). Moreover, metabolic waste products, such as lactate, accumulate in the TME and suppress T cells (<xref ref-type="bibr" rid="bib23">Brand et al., 2016</xref>). Finally, tumors often induce cell-intrinsic metabolic changes in T cells, like reduced mitochondrial mass and function, which impair their anti-tumor functionality (<xref ref-type="bibr" rid="bib107">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="bib203">Scharping et al., 2016</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Shifts in the tumor immune infiltrate affect anti-tumor CD8<sup>+</sup> T cell function in distinct systemic conditions.</title><p>In addition to CD8<sup>+</sup> T cells, the TME contains other immune populations, some of which are immunostimulatory (e.g. M1-polarized macrophages), while others are suppressive (e.g. M2-polarized macrophages, MDSCs and Tregs). In aging, enhanced MDSC numbers and potentially M2 macrophages contribute to immunosuppression, resulting in a reduced anti-tumor CD8<sup>+</sup> T cell response. Tregs may be either increased or decreased with aging. Similar shifts in cellular populations in the TME exist with obesity. In dietary restriction, Treg and MDSC numbers are reduced while macrophage polarization is shifted toward the M1 phenotype, resulting in an increased anti-tumor CD8<sup>+</sup> T cell response. MDSC, myeloid-derived suppressor cell. TME, tumor microenvironment. Treg, regulatory T cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62420-fig4-v2.tif"/></fig></sec><sec id="s1-10"><title>Immune modulation in the tumor microenvironment with aging</title><p>Aging alters the TME in various ways (<xref ref-type="bibr" rid="bib60">Fane and Weeraratna, 2020</xref>). For example, the aged TME is characterized by increased immunosuppressive immune populations. Both Tregs and MDSCs have been implicated in enhanced immunosuppression in aged tumors (<xref ref-type="bibr" rid="bib53">Dominguez and Lustgarten, 2008</xref>; <xref ref-type="bibr" rid="bib73">Grizzle et al., 2007</xref>; <xref ref-type="bibr" rid="bib85">Hurez et al., 2012</xref>; <xref ref-type="bibr" rid="bib205">Sekido et al., 2019</xref>; <xref ref-type="bibr" rid="bib207">Sharma et al., 2006</xref>), although the literature on Tregs is inconsistent, as some studies have described reduced Tregs numbers in tumors in aged animals (<xref ref-type="bibr" rid="bib104">Kugel et al., 2018</xref>). As for the mechanisms underlying increased MDSC infiltration in aged tumors, local senescent stromal cells, most notably fibroblasts, promote MDSC accumulation in the TME through the secretion of inflammatory cytokines like IL-6 (<xref ref-type="bibr" rid="bib198">Ruhland et al., 2016</xref>). M2 macrophages, another immunosuppressive myeloid population, have been less studied in this context, but they are also enriched in lymphoid tissues of aged mice (<xref ref-type="bibr" rid="bib90">Jackaman et al., 2013</xref>) and might be enhanced in tumors as well (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><p>Aged fibroblasts can also perform additional immunosuppressive roles. For example, mitochondrial dysfunction in cancer-associated fibroblasts may lead to enhanced secretion of reactive oxygen species and lactate (<xref ref-type="bibr" rid="bib9">Balliet et al., 2011</xref>), thereby making the TME less permissive to T cell function. Moreover, fibroblast dysfunction contributes to a decrease in extracellular matrix (ECM) integrity with age, which, in addition to promoting cancer metastasis, likely impairs CD8<sup>+</sup> T cell infiltration (<xref ref-type="bibr" rid="bib99">Kaur et al., 2019</xref>). The aged microenvironment can also impact cancer cell-intrinsic signaling pathways, such as Wnt signaling (<xref ref-type="bibr" rid="bib98">Kaur et al., 2016</xref>), which in turn might affect immune infiltration (<xref ref-type="bibr" rid="bib213">Spranger et al., 2015</xref>). However, the tumor cell-intrinsic signaling and metabolic changes with aging are generally not well-understood.</p></sec><sec id="s1-11"><title>Immune modulation in the tumor microenvironment with obesity</title><p>Little is currently known about how the systemic metabolic alterations associated with obesity impact the metabolic conditions in the TME locally. Changes to the intratumoral cellular populations are somewhat better understood. Most notably and similar to aging, the TME contains higher numbers of immunosuppressive myeloid cells with obesity, including MDSCs (<xref ref-type="bibr" rid="bib39">Clements et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">Hale et al., 2015</xref>; <xref ref-type="bibr" rid="bib220">Turbitt et al., 2019</xref>), neutrophils (<xref ref-type="bibr" rid="bib87">Incio et al., 2016</xref>), and dysfunctional dendritic cells (<xref ref-type="bibr" rid="bib93">James et al., 2012</xref>) in multiple cancer models. These populations contribute to cancer progression, metastasis, and suppression of CD8<sup>+</sup> T cell function (<xref ref-type="bibr" rid="bib39">Clements et al., 2018</xref>; <xref ref-type="bibr" rid="bib87">Incio et al., 2016</xref>; <xref ref-type="bibr" rid="bib93">James et al., 2012</xref>; <xref ref-type="bibr" rid="bib159">Norian et al., 2009</xref>; <xref ref-type="bibr" rid="bib179">Quail et al., 2017</xref>). M2-polarized macrophage numbers are increased in human breast adipose tissue with obesity, suggesting that these may also play a role in the context of cancer (<xref ref-type="bibr" rid="bib214">Springer et al., 2019</xref>). In contrast, Treg infiltration in tumors is similar in animals with diet-induced obesity compared to controls (<xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>), suggesting that enhanced immunosuppression in the obese TME is largely mediated by myeloid populations (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s1-12"><title>Immune modulation in the tumor microenvironment with dietary restriction</title><p>Some of the beneficial effect of dietary restriction on anti-tumor immunity is likely caused by tumor cell-intrinsic metabolic changes. For example, a low-protein diet induces tumoral endoplasmic reticulum (ER) stress pathways, mediated by inositol-requiring enzyme (IRE)1α, and retinoic acid-inducible gene (RIG)-I activation, which may induce an immunostimulatory cytokine response (<xref ref-type="bibr" rid="bib196">Rubio-Patiño et al., 2018</xref>). Tumor cell-intrinsic changes also stimulate the anti-tumor immune response by reducing immunosuppressive populations in the TME, such as Tregs. For example, dietary restriction or a CRM enhances the efficacy of chemotherapy and anti-tumor CD8<sup>+</sup> T cell response in a manner dependent on cancer cell autophagy, which may deplete Tregs from the tumor bed by releasing ATP (<xref ref-type="bibr" rid="bib172">Pietrocola et al., 2016</xref>). FMD also prevents Treg accumulation in the TME, which is partially dependent on downregulation of heme oxygenase (HO)−1 in tumors (<xref ref-type="bibr" rid="bib52">Di Biase et al., 2016</xref>).</p><p>In addition to Tregs, dietary restriction also reduces myeloid cell-mediated immunosuppression in the TME. MDSC numbers are reduced in tumors in mice with dietary restriction, correlating with enhanced CD8<sup>+</sup> T cell infiltration (<xref ref-type="bibr" rid="bib220">Turbitt et al., 2019</xref>), and there is evidence to suggest that shifting away from mTOR-mediated and toward AMPK-mediated metabolism impairs the suppressive capacity of MDSCs (<xref ref-type="bibr" rid="bib50">Deng et al., 2018</xref>; <xref ref-type="bibr" rid="bib200">Salminen et al., 2019</xref>). Low-protein diet shifts the balance of tumor-associated macrophages away from the immunosuppressive M2 phenotype and toward the inflammatory M1 phenotype (<xref ref-type="bibr" rid="bib164">Orillion et al., 2018</xref>). Thus, tumor cell-intrinsic metabolic changes and a reduction in suppressive immune populations appear to be the main drivers for the enhanced anti-tumor CD8<sup>+</sup> T cell response seen with dietary restriction (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s1-13"><title>Cancer immunotherapies</title><p>Cancer immunotherapeutic strategies include immune checkpoint blockade (ICB), adoptive cell therapy, cancer vaccines, and engagement of innate (e.g., Toll-like receptors) or adaptive (e.g. OX40) immunostimulatory receptors. Immune checkpoint blockade (ICB) and adoptive cell therapy are now FDA-approved cancer immunotherapies. With ICB, antibodies are used to prevent the binding of inhibitory receptors on T cells, such as CTLA-4 and PD-1, to their ligands. CTLA-4-targeting antibodies were approved for melanoma treatment in 2011, making them the first approved form of ICB for cancer therapy (<xref ref-type="bibr" rid="bib12">Baumeister et al., 2016</xref>). Anti-PD-1 therapies were approved for melanoma in 2014 and PD-1 pathway blockade is now approved for many other cancer types, including solid tumors with a high degree of microsatellite instability or DNA mismatch repair deficiency regardless of anatomical location or tissue of origin (<xref ref-type="bibr" rid="bib22">Boyiadzis et al., 2018</xref>; <xref ref-type="bibr" rid="bib227">Waldman et al., 2020</xref>). An exciting feature of ICB therapies is that they induce very long-lasting responses in some patients (<xref ref-type="bibr" rid="bib112">Ledford, 2016</xref>). However, many patients currently do not respond to ICB, and innovative strategies to provide the therapeutic benefits of ICB to more patients are therefore highly sought after (<xref ref-type="bibr" rid="bib167">Park et al., 2018</xref>).</p><p>Another therapeutic strategy to induce an anti-tumor T cell response is the administration of T cells that can recognize cancer antigens. There are two main adoptive T cell therapy approaches. First, T cells can be isolated from a tumor and expanded ex vivo; this approach has had some success in melanoma (<xref ref-type="bibr" rid="bib192">Rosenberg and Restifo, 2015</xref>). Second, T cells can be transduced with a TCR or a chimeric antigen receptor (CAR) specific for a cancer antigen. CAR T cell therapies have been most efficacious in hematological cancers by targeting the B cell antigen CD19, while success in solid tumors has been limited so far (<xref ref-type="bibr" rid="bib92">Jacoby et al., 2019</xref>; <xref ref-type="bibr" rid="bib96">June et al., 2018</xref>).</p></sec><sec id="s1-14"><title>Cancer immunotherapies with aging</title><p>Several immunotherapeutic modalities, such as engagement of immunostimulatory receptors (e.g. TLRs or OX40) and cancer vaccination strategies (using DNA, tumor cells or dendritic cells), are less effective in aged animals (<xref ref-type="bibr" rid="bib29">Castro et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Dominguez and Lustgarten, 2008</xref>; <xref ref-type="bibr" rid="bib75">Grolleau-Julius et al., 2008</xref>; <xref ref-type="bibr" rid="bib178">Provinciali et al., 2003</xref>; <xref ref-type="bibr" rid="bib177">Provinciali et al., 2000</xref>; <xref ref-type="bibr" rid="bib197">Ruby and Weinberg, 2009</xref>). Fewer T cells are recovered following adoptive transfer of young T cells into aged compared to young tumor-bearing mice (<xref ref-type="bibr" rid="bib61">Farazi et al., 2014</xref>), suggesting that adoptive cell therapies may also be less effective with aging, in a manner dependent on the aged host environment. These results have contributed to the general notion of decreased anti-tumor immune function with age.</p><p>In contrast, most available data suggest that the efficacy of ICB is intact in aged human cancer patients and in animal tumor models (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Kugel et al. found that responsiveness to anti-PD-1 was even enhanced in older human melanoma patients and aged mice, and this was associated with increased CD8<sup>+</sup> T cell infiltration (<xref ref-type="bibr" rid="bib104">Kugel et al., 2018</xref>). Others have also found good ICB responsiveness in elderly patients with melanoma (<xref ref-type="bibr" rid="bib15">Ben-Betzalel et al., 2019</xref>; <xref ref-type="bibr" rid="bib17">Betof et al., 2017</xref>) or non-small cell lung cancer (<xref ref-type="bibr" rid="bib117">Lichtenstein et al., 2019</xref>), and across multiple cancer types (<xref ref-type="bibr" rid="bib44">Corbaux et al., 2019</xref>). Overall, most human studies show at least similar efficacy of anti-CTLA-4 and anti-PD-(L)1 therapies in older compared to younger patients (<xref ref-type="bibr" rid="bib83">Huang et al., 2020</xref>; <xref ref-type="bibr" rid="bib168">Pawelec, 2019</xref>; <xref ref-type="bibr" rid="bib176">Poropatich et al., 2017</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The net effects of systemic conditions on anti-tumor immunity and ICB responsiveness.</title><p>Aging and obesity lead to a reduced anti-tumor T cell response compared to a young, lean adult at baseline, i.e. without immunotherapy, while dietary restriction enhances the baseline anti-tumor immune response. However, the efficacy of ICB therapy is intact or even enhanced with aging and mostly increased with obesity, although this may not apply to all cancer types and patient subsets. ICB responsiveness with dietary restriction has not been sufficiently studied to know whether this is altered. ICB, immune checkpoint blockade.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62420-fig5-v2.tif"/></fig><p>In murine studies, the responsiveness to ICB varies with cancer type and the immunotherapy used. Anti-CTLA-4, anti-PD-1 and anti-PD-L1 monotherapies are all highly effective in aged animals with an oral cancer model (<xref ref-type="bibr" rid="bib205">Sekido et al., 2019</xref>). Aged and young mice respond similarly to anti-PD-L1 immunotherapy in a hematological malignancy model (<xref ref-type="bibr" rid="bib146">Mirza et al., 2010</xref>). However, in the B16 melanoma model, anti-PD-1 is equally effective between aged and young mice, whereas anti-CTLA-4 works less well and anti-PD-L1 does not work at all (<xref ref-type="bibr" rid="bib165">Padrón et al., 2018</xref>). Responsiveness to anti-CTLA-4 and anti-PD-L1 is also reduced in aged breast cancer models, but efficacy can be improved by enhancing interferon signaling in the TME (<xref ref-type="bibr" rid="bib202">Sceneay et al., 2019</xref>). Thus, while ICB appears to remain efficacious with aging in mice and humans, further studies are needed to delineate the (determinants of) efficacy of different immunotherapeutic modalities in aged populations.</p></sec><sec id="s1-15"><title>Cancer immunotherapies with obesity</title><p>Surprisingly, although obesity reduces the anti-tumor immune response, the efficacy of ICB cancer immunotherapy is enhanced in both animal models and human obesity in multiple cancer types (<xref ref-type="bibr" rid="bib136">McQuade et al., 2018</xref>; <xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="bib236">Xu et al., 2019</xref>; <xref ref-type="fig" rid="fig5">Figure 5</xref>). However, not all studies have found enhanced efficacy of ICB immunotherapy in mice with diet-induced obesity (<xref ref-type="bibr" rid="bib149">Murphy et al., 2018</xref>). This may be explained by several differences, including the mouse strain (BALB/c versus C57/BL6), cancer model (renal cell carcinoma versus melanoma and lung carcinoma models) and modalities of immunotherapy (anti-CTLA-4 combined with other immunostimulants versus anti-PD-1) (<xref ref-type="bibr" rid="bib149">Murphy et al., 2018</xref>; <xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>). The discrepancy in results obtained with these different animal models correlates with human data, where obesity improves the efficacy of ICB in patients with melanoma and non-small cell lung cancer, but not renal cell carcinoma (<xref ref-type="bibr" rid="bib236">Xu et al., 2019</xref>). Sex may also be a relevant factor, since some studies have found that better outcomes after ICB with obesity are mostly driven by male patients (<xref ref-type="bibr" rid="bib136">McQuade et al., 2018</xref>; <xref ref-type="bibr" rid="bib151">Naik et al., 2019</xref>), although a meta-analysis found that they are independent of sex (<xref ref-type="bibr" rid="bib236">Xu et al., 2019</xref>). Further studies are needed to determine which patient and cancer subsets display improved outcomes upon ICB therapy with obesity.</p><p>The increase in responsiveness to cancer immunotherapy with obesity in many cancer types suggests that obesity-associated immunosuppressive factors can be overcome with the removal of inhibitory signals like PD-(L)1 signaling. It is currently unknown whether the enhanced efficacy of ICB in obese compared to non-obese subjects can be explained by obesity-related systemic alterations that directly promote T cell function, or by indirect factors, such as tumor cells being more prone to immune attack. Finally, the findings of ICB responsiveness with obesity likely do not translate to all types of cancer immunotherapy, as other modalities have shown decreased functionality (<xref ref-type="bibr" rid="bib93">James et al., 2012</xref>). This suggests that, like with aging, ICB responsiveness may be better than other immunotherapies in obesity.</p></sec><sec id="s1-16"><title>Cancer immunotherapies with dietary restriction</title><p>Very little information is available on responsiveness to cancer immunotherapy with dietary restriction. In one study, low-protein diet did not change anti-tumor immunity alone, but it did enhance responsiveness to anti-PD-1 in a mouse model of renal cell cancer (<xref ref-type="bibr" rid="bib164">Orillion et al., 2018</xref>). This contrasts with a study discussed above, in which low-protein diet alone reduced tumor progression in murine lymphoma, colorectal adenocarcinoma and melanoma models (<xref ref-type="bibr" rid="bib196">Rubio-Patiño et al., 2018</xref>). Dietary restriction improves the efficacy of OX40 agonist immunotherapy in murine tumors as well as activation of CD4<sup>+</sup>, but not CD8<sup>+</sup>, T cells (<xref ref-type="bibr" rid="bib61">Farazi et al., 2014</xref>). The limited data available from animal studies suggest that there is no paradoxical reduction of ICB efficacy with dietary restriction, as might have been feared based on the data described above for aging and diet-induced obesity, but more studies are needed.</p></sec></sec><sec id="s2"><title>Concluding remarks</title><p>While many outstanding questions remain, age and systemic metabolic state impact anti-tumor CD8<sup>+</sup> T cell responses. Systemic and TME-specific factors in the host environment as well as CD8<sup>+</sup> T cell-intrinsic factors play a role. There are striking similarities in the changes observed with aging and obesity: both induce a chronic inflammatory state, reduce naïve CD8<sup>+</sup> T cell generation, promote dysfunctional T cell states, and increase immunosuppressive myeloid cell populations in tumors. Together, these factors significantly reduce the anti-tumor CD8<sup>+</sup> T cell response. In contrast, dietary restriction promotes anti-tumor immunity by opposing most of these age- and obesity-related mechanisms. Dietary restriction also causes cancer cell-intrinsic metabolic changes, such as induction of autophagy and ER stress, which benefit the anti-tumor T cell response. A dietary restriction-induced systemic shift toward AMPK-mediated oxidative metabolism likely contributes to the development of an environment that is more conducive to anti-tumor CD8<sup>+</sup> T cell function by reducing systemic inflammation and improving the TME cellular landscape. Additionally, enhanced AMPK signaling in CD8<sup>+</sup> T cells themselves may promote their survival and function in the TME.</p><p>The parallels between aging and obesity, and how they contrast with dietary restriction, are further emphasized by research looking at a combination of these conditions. For example, the observed increase in expression of PD-1 and other exhaustion markers on T cells in melanoma tumors with high body weight was more pronounced in patients over 60 years of age (<xref ref-type="bibr" rid="bib230">Wang et al., 2019</xref>). Moreover, dietary restriction can restore some of the age-related decline in anti-tumor function of CD4<sup>+</sup> T cells and responsiveness to OX40 immunotherapy (<xref ref-type="bibr" rid="bib61">Farazi et al., 2014</xref>). Aged and obese mice display a similar immune dysregulation, leading to a harmful cytokine storm upon administration of immunotherapy consisting of a costimulatory receptor CD40 agonist combined with IL-2, which caloric restriction protects against (<xref ref-type="bibr" rid="bib145">Mirsoian et al., 2014</xref>). These findings suggest that aging and obesity activate common pathways to impair the anti-tumor immune response, and these can be counteracted by dietary restriction.</p><p>The observation that responsiveness to ICB immunotherapies, like anti-PD-1, is intact or even enhanced in aged or obese individuals is surprising. Typically, having a better pre-existing anti-tumor CD8<sup>+</sup> T cell response, as evidenced by intratumoral CD8<sup>+</sup> T cell infiltration, increases the chances of responding to ICB (<xref ref-type="bibr" rid="bib94">Ji et al., 2012</xref>). The mechanisms underlying this paradox in the context of age and obesity are unclear. Perhaps some of the dysfunctional T cell populations in aging and obesity are more prone to (re)activation by blockade of coinhibitory receptor signaling. If so, that would also explain why, in contrast to ICB, other immunotherapy modalities yield reduced responses with age and obesity in animal models. Intratumoral exhausted CD8<sup>+</sup> T cells can be divided into several subpopulations including ‘terminally exhausted’ and ‘progenitor exhausted’ populations, the former having higher cytolytic function and the latter being more important for responsiveness to anti-PD-1 therapy (<xref ref-type="bibr" rid="bib14">Beltra et al., 2020</xref>; <xref ref-type="bibr" rid="bib84">Hudson et al., 2019</xref>; <xref ref-type="bibr" rid="bib86">Im et al., 2016</xref>; <xref ref-type="bibr" rid="bib143">Miller et al., 2019</xref>). It would be interesting to investigate whether an altered distribution of intratumoral CD8<sup>+</sup> T cells between these populations with aging or obesity could contribute to the observed paradox of reduced baseline anti-tumor immunity with intact ICB responses.</p><p>Despite much progress over recent years, many important questions remain unanswered. First, how conditions of obesity or dietary restriction impact nutrient availability in the TME is largely a black box. Dietary changes can alter the metabolic composition of the TME (<xref ref-type="bibr" rid="bib127">Maddocks et al., 2017</xref>; <xref ref-type="bibr" rid="bib215">Sullivan et al., 2019</xref>), but this has not been analyzed for HFD or dietary restriction. Given the limited blood supply and high local metabolic rates in a tumor, alterations in metabolite concentrations in the circulation may not be proportionally reflected in the TME (<xref ref-type="bibr" rid="bib215">Sullivan et al., 2019</xref>). Moreover, diet can change cancer cell metabolism (<xref ref-type="bibr" rid="bib21">Bose et al., 2020</xref>; <xref ref-type="bibr" rid="bib118">Lien and Vander Heiden, 2019</xref>), further shaping the metabolic conditions in the TME and in some cases benefitting specific intratumoral cell populations (<xref ref-type="bibr" rid="bib105">Kumagai et al., 2020</xref>). Second, it is largely unknown what the intracellular fates of nutrients in the TME are and how these may differ between cell types. Third, there are various systemic conditions in addition to the ones discussed here for which the effects on anti-tumor immunity are unknown, and it would be interesting to explore those. Fourth, since mouse research studying obesity often involves the feeding of a HFD, the question arises whether the observed effects are due to the diet itself or the obese state. Delineating the contributions of diet and obese state to both systemic and TME-specific metabolic alterations will be an exciting avenue for future studies with potential therapeutic implications. And finally, preclinical findings with dietary restriction, suggesting enhanced anti-tumor T cell responses, look promising. It needs to be determined whether combination of dietary restriction and CRMs with immunotherapies can boost anti-tumor immunity, and some such trials are already underway (<xref ref-type="bibr" rid="bib115">Lévesque et al., 2019</xref>). To further facilitate this, it would be important to assess which exact dietary interventions are most beneficial in which context and what metabolic changes underly any therapeutic benefit.</p><p>Research investigating the impact of age and metabolic state on both cancer biology and anti-tumor immunity also has methodological implications and highlights shortcomings of the currently available technologies. For one, it may be important to use aged and/or metabolically unhealthy animals for investigations into the anti-tumor immune response, in addition to the lean, young animals that are most commonly used, to better model cancer patients and improve the translatability of any findings. In that regard, it is noteworthy that there is a high degree of congruency between existing human and animal data concerning anti-tumor immunity and ICB responsiveness with age, obesity, and dietary restriction. Moreover, despite the value and practicality of using implantable tumor models for animal studies, they have some limitations, including (1) they do not assess effects of the ‘agedness’ of cancer cells themselves, and (2) they study cancer progression, whereas most human studies quantify cancer incidence. There may be value in using animal models of spontaneous tumor growth to assess how age and diet alter immune surveillance, although there are challenges to this approach, as genetic cancer models are typically not very immunogenic. Finally, it remains very challenging to determine the activity intracellular metabolic pathways in distinct cell populations in a tissue, for example a tumor, in vivo. Mass spectrometry-based approaches are complicated, given that only limited CD8<sup>+</sup> T cell numbers can be obtained from a tumor and extensive processing and sorting procedures are required for their isolation, which are bound to impact metabolite pool sizes. Recently, several groups have made progress in this area, for example using in vivo infusion of isotopically labeled glucose to assess T cell metabolism (<xref ref-type="bibr" rid="bib126">Ma et al., 2019</xref>) or tracing isotopically labeled nutrients into macromolecules with a slow turnover rate in distinct intratumoral cell populations, specifically cancer cells and fibroblasts (<xref ref-type="bibr" rid="bib110">Lau et al., 2020</xref>). Others have developed advanced flow cytometric strategies for reading out metabolic characteristics at a single-cell level (<xref ref-type="bibr" rid="bib2">Ahl et al., 2020</xref>).</p><p>Cancer represents a huge public health burden, and the cancer risk factors of old age and obesity are increasing in prevalence. It is therefore increasingly critical to consider these factors in the design of cancer immunotherapies. Expanding our knowledge of the macroenvironmental determinants of anti-tumor immunity should reveal new ways to extend the benefit of cancer immunotherapies to more patients.</p></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Dr. Alison Ringel for helpful discussions and feedback. The authors were supported by a grant from the Ludwig Center at Harvard and NIH grant U54-CA225088 (MCH and AHS). JMD was supported by a predoctoral F31 NIH fellowship (5F31CA224601). <xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref> contain elements from <ext-link ext-link-type="uri" xlink:href="http://biorender.com/">BioRender.com</ext-link> and <xref ref-type="fig" rid="fig5">Figure 5</xref> contains elements modeled after <ext-link ext-link-type="uri" xlink:href="http://biorender.com/">BioRender.com</ext-link> figures.</p></ack><sec id="s3" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>Jefte M Drijvers has consulted for ElevateBio and Third Rock Ventures.</p></fn><fn fn-type="COI-statement" id="conf2"><p>Arlene Sharpe has patents 7432059, 7722868, 8652465, 9457080, 9683048, 9815898, 9845356, 10202454, 10457733, 9580684, 9988452, 10370446 on the PD-1 pathway licensed by Roche/Genentech and Novartis, consults for Novartis, is on the scientific advisory boards for Surface Oncology, Sqz Biotech, Elstar Therapeutics, Elpiscience, Selecta and Monopteros and has research funding from Merck, Novartis, Roche, Ipsen, and Quark Ventures.</p></fn><fn fn-type="COI-statement" id="conf3"><p>Marcia Haigis consults for Pori Therapeutics and receives research funding from Roche.</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ables</surname> <given-names>GP</given-names></name><name><surname>Perrone</surname> <given-names>CE</given-names></name><name><surname>Orentreich</surname> <given-names>D</given-names></name><name><surname>Orentreich</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e51357</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0051357</pub-id><pub-id pub-id-type="pmid">23236485</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahl</surname> <given-names>PJ</given-names></name><name><surname>Hopkins</surname> <given-names>RA</given-names></name><name><surname>Xiang</surname> <given-names>WW</given-names></name><name><surname>Au</surname> <given-names>B</given-names></name><name><surname>Kaliaperumal</surname> <given-names>N</given-names></name><name><surname>Fairhurst</surname> <given-names>AM</given-names></name><name><surname>Connolly</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations</article-title><source>Communications Biology</source><volume>3</volume><elocation-id>305</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-020-1027-9</pub-id><pub-id pub-id-type="pmid">32533056</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosi</surname> <given-names>TH</given-names></name><name><surname>Scialdone</surname> <given-names>A</given-names></name><name><surname>Graja</surname> <given-names>A</given-names></name><name><surname>Gohlke</surname> <given-names>S</given-names></name><name><surname>Jank</surname> <given-names>AM</given-names></name><name><surname>Bocian</surname> <given-names>C</given-names></name><name><surname>Woelk</surname> <given-names>L</given-names></name><name><surname>Fan</surname> <given-names>H</given-names></name><name><surname>Logan</surname> <given-names>DW</given-names></name><name><surname>Schürmann</surname> <given-names>A</given-names></name><name><surname>Saraiva</surname> <given-names>LR</given-names></name><name><surname>Schulz</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adipocyte accumulation in the bone marrow during obesity and aging impairs stem Cell-Based hematopoietic and bone regeneration</article-title><source>Cell Stem Cell</source><volume>20</volume><fpage>771</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2017.02.009</pub-id><pub-id pub-id-type="pmid">28330582</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amor</surname> <given-names>C</given-names></name><name><surname>Feucht</surname> <given-names>J</given-names></name><name><surname>Leibold</surname> <given-names>J</given-names></name><name><surname>Ho</surname> <given-names>YJ</given-names></name><name><surname>Zhu</surname> <given-names>C</given-names></name><name><surname>Alonso-Curbelo</surname> <given-names>D</given-names></name><name><surname>Mansilla-Soto</surname> <given-names>J</given-names></name><name><surname>Boyer</surname> <given-names>JA</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Giavridis</surname> <given-names>T</given-names></name><name><surname>Kulick</surname> <given-names>A</given-names></name><name><surname>Houlihan</surname> <given-names>S</given-names></name><name><surname>Peerschke</surname> <given-names>E</given-names></name><name><surname>Friedman</surname> <given-names>SL</given-names></name><name><surname>Ponomarev</surname> <given-names>V</given-names></name><name><surname>Piersigilli</surname> <given-names>A</given-names></name><name><surname>Sadelain</surname> <given-names>M</given-names></name><name><surname>Lowe</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Senolytic CAR T cells reverse senescence-associated pathologies</article-title><source>Nature</source><volume>583</volume><fpage>127</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2403-9</pub-id><pub-id pub-id-type="pmid">32555459</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>KG</given-names></name><name><surname>Stromnes</surname> <given-names>IM</given-names></name><name><surname>Greenberg</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Obstacles posed by the tumor microenvironment to T cell Activity: A Case for Synergistic Therapies</article-title><source>Cancer Cell</source><volume>31</volume><fpage>311</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2017.02.008</pub-id><pub-id pub-id-type="pmid">28292435</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname> <given-names>K</given-names></name><name><surname>Turner</surname> <given-names>AP</given-names></name><name><surname>Shaffer</surname> <given-names>VO</given-names></name><name><surname>Gangappa</surname> <given-names>S</given-names></name><name><surname>Keller</surname> <given-names>SA</given-names></name><name><surname>Bachmann</surname> <given-names>MF</given-names></name><name><surname>Larsen</surname> <given-names>CP</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>mTOR regulates memory CD8 Tcell differentiation</article-title><source>Nature</source><volume>460</volume><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1038/nature08155</pub-id><pub-id pub-id-type="pmid">19543266</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="report"><person-group person-group-type="author"><name><surname>Arias</surname> <given-names>E</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><source>United States Life Tables, 2017</source><publisher-name>Natl Vital Stat Reports</publisher-name></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bains</surname> <given-names>I</given-names></name><name><surname>Thiébaut</surname> <given-names>R</given-names></name><name><surname>Yates</surname> <given-names>AJ</given-names></name><name><surname>Callard</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Quantifying thymic export: combining models of naive T cell proliferation and TCR excision circle dynamics gives an explicit measure of thymic output</article-title><source>The Journal of Immunology</source><volume>183</volume><fpage>4329</fpage><lpage>4336</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900743</pub-id><pub-id pub-id-type="pmid">19734223</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balliet</surname> <given-names>RM</given-names></name><name><surname>Capparelli</surname> <given-names>C</given-names></name><name><surname>Guido</surname> <given-names>C</given-names></name><name><surname>Pestell</surname> <given-names>TG</given-names></name><name><surname>Martinez-Outschoorn</surname> <given-names>UE</given-names></name><name><surname>Lin</surname> <given-names>Z</given-names></name><name><surname>Whitaker-Menezes</surname> <given-names>D</given-names></name><name><surname>Chiavarina</surname> <given-names>B</given-names></name><name><surname>Pestell</surname> <given-names>RG</given-names></name><name><surname>Howell</surname> <given-names>A</given-names></name><name><surname>Sotgia</surname> <given-names>F</given-names></name><name><surname>Lisanti</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast Cancer tumor growth</article-title><source>Cell Cycle</source><volume>10</volume><fpage>4065</fpage><lpage>4073</lpage><pub-id pub-id-type="doi">10.4161/cc.10.23.18254</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname> <given-names>DL</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Masopust</surname> <given-names>D</given-names></name><name><surname>Zhu</surname> <given-names>B</given-names></name><name><surname>Allison</surname> <given-names>JP</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Restoring function in exhausted CD8 T cells during chronic viral infection</article-title><source>Nature</source><volume>439</volume><fpage>682</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nature04444</pub-id><pub-id pub-id-type="pmid">16382236</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barzilai</surname> <given-names>N</given-names></name><name><surname>Huffman</surname> <given-names>DM</given-names></name><name><surname>Muzumdar</surname> <given-names>RH</given-names></name><name><surname>Bartke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The critical role of metabolic pathways in aging</article-title><source>Diabetes</source><volume>61</volume><fpage>1315</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.2337/db11-1300</pub-id><pub-id pub-id-type="pmid">22618766</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumeister</surname> <given-names>SH</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Dranoff</surname> <given-names>G</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Coinhibitory pathways in immunotherapy for Cancer</article-title><source>Annual Review of Immunology</source><volume>34</volume><fpage>539</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112049</pub-id><pub-id pub-id-type="pmid">26927206</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beerman</surname> <given-names>I</given-names></name><name><surname>Bhattacharya</surname> <given-names>D</given-names></name><name><surname>Zandi</surname> <given-names>S</given-names></name><name><surname>Sigvardsson</surname> <given-names>M</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name><name><surname>Rossi</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion</article-title><source>PNAS</source><volume>107</volume><fpage>5465</fpage><lpage>5470</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000834107</pub-id><pub-id pub-id-type="pmid">20304793</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltra</surname> <given-names>JC</given-names></name><name><surname>Manne</surname> <given-names>S</given-names></name><name><surname>Abdel-Hakeem</surname> <given-names>MS</given-names></name><name><surname>Kurachi</surname> <given-names>M</given-names></name><name><surname>Giles</surname> <given-names>JR</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Casella</surname> <given-names>V</given-names></name><name><surname>Ngiow</surname> <given-names>SF</given-names></name><name><surname>Khan</surname> <given-names>O</given-names></name><name><surname>Huang</surname> <given-names>YJ</given-names></name><name><surname>Yan</surname> <given-names>P</given-names></name><name><surname>Nzingha</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Amaravadi</surname> <given-names>RK</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Karakousis</surname> <given-names>GC</given-names></name><name><surname>Mitchell</surname> <given-names>TC</given-names></name><name><surname>Schuchter</surname> <given-names>LM</given-names></name><name><surname>Huang</surname> <given-names>AC</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Developmental relationships of four exhausted CD8<sup>+ </sup>T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms</article-title><source>Immunity</source><volume>52</volume><fpage>825</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.04.014</pub-id><pub-id pub-id-type="pmid">32396847</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Betzalel</surname> <given-names>G</given-names></name><name><surname>Steinberg-Silman</surname> <given-names>Y</given-names></name><name><surname>Stoff</surname> <given-names>R</given-names></name><name><surname>Asher</surname> <given-names>N</given-names></name><name><surname>Shapira-Frommer</surname> <given-names>R</given-names></name><name><surname>Schachter</surname> <given-names>J</given-names></name><name><surname>Markel</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients</article-title><source>European Journal of Cancer</source><volume>108</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2018.12.012</pub-id><pub-id pub-id-type="pmid">30648631</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bénéteau</surname> <given-names>M</given-names></name><name><surname>Zunino</surname> <given-names>B</given-names></name><name><surname>Jacquin</surname> <given-names>MA</given-names></name><name><surname>Meynet</surname> <given-names>O</given-names></name><name><surname>Chiche</surname> <given-names>J</given-names></name><name><surname>Pradelli</surname> <given-names>LA</given-names></name><name><surname>Marchetti</surname> <given-names>S</given-names></name><name><surname>Cornille</surname> <given-names>A</given-names></name><name><surname>Carles</surname> <given-names>M</given-names></name><name><surname>Ricci</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response</article-title><source>PNAS</source><volume>109</volume><fpage>20071</fpage><lpage>20076</lpage><pub-id pub-id-type="doi">10.1073/pnas.1206360109</pub-id><pub-id pub-id-type="pmid">23169636</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betof</surname> <given-names>AS</given-names></name><name><surname>Nipp</surname> <given-names>RD</given-names></name><name><surname>Giobbie-Hurder</surname> <given-names>A</given-names></name><name><surname>Johnpulle</surname> <given-names>RAN</given-names></name><name><surname>Rubin</surname> <given-names>K</given-names></name><name><surname>Rubinstein</surname> <given-names>SM</given-names></name><name><surname>Flaherty</surname> <given-names>KT</given-names></name><name><surname>Lawrence</surname> <given-names>DP</given-names></name><name><surname>Johnson</surname> <given-names>DB</given-names></name><name><surname>Sullivan</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of age on outcomes with immunotherapy for patients with melanoma</article-title><source>The Oncologist</source><volume>22</volume><fpage>963</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2016-0450</pub-id><pub-id pub-id-type="pmid">28476944</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharath</surname> <given-names>LP</given-names></name><name><surname>Agrawal</surname> <given-names>M</given-names></name><name><surname>McCambridge</surname> <given-names>G</given-names></name><name><surname>Nicholas</surname> <given-names>DA</given-names></name><name><surname>Hasturk</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Guo</surname> <given-names>Z</given-names></name><name><surname>Deeney</surname> <given-names>J</given-names></name><name><surname>Apovian</surname> <given-names>CM</given-names></name><name><surname>Snyder-Cappione</surname> <given-names>J</given-names></name><name><surname>Hawk</surname> <given-names>GS</given-names></name><name><surname>Fleeman</surname> <given-names>RM</given-names></name><name><surname>Pihl</surname> <given-names>RMF</given-names></name><name><surname>Thompson</surname> <given-names>K</given-names></name><name><surname>Belkina</surname> <given-names>AC</given-names></name><name><surname>Cui</surname> <given-names>L</given-names></name><name><surname>Proctor</surname> <given-names>EA</given-names></name><name><surname>Kern</surname> <given-names>PA</given-names></name><name><surname>Nikolajczyk</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Metformin enhances autophagy and normalizes mitochondrial function to alleviate Aging-Associated inflammation</article-title><source>Cell Metabolism</source><volume>32</volume><fpage>44</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.04.015</pub-id><pub-id pub-id-type="pmid">32402267</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburn</surname> <given-names>SD</given-names></name><name><surname>Shin</surname> <given-names>H</given-names></name><name><surname>Haining</surname> <given-names>WN</given-names></name><name><surname>Zou</surname> <given-names>T</given-names></name><name><surname>Workman</surname> <given-names>CJ</given-names></name><name><surname>Polley</surname> <given-names>A</given-names></name><name><surname>Betts</surname> <given-names>MR</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Vignali</surname> <given-names>DA</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection</article-title><source>Nature Immunology</source><volume>10</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/ni.1679</pub-id><pub-id pub-id-type="pmid">19043418</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blagih</surname> <given-names>J</given-names></name><name><surname>Coulombe</surname> <given-names>F</given-names></name><name><surname>Vincent</surname> <given-names>EE</given-names></name><name><surname>Dupuy</surname> <given-names>F</given-names></name><name><surname>Galicia-Vázquez</surname> <given-names>G</given-names></name><name><surname>Yurchenko</surname> <given-names>E</given-names></name><name><surname>Raissi</surname> <given-names>TC</given-names></name><name><surname>van der Windt</surname> <given-names>GJ</given-names></name><name><surname>Viollet</surname> <given-names>B</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name><name><surname>Pelletier</surname> <given-names>J</given-names></name><name><surname>Piccirillo</surname> <given-names>CA</given-names></name><name><surname>Krawczyk</surname> <given-names>CM</given-names></name><name><surname>Divangahi</surname> <given-names>M</given-names></name><name><surname>Jones</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo</article-title><source>Immunity</source><volume>42</volume><fpage>41</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.12.030</pub-id><pub-id pub-id-type="pmid">25607458</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname> <given-names>S</given-names></name><name><surname>Allen</surname> <given-names>AE</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The molecular link from diet to Cancer cell metabolism</article-title><source>Molecular Cell</source><volume>78</volume><fpage>1034</fpage><lpage>1044</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.05.018</pub-id><pub-id pub-id-type="pmid">32504556</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyiadzis</surname> <given-names>MM</given-names></name><name><surname>Kirkwood</surname> <given-names>JM</given-names></name><name><surname>Marshall</surname> <given-names>JL</given-names></name><name><surname>Pritchard</surname> <given-names>CC</given-names></name><name><surname>Azad</surname> <given-names>NS</given-names></name><name><surname>Gulley</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease</article-title><source>Journal for ImmunoTherapy of Cancer</source><volume>6</volume><elocation-id>35</elocation-id><pub-id pub-id-type="doi">10.1186/s40425-018-0342-x</pub-id><pub-id pub-id-type="pmid">29754585</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname> <given-names>A</given-names></name><name><surname>Singer</surname> <given-names>K</given-names></name><name><surname>Koehl</surname> <given-names>GE</given-names></name><name><surname>Kolitzus</surname> <given-names>M</given-names></name><name><surname>Schoenhammer</surname> <given-names>G</given-names></name><name><surname>Thiel</surname> <given-names>A</given-names></name><name><surname>Matos</surname> <given-names>C</given-names></name><name><surname>Bruss</surname> <given-names>C</given-names></name><name><surname>Klobuch</surname> <given-names>S</given-names></name><name><surname>Peter</surname> <given-names>K</given-names></name><name><surname>Kastenberger</surname> <given-names>M</given-names></name><name><surname>Bogdan</surname> <given-names>C</given-names></name><name><surname>Schleicher</surname> <given-names>U</given-names></name><name><surname>Mackensen</surname> <given-names>A</given-names></name><name><surname>Ullrich</surname> <given-names>E</given-names></name><name><surname>Fichtner-Feigl</surname> <given-names>S</given-names></name><name><surname>Kesselring</surname> <given-names>R</given-names></name><name><surname>Mack</surname> <given-names>M</given-names></name><name><surname>Ritter</surname> <given-names>U</given-names></name><name><surname>Schmid</surname> <given-names>M</given-names></name><name><surname>Blank</surname> <given-names>C</given-names></name><name><surname>Dettmer</surname> <given-names>K</given-names></name><name><surname>Oefner</surname> <given-names>PJ</given-names></name><name><surname>Hoffmann</surname> <given-names>P</given-names></name><name><surname>Walenta</surname> <given-names>S</given-names></name><name><surname>Geissler</surname> <given-names>EK</given-names></name><name><surname>Pouyssegur</surname> <given-names>J</given-names></name><name><surname>Villunger</surname> <given-names>A</given-names></name><name><surname>Steven</surname> <given-names>A</given-names></name><name><surname>Seliger</surname> <given-names>B</given-names></name><name><surname>Schreml</surname> <given-names>S</given-names></name><name><surname>Haferkamp</surname> <given-names>S</given-names></name><name><surname>Kohl</surname> <given-names>E</given-names></name><name><surname>Karrer</surname> <given-names>S</given-names></name><name><surname>Berneburg</surname> <given-names>M</given-names></name><name><surname>Herr</surname> <given-names>W</given-names></name><name><surname>Mueller-Klieser</surname> <given-names>W</given-names></name><name><surname>Renner</surname> <given-names>K</given-names></name><name><surname>Kreutz</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells</article-title><source>Cell Metabolism</source><volume>24</volume><fpage>657</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.08.011</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bremer</surname> <given-names>AA</given-names></name><name><surname>Jialal</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adipose tissue dysfunction in nascent metabolic syndrome</article-title><source>Journal of Obesity</source><volume>2013</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2013/393192</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname> <given-names>MD</given-names></name><name><surname>O'Sullivan</surname> <given-names>D</given-names></name><name><surname>Klein Geltink</surname> <given-names>RI</given-names></name><name><surname>Curtis</surname> <given-names>JD</given-names></name><name><surname>Chang</surname> <given-names>CH</given-names></name><name><surname>Sanin</surname> <given-names>DE</given-names></name><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>Kretz</surname> <given-names>O</given-names></name><name><surname>Braas</surname> <given-names>D</given-names></name><name><surname>van der Windt</surname> <given-names>GJ</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Huang</surname> <given-names>SC</given-names></name><name><surname>O'Neill</surname> <given-names>CM</given-names></name><name><surname>Edelson</surname> <given-names>BT</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Sesaki</surname> <given-names>H</given-names></name><name><surname>Huber</surname> <given-names>TB</given-names></name><name><surname>Rambold</surname> <given-names>AS</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial dynamics controls T cell fate through metabolic programming</article-title><source>Cell</source><volume>166</volume><fpage>63</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.035</pub-id><pub-id pub-id-type="pmid">27293185</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname> <given-names>MD</given-names></name><name><surname>Sowell</surname> <given-names>RT</given-names></name><name><surname>Kaech</surname> <given-names>SM</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolic instruction of immunity</article-title><source>Cell</source><volume>169</volume><fpage>570</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.04.004</pub-id><pub-id pub-id-type="pmid">28475890</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnet</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1957">1957</year><article-title>Cancer: a biological approach</article-title><source>British Medical Journal</source><volume>1</volume><fpage>841</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.5023.841</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cash</surname> <given-names>H</given-names></name><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Moore</surname> <given-names>E</given-names></name><name><surname>Caruso</surname> <given-names>A</given-names></name><name><surname>Uppaluri</surname> <given-names>R</given-names></name><name><surname>Van Waes</surname> <given-names>C</given-names></name><name><surname>Allen</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity Cancer</article-title><source>Oncotarget</source><volume>6</volume><fpage>36400</fpage><lpage>36417</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.5063</pub-id><pub-id pub-id-type="pmid">26506415</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname> <given-names>F</given-names></name><name><surname>Leal</surname> <given-names>B</given-names></name><name><surname>Denny</surname> <given-names>A</given-names></name><name><surname>Bahar</surname> <given-names>R</given-names></name><name><surname>Lampkin</surname> <given-names>S</given-names></name><name><surname>Reddick</surname> <given-names>R</given-names></name><name><surname>Lu</surname> <given-names>S</given-names></name><name><surname>Gravekamp</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast Cancer</article-title><source>British Journal of Cancer</source><volume>101</volume><fpage>1329</fpage><lpage>1337</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6605329</pub-id><pub-id pub-id-type="pmid">19826426</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname> <given-names>JH</given-names></name><name><surname>Yang</surname> <given-names>WH</given-names></name><name><surname>Xia</surname> <given-names>W</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Chan</surname> <given-names>LC</given-names></name><name><surname>Lim</surname> <given-names>SO</given-names></name><name><surname>Li</surname> <given-names>CW</given-names></name><name><surname>Kim</surname> <given-names>T</given-names></name><name><surname>Chang</surname> <given-names>SS</given-names></name><name><surname>Lee</surname> <given-names>HH</given-names></name><name><surname>Hsu</surname> <given-names>JL</given-names></name><name><surname>Wang</surname> <given-names>HL</given-names></name><name><surname>Kuo</surname> <given-names>CW</given-names></name><name><surname>Chang</surname> <given-names>WC</given-names></name><name><surname>Hadad</surname> <given-names>S</given-names></name><name><surname>Purdie</surname> <given-names>CA</given-names></name><name><surname>McCoy</surname> <given-names>AM</given-names></name><name><surname>Cai</surname> <given-names>S</given-names></name><name><surname>Tu</surname> <given-names>Y</given-names></name><name><surname>Litton</surname> <given-names>JK</given-names></name><name><surname>Mittendorf</surname> <given-names>EA</given-names></name><name><surname>Moulder</surname> <given-names>SL</given-names></name><name><surname>Symmans</surname> <given-names>WF</given-names></name><name><surname>Thompson</surname> <given-names>AM</given-names></name><name><surname>Piwnica-Worms</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Khoo</surname> <given-names>KH</given-names></name><name><surname>Hung</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metformin promotes antitumor immunity via Endoplasmic-Reticulum-Associated degradation of PD-L1</article-title><source>Molecular Cell</source><volume>71</volume><fpage>606</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.07.030</pub-id><pub-id pub-id-type="pmid">30118680</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>CH</given-names></name><name><surname>Curtis</surname> <given-names>JD</given-names></name><name><surname>Maggi</surname> <given-names>LB</given-names></name><name><surname>Faubert</surname> <given-names>B</given-names></name><name><surname>Villarino</surname> <given-names>AV</given-names></name><name><surname>O'Sullivan</surname> <given-names>D</given-names></name><name><surname>Huang</surname> <given-names>SC</given-names></name><name><surname>van der Windt</surname> <given-names>GJ</given-names></name><name><surname>Blagih</surname> <given-names>J</given-names></name><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>Weber</surname> <given-names>JD</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Jones</surname> <given-names>RG</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Posttranscriptional control of T cell effector function by aerobic glycolysis</article-title><source>Cell</source><volume>153</volume><fpage>1239</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.016</pub-id><pub-id pub-id-type="pmid">23746840</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>CH</given-names></name><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>O'Sullivan</surname> <given-names>D</given-names></name><name><surname>Buck</surname> <given-names>MD</given-names></name><name><surname>Noguchi</surname> <given-names>T</given-names></name><name><surname>Curtis</surname> <given-names>JD</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Gindin</surname> <given-names>M</given-names></name><name><surname>Gubin</surname> <given-names>MM</given-names></name><name><surname>van der Windt</surname> <given-names>GJ</given-names></name><name><surname>Tonc</surname> <given-names>E</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Metabolic competition in the tumor microenvironment is a driver of Cancer progression</article-title><source>Cell</source><volume>162</volume><fpage>1229</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.08.016</pub-id><pub-id pub-id-type="pmid">26321679</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaoul</surname> <given-names>N</given-names></name><name><surname>Fayolle</surname> <given-names>C</given-names></name><name><surname>Desrues</surname> <given-names>B</given-names></name><name><surname>Oberkampf</surname> <given-names>M</given-names></name><name><surname>Tang</surname> <given-names>A</given-names></name><name><surname>Ladant</surname> <given-names>D</given-names></name><name><surname>Leclerc</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rapamycin impairs antitumor CD8+ T-cell responses and Vaccine-Induced tumor eradication</article-title><source>Cancer Research</source><volume>75</volume><fpage>3279</fpage><lpage>3291</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-0454</pub-id><pub-id pub-id-type="pmid">26122844</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaplin</surname> <given-names>DD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Overview of the immune response</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>125</volume><fpage>S3</fpage><lpage>S23</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2009.12.980</pub-id><pub-id pub-id-type="pmid">20176265</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname> <given-names>S</given-names></name><name><surname>Daenthanasanmak</surname> <given-names>A</given-names></name><name><surname>Chakraborty</surname> <given-names>P</given-names></name><name><surname>Wyatt</surname> <given-names>MW</given-names></name><name><surname>Dhar</surname> <given-names>P</given-names></name><name><surname>Selvam</surname> <given-names>SP</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Nguyen</surname> <given-names>H</given-names></name><name><surname>Kang</surname> <given-names>I</given-names></name><name><surname>Toth</surname> <given-names>K</given-names></name><name><surname>Al-Homrani</surname> <given-names>M</given-names></name><name><surname>Husain</surname> <given-names>M</given-names></name><name><surname>Beeson</surname> <given-names>G</given-names></name><name><surname>Ball</surname> <given-names>L</given-names></name><name><surname>Helke</surname> <given-names>K</given-names></name><name><surname>Husain</surname> <given-names>S</given-names></name><name><surname>Garrett-Mayer</surname> <given-names>E</given-names></name><name><surname>Hardiman</surname> <given-names>G</given-names></name><name><surname>Mehrotra</surname> <given-names>M</given-names></name><name><surname>Nishimura</surname> <given-names>MI</given-names></name><name><surname>Beeson</surname> <given-names>CC</given-names></name><name><surname>Bupp</surname> <given-names>MG</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Ogretmen</surname> <given-names>B</given-names></name><name><surname>Paulos</surname> <given-names>CM</given-names></name><name><surname>Rathmell</surname> <given-names>J</given-names></name><name><surname>Yu</surname> <given-names>XZ</given-names></name><name><surname>Mehrotra</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CD38-NAD<sup>+</sup>Axis regulates immunotherapeutic Anti-Tumor T cell response</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>85</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.10.006</pub-id><pub-id pub-id-type="pmid">29129787</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells</article-title><source>Science Signaling</source><volume>2</volume><elocation-id>ra75</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2000559</pub-id><pub-id pub-id-type="pmid">19934433</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname> <given-names>BC</given-names></name><name><surname>Martin</surname> <given-names>BE</given-names></name><name><surname>Stolberg</surname> <given-names>VR</given-names></name><name><surname>Chensue</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cutting edge: central memory CD8 T cells in aged mice are virtual memory cells</article-title><source>The Journal of Immunology</source><volume>191</volume><fpage>5793</fpage><lpage>5796</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302509</pub-id><pub-id pub-id-type="pmid">24227783</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname> <given-names>PS</given-names></name><name><surname>Chamoto</surname> <given-names>K</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Honjo</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PPAR-Induced fatty acid oxidation in T cells increases the number of Tumor-Reactive CD8<sup>+</sup> T Cells and Facilitates Anti-PD-1 Therapy</article-title><source>Cancer Immunology Research</source><volume>6</volume><fpage>1375</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-18-0095</pub-id><pub-id pub-id-type="pmid">30143538</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clements</surname> <given-names>VK</given-names></name><name><surname>Long</surname> <given-names>T</given-names></name><name><surname>Long</surname> <given-names>R</given-names></name><name><surname>Figley</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>DMC</given-names></name><name><surname>Ostrand-Rosenberg</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Frontline science: high fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells</article-title><source>Journal of Leukocyte Biology</source><volume>103</volume><fpage>395</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1002/JLB.4HI0517-210R</pub-id><pub-id pub-id-type="pmid">29345342</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>HY</given-names></name><name><surname>Miller</surname> <given-names>C</given-names></name><name><surname>Bitterman</surname> <given-names>KJ</given-names></name><name><surname>Wall</surname> <given-names>NR</given-names></name><name><surname>Hekking</surname> <given-names>B</given-names></name><name><surname>Kessler</surname> <given-names>B</given-names></name><name><surname>Howitz</surname> <given-names>KT</given-names></name><name><surname>Gorospe</surname> <given-names>M</given-names></name><name><surname>de Cabo</surname> <given-names>R</given-names></name><name><surname>Sinclair</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase</article-title><source>Science</source><volume>305</volume><fpage>390</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1126/science.1099196</pub-id><pub-id pub-id-type="pmid">15205477</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>N</given-names></name><name><surname>Han</surname> <given-names>SJ</given-names></name><name><surname>Enamorado</surname> <given-names>M</given-names></name><name><surname>Link</surname> <given-names>VM</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Moseman</surname> <given-names>EA</given-names></name><name><surname>Kishton</surname> <given-names>RJ</given-names></name><name><surname>Shannon</surname> <given-names>JP</given-names></name><name><surname>Dixit</surname> <given-names>D</given-names></name><name><surname>Schwab</surname> <given-names>SR</given-names></name><name><surname>Hickman</surname> <given-names>HD</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name><name><surname>McGavern</surname> <given-names>DB</given-names></name><name><surname>Schwartzberg</surname> <given-names>PL</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The bone marrow protects and optimizes immunological memory during dietary restriction</article-title><source>Cell</source><volume>178</volume><fpage>1088</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.07.049</pub-id><pub-id pub-id-type="pmid">31442402</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colman</surname> <given-names>RJ</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Johnson</surname> <given-names>SC</given-names></name><name><surname>Kastman</surname> <given-names>EK</given-names></name><name><surname>Kosmatka</surname> <given-names>KJ</given-names></name><name><surname>Beasley</surname> <given-names>TM</given-names></name><name><surname>Allison</surname> <given-names>DB</given-names></name><name><surname>Cruzen</surname> <given-names>C</given-names></name><name><surname>Simmons</surname> <given-names>HA</given-names></name><name><surname>Kemnitz</surname> <given-names>JW</given-names></name><name><surname>Weindruch</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Caloric restriction delays disease onset and mortality in rhesus monkeys</article-title><source>Science</source><volume>325</volume><fpage>201</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1126/science.1173635</pub-id><pub-id pub-id-type="pmid">19590001</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>MD</given-names></name><name><surname>Peterson</surname> <given-names>RD</given-names></name><name><surname>Good</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Delineation of the thymic and bursal lymphoid systems in the chicken</article-title><source>Nature</source><volume>205</volume><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/205143a0</pub-id><pub-id pub-id-type="pmid">14276257</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbaux</surname> <given-names>P</given-names></name><name><surname>Maillet</surname> <given-names>D</given-names></name><name><surname>Boespflug</surname> <given-names>A</given-names></name><name><surname>Locatelli-Sanchez</surname> <given-names>M</given-names></name><name><surname>Perier-Muzet</surname> <given-names>M</given-names></name><name><surname>Duruisseaux</surname> <given-names>M</given-names></name><name><surname>Kiakouama-Maleka</surname> <given-names>L</given-names></name><name><surname>Dalle</surname> <given-names>S</given-names></name><name><surname>Falandry</surname> <given-names>C</given-names></name><name><surname>Péron</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting</article-title><source>European Journal of Cancer</source><volume>121</volume><fpage>192</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2019.08.027</pub-id><pub-id pub-id-type="pmid">31590080</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname> <given-names>B</given-names></name><name><surname>Eberlein</surname> <given-names>J</given-names></name><name><surname>van der Heide</surname> <given-names>V</given-names></name><name><surname>Jhun</surname> <given-names>K</given-names></name><name><surname>Nguyen</surname> <given-names>TT</given-names></name><name><surname>Victorino</surname> <given-names>F</given-names></name><name><surname>Trotta</surname> <given-names>A</given-names></name><name><surname>Chipuk</surname> <given-names>J</given-names></name><name><surname>Yi</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Clambey</surname> <given-names>ET</given-names></name><name><surname>Scott</surname> <given-names>DK</given-names></name><name><surname>Homann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Aging of antiviral CD8<sup>+</sup>memory T cells fosters increased survival, metabolic adaptations, and lymphoid tissue homing</article-title><source>The Journal of Immunology</source><volume>202</volume><fpage>460</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1801277</pub-id><pub-id pub-id-type="pmid">30552164</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Cabo</surname> <given-names>R</given-names></name><name><surname>Mattson</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Effects of intermittent fasting on health, aging, and disease</article-title><source>New England Journal of Medicine</source><volume>381</volume><fpage>2541</fpage><lpage>2551</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1905136</pub-id><pub-id pub-id-type="pmid">31881139</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname> <given-names>WK</given-names></name><name><surname>da Silva</surname> <given-names>RF</given-names></name><name><surname>Sanabria</surname> <given-names>MH</given-names></name><name><surname>Angelo</surname> <given-names>LS</given-names></name><name><surname>Guimarães</surname> <given-names>F</given-names></name><name><surname>Burt</surname> <given-names>BM</given-names></name><name><surname>Kheradmand</surname> <given-names>F</given-names></name><name><surname>Paust</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cancer immunotherapy: historical perspective of a clinical revolution and emerging preclinical animal models</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>829</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00829</pub-id><pub-id pub-id-type="pmid">28824608</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decman</surname> <given-names>V</given-names></name><name><surname>Laidlaw</surname> <given-names>BJ</given-names></name><name><surname>Dimenna</surname> <given-names>LJ</given-names></name><name><surname>Abdulla</surname> <given-names>S</given-names></name><name><surname>Mozdzanowska</surname> <given-names>K</given-names></name><name><surname>Erikson</surname> <given-names>J</given-names></name><name><surname>Ertl</surname> <given-names>HC</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection</article-title><source>The Journal of Immunology</source><volume>184</volume><fpage>5151</fpage><lpage>5159</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902063</pub-id><pub-id pub-id-type="pmid">20368274</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decman</surname> <given-names>V</given-names></name><name><surname>Laidlaw</surname> <given-names>BJ</given-names></name><name><surname>Doering</surname> <given-names>TA</given-names></name><name><surname>Leng</surname> <given-names>J</given-names></name><name><surname>Ertl</surname> <given-names>HC</given-names></name><name><surname>Goldstein</surname> <given-names>DR</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors</article-title><source>The Journal of Immunology</source><volume>188</volume><fpage>1933</fpage><lpage>1941</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101098</pub-id><pub-id pub-id-type="pmid">22246631</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Luo</surname> <given-names>F</given-names></name><name><surname>Qian</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name><name><surname>Chu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells</article-title><source>Cancer Immunology, Immunotherapy</source><volume>67</volume><fpage>1355</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1007/s00262-018-2177-1</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desdín-Micó</surname> <given-names>G</given-names></name><name><surname>Soto-Heredero</surname> <given-names>G</given-names></name><name><surname>Aranda</surname> <given-names>JF</given-names></name><name><surname>Oller</surname> <given-names>J</given-names></name><name><surname>Carrasco</surname> <given-names>E</given-names></name><name><surname>Gabandé-Rodríguez</surname> <given-names>E</given-names></name><name><surname>Blanco</surname> <given-names>EM</given-names></name><name><surname>Alfranca</surname> <given-names>A</given-names></name><name><surname>Cussó</surname> <given-names>L</given-names></name><name><surname>Desco</surname> <given-names>M</given-names></name><name><surname>Ibañez</surname> <given-names>B</given-names></name><name><surname>Gortazar</surname> <given-names>AR</given-names></name><name><surname>Fernández-Marcos</surname> <given-names>P</given-names></name><name><surname>Navarro</surname> <given-names>MN</given-names></name><name><surname>Hernaez</surname> <given-names>B</given-names></name><name><surname>Alcamí</surname> <given-names>A</given-names></name><name><surname>Baixauli</surname> <given-names>F</given-names></name><name><surname>Mittelbrunn</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>T cells with dysfunctional mitochondria induce multimorbidity and premature senescence</article-title><source>Science</source><volume>368</volume><fpage>1371</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1126/science.aax0860</pub-id><pub-id pub-id-type="pmid">32439659</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Biase</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Brandhorst</surname> <given-names>S</given-names></name><name><surname>Manes</surname> <given-names>B</given-names></name><name><surname>Buono</surname> <given-names>R</given-names></name><name><surname>Cheng</surname> <given-names>CW</given-names></name><name><surname>Cacciottolo</surname> <given-names>M</given-names></name><name><surname>Martin-Montalvo</surname> <given-names>A</given-names></name><name><surname>de Cabo</surname> <given-names>R</given-names></name><name><surname>Wei</surname> <given-names>M</given-names></name><name><surname>Morgan</surname> <given-names>TE</given-names></name><name><surname>Longo</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fasting-Mimicking diet reduces HO-1 to promote T Cell-Mediated Tumor Cytotoxicity</article-title><source>Cancer Cell</source><volume>30</volume><fpage>136</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.06.005</pub-id><pub-id pub-id-type="pmid">27411588</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname> <given-names>AL</given-names></name><name><surname>Lustgarten</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Implications of aging and self-tolerance on the generation of immune and antitumor immune responses</article-title><source>Cancer Research</source><volume>68</volume><fpage>5423</fpage><lpage>5431</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-6436</pub-id><pub-id pub-id-type="pmid">18593945</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>H</given-names></name><name><surname>Strome</surname> <given-names>SE</given-names></name><name><surname>Salomao</surname> <given-names>DR</given-names></name><name><surname>Tamura</surname> <given-names>H</given-names></name><name><surname>Hirano</surname> <given-names>F</given-names></name><name><surname>Flies</surname> <given-names>DB</given-names></name><name><surname>Roche</surname> <given-names>PC</given-names></name><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>G</given-names></name><name><surname>Tamada</surname> <given-names>K</given-names></name><name><surname>Lennon</surname> <given-names>VA</given-names></name><name><surname>Celis</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion</article-title><source>Nature Medicine</source><volume>8</volume><fpage>793</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1038/nm730</pub-id><pub-id pub-id-type="pmid">12091876</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname> <given-names>GP</given-names></name><name><surname>Bruce</surname> <given-names>AT</given-names></name><name><surname>Ikeda</surname> <given-names>H</given-names></name><name><surname>Old</surname> <given-names>LJ</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cancer immunoediting: from immunosurveillance to tumor escape</article-title><source>Nature Immunology</source><volume>3</volume><fpage>991</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1038/ni1102-991</pub-id><pub-id pub-id-type="pmid">12407406</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyck</surname> <given-names>L</given-names></name><name><surname>Lynch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cancer, obesity and immunometabolism – Connecting the dots</article-title><source>Cancer Letters</source><volume>417</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2017.12.019</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1909">1909</year><article-title>Über den jetzigen stand der karzinomforschung</article-title><source>Nederlands Tijdschrift Voor Geneeskunde</source><volume>5</volume><fpage>273</fpage><lpage>290</lpage></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eikawa</surname> <given-names>S</given-names></name><name><surname>Nishida</surname> <given-names>M</given-names></name><name><surname>Mizukami</surname> <given-names>S</given-names></name><name><surname>Yamazaki</surname> <given-names>C</given-names></name><name><surname>Nakayama</surname> <given-names>E</given-names></name><name><surname>Udono</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune-mediated antitumor effect by type 2 diabetes drug, metformin</article-title><source>PNAS</source><volume>112</volume><fpage>1809</fpage><lpage>1814</lpage><pub-id pub-id-type="doi">10.1073/pnas.1417636112</pub-id><pub-id pub-id-type="pmid">25624476</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esensten</surname> <given-names>JH</given-names></name><name><surname>Helou</surname> <given-names>YA</given-names></name><name><surname>Chopra</surname> <given-names>G</given-names></name><name><surname>Weiss</surname> <given-names>A</given-names></name><name><surname>Bluestone</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>CD28 costimulation: from mechanism to therapy</article-title><source>Immunity</source><volume>44</volume><fpage>973</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.04.020</pub-id><pub-id pub-id-type="pmid">27192564</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fane</surname> <given-names>M</given-names></name><name><surname>Weeraratna</surname> <given-names>AT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>How the ageing microenvironment influences tumour progression</article-title><source>Nature Reviews Cancer</source><volume>20</volume><fpage>89</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0222-9</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farazi</surname> <given-names>M</given-names></name><name><surname>Nguyen</surname> <given-names>J</given-names></name><name><surname>Goldufsky</surname> <given-names>J</given-names></name><name><surname>Linnane</surname> <given-names>S</given-names></name><name><surname>Lukaesko</surname> <given-names>L</given-names></name><name><surname>Weinberg</surname> <given-names>AD</given-names></name><name><surname>Ruby</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging</article-title><source>Cancer Immunology, Immunotherapy</source><volume>63</volume><fpage>615</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1007/s00262-014-1542-y</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farhood</surname> <given-names>B</given-names></name><name><surname>Najafi</surname> <given-names>M</given-names></name><name><surname>Mortezaee</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CD8<sup>+</sup> cytotoxic T lymphocytes in Cancer immunotherapy: a review</article-title><source>Journal of Cellular Physiology</source><volume>234</volume><fpage>8509</fpage><lpage>8521</lpage><pub-id pub-id-type="doi">10.1002/jcp.27782</pub-id><pub-id pub-id-type="pmid">30520029</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>G</given-names></name><name><surname>Yunis</surname> <given-names>EJ</given-names></name><name><surname>Good</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Suppression of adenocarcinoma by the immunological consequences of calorie restriction</article-title><source>Nature</source><volume>263</volume><fpage>504</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1038/263504b0</pub-id><pub-id pub-id-type="pmid">1085916</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feuerer</surname> <given-names>M</given-names></name><name><surname>Herrero</surname> <given-names>L</given-names></name><name><surname>Cipolletta</surname> <given-names>D</given-names></name><name><surname>Naaz</surname> <given-names>A</given-names></name><name><surname>Wong</surname> <given-names>J</given-names></name><name><surname>Nayer</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Goldfine</surname> <given-names>AB</given-names></name><name><surname>Benoist</surname> <given-names>C</given-names></name><name><surname>Shoelson</surname> <given-names>S</given-names></name><name><surname>Mathis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters</article-title><source>Nature Medicine</source><volume>15</volume><fpage>930</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1038/nm.2002</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filaci</surname> <given-names>G</given-names></name><name><surname>Fenoglio</surname> <given-names>D</given-names></name><name><surname>Fravega</surname> <given-names>M</given-names></name><name><surname>Ansaldo</surname> <given-names>G</given-names></name><name><surname>Borgonovo</surname> <given-names>G</given-names></name><name><surname>Traverso</surname> <given-names>P</given-names></name><name><surname>Villaggio</surname> <given-names>B</given-names></name><name><surname>Ferrera</surname> <given-names>A</given-names></name><name><surname>Kunkl</surname> <given-names>A</given-names></name><name><surname>Rizzi</surname> <given-names>M</given-names></name><name><surname>Ferrera</surname> <given-names>F</given-names></name><name><surname>Balestra</surname> <given-names>P</given-names></name><name><surname>Ghio</surname> <given-names>M</given-names></name><name><surname>Contini</surname> <given-names>P</given-names></name><name><surname>Setti</surname> <given-names>M</given-names></name><name><surname>Olive</surname> <given-names>D</given-names></name><name><surname>Azzarone</surname> <given-names>B</given-names></name><name><surname>Carmignani</surname> <given-names>G</given-names></name><name><surname>Ravetti</surname> <given-names>JL</given-names></name><name><surname>Torre</surname> <given-names>G</given-names></name><name><surname>Indiveri</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>CD8<sup>+</sup> CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers</article-title><source>Journal of Immunology</source><volume>179</volume><fpage>4323</fpage><lpage>4334</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.7.4323</pub-id><pub-id pub-id-type="pmid">17878327</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>HJ</given-names></name><name><surname>Sie</surname> <given-names>C</given-names></name><name><surname>Schumann</surname> <given-names>E</given-names></name><name><surname>Witte</surname> <given-names>AK</given-names></name><name><surname>Dressel</surname> <given-names>R</given-names></name><name><surname>van den Brandt</surname> <given-names>J</given-names></name><name><surname>Reichardt</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The insulin receptor plays a critical role in T cell function and adaptive immunity</article-title><source>The Journal of Immunology</source><volume>198</volume><fpage>1910</fpage><lpage>1920</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601011</pub-id><pub-id pub-id-type="pmid">28115529</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname> <given-names>L</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Promoting health and longevity through diet: from model organisms to humans</article-title><source>Cell</source><volume>161</volume><fpage>106</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.02.020</pub-id><pub-id pub-id-type="pmid">25815989</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Sanderson</surname> <given-names>SM</given-names></name><name><surname>Dai</surname> <given-names>Z</given-names></name><name><surname>Reid</surname> <given-names>MA</given-names></name><name><surname>Cooper</surname> <given-names>DE</given-names></name><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Richie</surname> <given-names>JP</given-names></name><name><surname>Ciccarella</surname> <given-names>A</given-names></name><name><surname>Calcagnotto</surname> <given-names>A</given-names></name><name><surname>Mikhael</surname> <given-names>PG</given-names></name><name><surname>Mentch</surname> <given-names>SJ</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Ables</surname> <given-names>G</given-names></name><name><surname>Kirsch</surname> <given-names>DG</given-names></name><name><surname>Hsu</surname> <given-names>DS</given-names></name><name><surname>Nichenametla</surname> <given-names>SN</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dietary methionine influences therapy in mouse Cancer models and alters human metabolism</article-title><source>Nature</source><volume>572</volume><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1437-3</pub-id><pub-id pub-id-type="pmid">31367041</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname> <given-names>R</given-names></name><name><surname>Rieckmann</surname> <given-names>JC</given-names></name><name><surname>Wolf</surname> <given-names>T</given-names></name><name><surname>Basso</surname> <given-names>C</given-names></name><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Fuhrer</surname> <given-names>T</given-names></name><name><surname>Kogadeeva</surname> <given-names>M</given-names></name><name><surname>Picotti</surname> <given-names>P</given-names></name><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Zamboni</surname> <given-names>N</given-names></name><name><surname>Sallusto</surname> <given-names>F</given-names></name><name><surname>Lanzavecchia</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>L-Arginine modulates T cell metabolism and enhances survival and Anti-tumor activity</article-title><source>Cell</source><volume>167</volume><fpage>829</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.031</pub-id><pub-id pub-id-type="pmid">27745970</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerriets</surname> <given-names>VA</given-names></name><name><surname>Danzaki</surname> <given-names>K</given-names></name><name><surname>Kishton</surname> <given-names>RJ</given-names></name><name><surname>Eisner</surname> <given-names>W</given-names></name><name><surname>Nichols</surname> <given-names>AG</given-names></name><name><surname>Saucillo</surname> <given-names>DC</given-names></name><name><surname>Shinohara</surname> <given-names>ML</given-names></name><name><surname>MacIver</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity</article-title><source>European Journal of Immunology</source><volume>46</volume><fpage>1970</fpage><lpage>1983</lpage><pub-id pub-id-type="doi">10.1002/eji.201545861</pub-id><pub-id pub-id-type="pmid">27222115</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goronzy</surname> <given-names>JJ</given-names></name><name><surname>Weyand</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mechanisms underlying T cell ageing</article-title><source>Nature Reviews Immunology</source><volume>19</volume><fpage>573</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0180-1</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname> <given-names>JB</given-names></name><name><surname>Graham</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1959">1959</year><article-title>The effect of vaccine on Cancer patients</article-title><source>Plastic and Reconstructive Surgery</source><volume>24</volume><elocation-id>535</elocation-id><pub-id pub-id-type="doi">10.1097/00006534-195911000-00016</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grizzle</surname> <given-names>WE</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Stockard</surname> <given-names>CR</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Yu</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Mountz</surname> <given-names>JD</given-names></name><name><surname>Zhang</surname> <given-names>HG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice</article-title><source>Mechanisms of Ageing and Development</source><volume>128</volume><fpage>672</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2007.10.003</pub-id><pub-id pub-id-type="pmid">18036633</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grolleau-Julius</surname> <given-names>A</given-names></name><name><surname>Garg</surname> <given-names>MR</given-names></name><name><surname>Mo</surname> <given-names>R</given-names></name><name><surname>Stoolman</surname> <given-names>LL</given-names></name><name><surname>Yung</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Effect of aging on bone Marrow-Derived murine CD11c+CD4-CD8 - Dendritic Cell Function</article-title><source>The Journals of Gerontology Series A: Biological Sciences and Medical Sciences</source><volume>61</volume><fpage>1039</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1093/gerona/61.10.1039</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grolleau-Julius</surname> <given-names>A</given-names></name><name><surname>Harning</surname> <given-names>EK</given-names></name><name><surname>Abernathy</surname> <given-names>LM</given-names></name><name><surname>Yung</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Impaired dendritic cell function in aging leads to defective antitumor immunity</article-title><source>Cancer Research</source><volume>68</volume><fpage>6341</fpage><lpage>6349</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5769</pub-id><pub-id pub-id-type="pmid">18676859</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname> <given-names>M</given-names></name><name><surname>Itani</surname> <given-names>F</given-names></name><name><surname>Buchta</surname> <given-names>CM</given-names></name><name><surname>Wald</surname> <given-names>G</given-names></name><name><surname>Bing</surname> <given-names>M</given-names></name><name><surname>Norian</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0118784</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0118784</pub-id><pub-id pub-id-type="pmid">25769110</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>JM</given-names></name><name><surname>Patterson</surname> <given-names>SJ</given-names></name><name><surname>Speck</surname> <given-names>M</given-names></name><name><surname>Ehses</surname> <given-names>JA</given-names></name><name><surname>Levings</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Insulin Inhibits IL-10–Mediated Regulatory T Cell Function: Implications for Obesity</article-title><source>The Journal of Immunology</source><volume>192</volume><fpage>623</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302181</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helderman</surname> <given-names>JH</given-names></name><name><surname>Raskin</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>The T Lymphocyte insulin Receptor in Diabetes and Obesity: An Intrinsic Binding Defect</article-title><source>Diabetes</source><volume>29</volume><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.2337/diab.29.7.551</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henson</surname> <given-names>SM</given-names></name><name><surname>Lanna</surname> <given-names>A</given-names></name><name><surname>Riddell</surname> <given-names>NE</given-names></name><name><surname>Franzese</surname> <given-names>O</given-names></name><name><surname>Macaulay</surname> <given-names>R</given-names></name><name><surname>Griffiths</surname> <given-names>SJ</given-names></name><name><surname>Puleston</surname> <given-names>DJ</given-names></name><name><surname>Watson</surname> <given-names>AS</given-names></name><name><surname>Simon</surname> <given-names>AK</given-names></name><name><surname>Tooze</surname> <given-names>SA</given-names></name><name><surname>Akbar</surname> <given-names>AN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>4004</fpage><lpage>4016</lpage><pub-id pub-id-type="doi">10.1172/JCI75051</pub-id><pub-id pub-id-type="pmid">25083993</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>PC</given-names></name><name><surname>Bihuniak</surname> <given-names>JD</given-names></name><name><surname>Macintyre</surname> <given-names>AN</given-names></name><name><surname>Staron</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Amezquita</surname> <given-names>R</given-names></name><name><surname>Tsui</surname> <given-names>YC</given-names></name><name><surname>Cui</surname> <given-names>G</given-names></name><name><surname>Micevic</surname> <given-names>G</given-names></name><name><surname>Perales</surname> <given-names>JC</given-names></name><name><surname>Kleinstein</surname> <given-names>SH</given-names></name><name><surname>Abel</surname> <given-names>ED</given-names></name><name><surname>Insogna</surname> <given-names>KL</given-names></name><name><surname>Feske</surname> <given-names>S</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name><name><surname>Bosenberg</surname> <given-names>MW</given-names></name><name><surname>Rathmell</surname> <given-names>JC</given-names></name><name><surname>Kaech</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Phosphoenolpyruvate is a metabolic checkpoint of Anti-tumor T cell responses</article-title><source>Cell</source><volume>162</volume><fpage>1217</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.08.012</pub-id><pub-id pub-id-type="pmid">26321681</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotamisligil</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Foundations of immunometabolism and implications for metabolic health and disease</article-title><source>Immunity</source><volume>47</volume><fpage>406</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.08.009</pub-id><pub-id pub-id-type="pmid">28930657</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>PL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A comprehensive definition for metabolic syndrome</article-title><source>Disease Models &amp; Mechanisms</source><volume>2</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1242/dmm.001180</pub-id><pub-id pub-id-type="pmid">19407331</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>XZ</given-names></name><name><surname>Gao</surname> <given-names>P</given-names></name><name><surname>Song</surname> <given-names>YX</given-names></name><name><surname>Sun</surname> <given-names>JX</given-names></name><name><surname>Chen</surname> <given-names>XW</given-names></name><name><surname>Zhao</surname> <given-names>JH</given-names></name><name><surname>Wang</surname> <given-names>ZN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Efficacy of immune checkpoint inhibitors and age in Cancer patients</article-title><source>Immunotherapy</source><volume>12</volume><fpage>587</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.2217/imt-2019-0124</pub-id><pub-id pub-id-type="pmid">32378444</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname> <given-names>WH</given-names></name><name><surname>Gensheimer</surname> <given-names>J</given-names></name><name><surname>Hashimoto</surname> <given-names>M</given-names></name><name><surname>Wieland</surname> <given-names>A</given-names></name><name><surname>Valanparambil</surname> <given-names>RM</given-names></name><name><surname>Li</surname> <given-names>P</given-names></name><name><surname>Lin</surname> <given-names>JX</given-names></name><name><surname>Konieczny</surname> <given-names>BT</given-names></name><name><surname>Im</surname> <given-names>SJ</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Leonard</surname> <given-names>WJ</given-names></name><name><surname>Kissick</surname> <given-names>HT</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Proliferating transitory T cells with an Effector-like transcriptional signature emerge from PD-1<sup>+</sup> Stem-like CD8<sup>+</sup> T Cells during Chronic Infection</article-title><source>Immunity</source><volume>51</volume><fpage>1043</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.11.002</pub-id><pub-id pub-id-type="pmid">31810882</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurez</surname> <given-names>V</given-names></name><name><surname>Daniel</surname> <given-names>BJ</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>AJ</given-names></name><name><surname>Ludwig</surname> <given-names>SM</given-names></name><name><surname>Kious</surname> <given-names>MJ</given-names></name><name><surname>Thibodeaux</surname> <given-names>SR</given-names></name><name><surname>Pandeswara</surname> <given-names>S</given-names></name><name><surname>Murthy</surname> <given-names>K</given-names></name><name><surname>Livi</surname> <given-names>CB</given-names></name><name><surname>Wall</surname> <given-names>S</given-names></name><name><surname>Brumlik</surname> <given-names>MJ</given-names></name><name><surname>Shin</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Curiel</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice</article-title><source>Cancer Research</source><volume>72</volume><fpage>2089</fpage><lpage>2099</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-3019</pub-id><pub-id pub-id-type="pmid">22496463</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname> <given-names>SJ</given-names></name><name><surname>Hashimoto</surname> <given-names>M</given-names></name><name><surname>Gerner</surname> <given-names>MY</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Kissick</surname> <given-names>HT</given-names></name><name><surname>Burger</surname> <given-names>MC</given-names></name><name><surname>Shan</surname> <given-names>Q</given-names></name><name><surname>Hale</surname> <given-names>JS</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Nasti</surname> <given-names>TH</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name><name><surname>Nakaya</surname> <given-names>HI</given-names></name><name><surname>Xue</surname> <given-names>HH</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy</article-title><source>Nature</source><volume>537</volume><fpage>417</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/nature19330</pub-id><pub-id pub-id-type="pmid">27501248</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Incio</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Suboj</surname> <given-names>P</given-names></name><name><surname>Chin</surname> <given-names>SM</given-names></name><name><surname>Chen</surname> <given-names>IX</given-names></name><name><surname>Pinter</surname> <given-names>M</given-names></name><name><surname>Ng</surname> <given-names>MR</given-names></name><name><surname>Nia</surname> <given-names>HT</given-names></name><name><surname>Grahovac</surname> <given-names>J</given-names></name><name><surname>Kao</surname> <given-names>S</given-names></name><name><surname>Babykutty</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Jung</surname> <given-names>K</given-names></name><name><surname>Rahbari</surname> <given-names>NN</given-names></name><name><surname>Han</surname> <given-names>X</given-names></name><name><surname>Chauhan</surname> <given-names>VP</given-names></name><name><surname>Martin</surname> <given-names>JD</given-names></name><name><surname>Kahn</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>P</given-names></name><name><surname>Desphande</surname> <given-names>V</given-names></name><name><surname>Michaelson</surname> <given-names>J</given-names></name><name><surname>Michelakos</surname> <given-names>TP</given-names></name><name><surname>Ferrone</surname> <given-names>CR</given-names></name><name><surname>Soares</surname> <given-names>R</given-names></name><name><surname>Boucher</surname> <given-names>Y</given-names></name><name><surname>Fukumura</surname> <given-names>D</given-names></name><name><surname>Jain</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Obesity-Induced inflammation and desmoplasia promote pancreatic Cancer progression and resistance to chemotherapy</article-title><source>Cancer Discovery</source><volume>6</volume><fpage>852</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-15-1177</pub-id><pub-id pub-id-type="pmid">27246539</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islami</surname> <given-names>F</given-names></name><name><surname>Goding Sauer</surname> <given-names>A</given-names></name><name><surname>Gapstur</surname> <given-names>SM</given-names></name><name><surname>Jemal</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Proportion of Cancer cases attributable to excess body weight by US state, 2011-2015</article-title><source>JAMA Oncology</source><volume>5</volume><elocation-id>5639</elocation-id><pub-id pub-id-type="doi">10.1001/jamaoncol.2018.5639</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname> <given-names>SS</given-names></name><name><surname>Chatraw</surname> <given-names>JH</given-names></name><name><surname>Tan</surname> <given-names>WG</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Becker</surname> <given-names>TC</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name><name><surname>Kapasi</surname> <given-names>ZF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Protein energy malnutrition impairs homeostatic proliferation of memory CD8 T cells</article-title><source>The Journal of Immunology</source><volume>188</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1004027</pub-id><pub-id pub-id-type="pmid">22116826</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackaman</surname> <given-names>C</given-names></name><name><surname>Radley-Crabb</surname> <given-names>HG</given-names></name><name><surname>Soffe</surname> <given-names>Z</given-names></name><name><surname>Shavlakadze</surname> <given-names>T</given-names></name><name><surname>Grounds</surname> <given-names>MD</given-names></name><name><surname>Nelson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice</article-title><source>Aging Cell</source><volume>12</volume><fpage>345</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1111/acel.12062</pub-id><pub-id pub-id-type="pmid">23442123</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackaman</surname> <given-names>C</given-names></name><name><surname>Gardner</surname> <given-names>JK</given-names></name><name><surname>Tomay</surname> <given-names>F</given-names></name><name><surname>Spowart</surname> <given-names>J</given-names></name><name><surname>Crabb</surname> <given-names>H</given-names></name><name><surname>Dye</surname> <given-names>DE</given-names></name><name><surname>Fox</surname> <given-names>S</given-names></name><name><surname>Proksch</surname> <given-names>S</given-names></name><name><surname>Metharom</surname> <given-names>P</given-names></name><name><surname>Dhaliwal</surname> <given-names>SS</given-names></name><name><surname>Nelson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CD8<sup>+</sup> cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy</article-title><source>OncoImmunology</source><volume>8</volume><elocation-id>e1564452</elocation-id><pub-id pub-id-type="doi">10.1080/2162402X.2018.1564452</pub-id><pub-id pub-id-type="pmid">30906657</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacoby</surname> <given-names>E</given-names></name><name><surname>Shahani</surname> <given-names>SA</given-names></name><name><surname>Shah</surname> <given-names>NN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Updates on CAR T-cell therapy in B-cell malignancies</article-title><source>Immunological Reviews</source><volume>290</volume><fpage>39</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1111/imr.12774</pub-id><pub-id pub-id-type="pmid">31355492</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname> <given-names>BR</given-names></name><name><surname>Tomanek-Chalkley</surname> <given-names>A</given-names></name><name><surname>Askeland</surname> <given-names>EJ</given-names></name><name><surname>Kucaba</surname> <given-names>T</given-names></name><name><surname>Griffith</surname> <given-names>TS</given-names></name><name><surname>Norian</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth</article-title><source>The Journal of Immunology</source><volume>189</volume><fpage>1311</fpage><lpage>1321</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100587</pub-id><pub-id pub-id-type="pmid">22745381</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname> <given-names>RR</given-names></name><name><surname>Chasalow</surname> <given-names>SD</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Hamid</surname> <given-names>O</given-names></name><name><surname>Schmidt</surname> <given-names>H</given-names></name><name><surname>Cogswell</surname> <given-names>J</given-names></name><name><surname>Alaparthy</surname> <given-names>S</given-names></name><name><surname>Berman</surname> <given-names>D</given-names></name><name><surname>Jure-Kunkel</surname> <given-names>M</given-names></name><name><surname>Siemers</surname> <given-names>NO</given-names></name><name><surname>Jackson</surname> <given-names>JR</given-names></name><name><surname>Shahabi</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>An immune-active tumor microenvironment favors clinical response to ipilimumab</article-title><source>Cancer Immunology, Immunotherapy : CII</source><volume>61</volume><fpage>1019</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1007/s00262-011-1172-6</pub-id><pub-id pub-id-type="pmid">22146893</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>H</given-names></name><name><surname>Westerterp</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Ai</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice</article-title><source>Diabetologia</source><volume>57</volume><fpage>2393</fpage><lpage>2404</lpage><pub-id pub-id-type="doi">10.1007/s00125-014-3350-5</pub-id><pub-id pub-id-type="pmid">25120095</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>June</surname> <given-names>CH</given-names></name><name><surname>O’Connor</surname> <given-names>RS</given-names></name><name><surname>Kawalekar</surname> <given-names>OU</given-names></name><name><surname>Ghassemi</surname> <given-names>S</given-names></name><name><surname>Milone</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CAR T cell immunotherapy for human cancer</article-title><source>Science</source><volume>359</volume><fpage>1361</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1126/science.aar6711</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katewa</surname> <given-names>SD</given-names></name><name><surname>Kapahi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dietary restriction and aging, 2009</article-title><source>Aging Cell</source><volume>9</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00552.x</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname> <given-names>A</given-names></name><name><surname>Webster</surname> <given-names>MR</given-names></name><name><surname>Marchbank</surname> <given-names>K</given-names></name><name><surname>Behera</surname> <given-names>R</given-names></name><name><surname>Ndoye</surname> <given-names>A</given-names></name><name><surname>Kugel</surname> <given-names>CH</given-names></name><name><surname>Dang</surname> <given-names>VM</given-names></name><name><surname>Appleton</surname> <given-names>J</given-names></name><name><surname>O'Connell</surname> <given-names>MP</given-names></name><name><surname>Cheng</surname> <given-names>P</given-names></name><name><surname>Valiga</surname> <given-names>AA</given-names></name><name><surname>Morissette</surname> <given-names>R</given-names></name><name><surname>McDonnell</surname> <given-names>NB</given-names></name><name><surname>Ferrucci</surname> <given-names>L</given-names></name><name><surname>Kossenkov</surname> <given-names>AV</given-names></name><name><surname>Meeth</surname> <given-names>K</given-names></name><name><surname>Tang</surname> <given-names>HY</given-names></name><name><surname>Yin</surname> <given-names>X</given-names></name><name><surname>Wood</surname> <given-names>WH</given-names></name><name><surname>Lehrmann</surname> <given-names>E</given-names></name><name><surname>Becker</surname> <given-names>KG</given-names></name><name><surname>Flaherty</surname> <given-names>KT</given-names></name><name><surname>Frederick</surname> <given-names>DT</given-names></name><name><surname>Wargo</surname> <given-names>JA</given-names></name><name><surname>Cooper</surname> <given-names>ZA</given-names></name><name><surname>Tetzlaff</surname> <given-names>MT</given-names></name><name><surname>Hudgens</surname> <given-names>C</given-names></name><name><surname>Aird</surname> <given-names>KM</given-names></name><name><surname>Zhang</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Bartlett</surname> <given-names>E</given-names></name><name><surname>Karakousis</surname> <given-names>G</given-names></name><name><surname>Eroglu</surname> <given-names>Z</given-names></name><name><surname>Lo</surname> <given-names>RS</given-names></name><name><surname>Chan</surname> <given-names>M</given-names></name><name><surname>Menzies</surname> <given-names>AM</given-names></name><name><surname>Long</surname> <given-names>GV</given-names></name><name><surname>Johnson</surname> <given-names>DB</given-names></name><name><surname>Sosman</surname> <given-names>J</given-names></name><name><surname>Schilling</surname> <given-names>B</given-names></name><name><surname>Schadendorf</surname> <given-names>D</given-names></name><name><surname>Speicher</surname> <given-names>DW</given-names></name><name><surname>Bosenberg</surname> <given-names>M</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name><name><surname>Weeraratna</surname> <given-names>AT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance</article-title><source>Nature</source><volume>532</volume><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/nature17392</pub-id><pub-id pub-id-type="pmid">27042933</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname> <given-names>A</given-names></name><name><surname>Ecker</surname> <given-names>BL</given-names></name><name><surname>Douglass</surname> <given-names>SM</given-names></name><name><surname>Kugel</surname> <given-names>CH</given-names></name><name><surname>Webster</surname> <given-names>MR</given-names></name><name><surname>Almeida</surname> <given-names>FV</given-names></name><name><surname>Somasundaram</surname> <given-names>R</given-names></name><name><surname>Hayden</surname> <given-names>J</given-names></name><name><surname>Ban</surname> <given-names>E</given-names></name><name><surname>Ahmadzadeh</surname> <given-names>H</given-names></name><name><surname>Franco-Barraza</surname> <given-names>J</given-names></name><name><surname>Shah</surname> <given-names>N</given-names></name><name><surname>Mellis</surname> <given-names>IA</given-names></name><name><surname>Keeney</surname> <given-names>F</given-names></name><name><surname>Kossenkov</surname> <given-names>A</given-names></name><name><surname>Tang</surname> <given-names>HY</given-names></name><name><surname>Yin</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Fane</surname> <given-names>M</given-names></name><name><surname>Brafford</surname> <given-names>P</given-names></name><name><surname>Herlyn</surname> <given-names>M</given-names></name><name><surname>Speicher</surname> <given-names>DW</given-names></name><name><surname>Wargo</surname> <given-names>JA</given-names></name><name><surname>Tetzlaff</surname> <given-names>MT</given-names></name><name><surname>Haydu</surname> <given-names>LE</given-names></name><name><surname>Raj</surname> <given-names>A</given-names></name><name><surname>Shenoy</surname> <given-names>V</given-names></name><name><surname>Cukierman</surname> <given-names>E</given-names></name><name><surname>Weeraratna</surname> <given-names>AT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility</article-title><source>Cancer Discovery</source><volume>9</volume><fpage>64</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-18-0193</pub-id><pub-id pub-id-type="pmid">30279173</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>SH</given-names></name><name><surname>Hemann</surname> <given-names>EA</given-names></name><name><surname>Legge</surname> <given-names>KL</given-names></name><name><surname>Norian</surname> <given-names>LA</given-names></name><name><surname>Badovinac</surname> <given-names>VP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Diet-induced obesity does not impact the generation and maintenance of primary memory CD8 T cells</article-title><source>The Journal of Immunology</source><volume>193</volume><fpage>5873</fpage><lpage>5882</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1401685</pub-id><pub-id pub-id-type="pmid">25378592</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandekar</surname> <given-names>MJ</given-names></name><name><surname>Cohen</surname> <given-names>P</given-names></name><name><surname>Spiegelman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular mechanisms of Cancer development in obesity</article-title><source>Nature Reviews Cancer</source><volume>11</volume><fpage>886</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1038/nrc3174</pub-id><pub-id pub-id-type="pmid">22113164</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="report"><person-group person-group-type="author"><name><surname>Kochanek</surname> <given-names>KD</given-names></name><name><surname>Murphy</surname> <given-names>SL</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Arias</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><source>Deaths: Final Data for 2017</source><publisher-name>Natl Vital Stat Reports</publisher-name></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopeina</surname> <given-names>GS</given-names></name><name><surname>Senichkin</surname> <given-names>VV</given-names></name><name><surname>Zhivotovsky</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Caloric restriction - A promising anti-cancer approach: from molecular mechanisms to clinical trials</article-title><source>Biochimica Et Biophysica Acta (BBA) - Reviews on Cancer</source><volume>1867</volume><fpage>29</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2016.11.002</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kugel</surname> <given-names>CH</given-names></name><name><surname>Douglass</surname> <given-names>SM</given-names></name><name><surname>Webster</surname> <given-names>MR</given-names></name><name><surname>Kaur</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Yin</surname> <given-names>X</given-names></name><name><surname>Weiss</surname> <given-names>SA</given-names></name><name><surname>Darvishian</surname> <given-names>F</given-names></name><name><surname>Al-Rohil</surname> <given-names>RN</given-names></name><name><surname>Ndoye</surname> <given-names>A</given-names></name><name><surname>Behera</surname> <given-names>R</given-names></name><name><surname>Alicea</surname> <given-names>GM</given-names></name><name><surname>Ecker</surname> <given-names>BL</given-names></name><name><surname>Fane</surname> <given-names>M</given-names></name><name><surname>Allegrezza</surname> <given-names>MJ</given-names></name><name><surname>Svoronos</surname> <given-names>N</given-names></name><name><surname>Kumar</surname> <given-names>V</given-names></name><name><surname>Wang</surname> <given-names>DY</given-names></name><name><surname>Somasundaram</surname> <given-names>R</given-names></name><name><surname>Hu-Lieskovan</surname> <given-names>S</given-names></name><name><surname>Ozgun</surname> <given-names>A</given-names></name><name><surname>Herlyn</surname> <given-names>M</given-names></name><name><surname>Conejo-Garcia</surname> <given-names>JR</given-names></name><name><surname>Gabrilovich</surname> <given-names>D</given-names></name><name><surname>Stone</surname> <given-names>EL</given-names></name><name><surname>Nowicki</surname> <given-names>TS</given-names></name><name><surname>Sosman</surname> <given-names>J</given-names></name><name><surname>Rai</surname> <given-names>R</given-names></name><name><surname>Carlino</surname> <given-names>MS</given-names></name><name><surname>Long</surname> <given-names>GV</given-names></name><name><surname>Marais</surname> <given-names>R</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name><name><surname>Eroglu</surname> <given-names>Z</given-names></name><name><surname>Davies</surname> <given-names>MA</given-names></name><name><surname>Schilling</surname> <given-names>B</given-names></name><name><surname>Schadendorf</surname> <given-names>D</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Amaravadi</surname> <given-names>RK</given-names></name><name><surname>Menzies</surname> <given-names>AM</given-names></name><name><surname>McQuade</surname> <given-names>JL</given-names></name><name><surname>Johnson</surname> <given-names>DB</given-names></name><name><surname>Osman</surname> <given-names>I</given-names></name><name><surname>Weeraratna</surname> <given-names>AT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Age correlates with response to Anti-PD1, reflecting Age-Related differences in intratumoral effector and regulatory T-Cell populations</article-title><source>Clinical Cancer Research</source><volume>24</volume><fpage>5347</fpage><lpage>5356</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-1116</pub-id><pub-id pub-id-type="pmid">29898988</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumagai</surname> <given-names>S</given-names></name><name><surname>Togashi</surname> <given-names>Y</given-names></name><name><surname>Sakai</surname> <given-names>C</given-names></name><name><surname>Kawazoe</surname> <given-names>A</given-names></name><name><surname>Kawazu</surname> <given-names>M</given-names></name><name><surname>Ueno</surname> <given-names>T</given-names></name><name><surname>Sato</surname> <given-names>E</given-names></name><name><surname>Kuwata</surname> <given-names>T</given-names></name><name><surname>Kinoshita</surname> <given-names>T</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Nomura</surname> <given-names>S</given-names></name><name><surname>Tsukamoto</surname> <given-names>T</given-names></name><name><surname>Mano</surname> <given-names>H</given-names></name><name><surname>Shitara</surname> <given-names>K</given-names></name><name><surname>Nishikawa</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells</article-title><source>Immunity</source><volume>53</volume><fpage>187</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.06.016</pub-id><pub-id pub-id-type="pmid">32640259</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>V</given-names></name><name><surname>Patel</surname> <given-names>S</given-names></name><name><surname>Tcyganov</surname> <given-names>E</given-names></name><name><surname>Gabrilovich</surname> <given-names>DI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The nature of Myeloid-Derived suppressor cells in the tumor microenvironment</article-title><source>Trends in Immunology</source><volume>37</volume><fpage>208</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.it.2016.01.004</pub-id><pub-id pub-id-type="pmid">26858199</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Chamoto</surname> <given-names>K</given-names></name><name><surname>Chowdhury</surname> <given-names>PS</given-names></name><name><surname>Honjo</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy</article-title><source>eLife</source><volume>9</volume><elocation-id>e52330</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.52330</pub-id><pub-id pub-id-type="pmid">32122466</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lages</surname> <given-names>CS</given-names></name><name><surname>Lewkowich</surname> <given-names>I</given-names></name><name><surname>Sproles</surname> <given-names>A</given-names></name><name><surname>Wills-Karp</surname> <given-names>M</given-names></name><name><surname>Chougnet</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway</article-title><source>Aging Cell</source><volume>9</volume><fpage>785</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00611.x</pub-id><pub-id pub-id-type="pmid">20653631</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanna</surname> <given-names>A</given-names></name><name><surname>Gomes</surname> <given-names>DC</given-names></name><name><surname>Muller-Durovic</surname> <given-names>B</given-names></name><name><surname>McDonnell</surname> <given-names>T</given-names></name><name><surname>Escors</surname> <given-names>D</given-names></name><name><surname>Gilroy</surname> <given-names>DW</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Karin</surname> <given-names>M</given-names></name><name><surname>Akbar</surname> <given-names>AN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging</article-title><source>Nature Immunology</source><volume>18</volume><fpage>354</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1038/ni.3665</pub-id><pub-id pub-id-type="pmid">28114291</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname> <given-names>AN</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Danai</surname> <given-names>LV</given-names></name><name><surname>Westermark</surname> <given-names>AM</given-names></name><name><surname>Darnell</surname> <given-names>AM</given-names></name><name><surname>Ferreira</surname> <given-names>R</given-names></name><name><surname>Gocheva</surname> <given-names>V</given-names></name><name><surname>Sivanand</surname> <given-names>S</given-names></name><name><surname>Lien</surname> <given-names>EC</given-names></name><name><surname>Sapp</surname> <given-names>KM</given-names></name><name><surname>Mayers</surname> <given-names>JR</given-names></name><name><surname>Biffi</surname> <given-names>G</given-names></name><name><surname>Chin</surname> <given-names>CR</given-names></name><name><surname>Davidson</surname> <given-names>SM</given-names></name><name><surname>Tuveson</surname> <given-names>DA</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name><name><surname>Matheson</surname> <given-names>NJ</given-names></name><name><surname>Yilmaz</surname> <given-names>O</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma</article-title><source>eLife</source><volume>9</volume><elocation-id>e56782</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.56782</pub-id><pub-id pub-id-type="pmid">32648540</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauby-Secretan</surname> <given-names>B</given-names></name><name><surname>Scoccianti</surname> <given-names>C</given-names></name><name><surname>Loomis</surname> <given-names>D</given-names></name><name><surname>Grosse</surname> <given-names>Y</given-names></name><name><surname>Bianchini</surname> <given-names>F</given-names></name><name><surname>Straif</surname> <given-names>K</given-names></name><collab>International Agency for Research on Cancer Handbook Working Group</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Body fatness and Cancer--viewpoint of the IARC working group</article-title><source>New England Journal of Medicine</source><volume>375</volume><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1056/NEJMsr1606602</pub-id><pub-id pub-id-type="pmid">27557308</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledford</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cocktails for Cancer with a measure of immunotherapy</article-title><source>Nature</source><volume>532</volume><fpage>162</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1038/532162a</pub-id><pub-id pub-id-type="pmid">27075078</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>YH</given-names></name><name><surname>Kim</surname> <given-names>SR</given-names></name><name><surname>Han</surname> <given-names>DH</given-names></name><name><surname>Yu</surname> <given-names>HT</given-names></name><name><surname>Han</surname> <given-names>YD</given-names></name><name><surname>Kim</surname> <given-names>JH</given-names></name><name><surname>Kim</surname> <given-names>SH</given-names></name><name><surname>Lee</surname> <given-names>CJ</given-names></name><name><surname>Min</surname> <given-names>BH</given-names></name><name><surname>Kim</surname> <given-names>DH</given-names></name><name><surname>Kim</surname> <given-names>KH</given-names></name><name><surname>Cho</surname> <given-names>JW</given-names></name><name><surname>Lee</surname> <given-names>WW</given-names></name><name><surname>Shin</surname> <given-names>EC</given-names></name><name><surname>Park</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Senescent T cells predict the development of hyperglycemia in humans</article-title><source>Diabetes</source><volume>68</volume><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.2337/db17-1218</pub-id><pub-id pub-id-type="pmid">30389747</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leone</surname> <given-names>RD</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Englert</surname> <given-names>JM</given-names></name><name><surname>Sun</surname> <given-names>IM</given-names></name><name><surname>Oh</surname> <given-names>MH</given-names></name><name><surname>Sun</surname> <given-names>IH</given-names></name><name><surname>Arwood</surname> <given-names>ML</given-names></name><name><surname>Bettencourt</surname> <given-names>IA</given-names></name><name><surname>Patel</surname> <given-names>CH</given-names></name><name><surname>Wen</surname> <given-names>J</given-names></name><name><surname>Tam</surname> <given-names>A</given-names></name><name><surname>Blosser</surname> <given-names>RL</given-names></name><name><surname>Prchalova</surname> <given-names>E</given-names></name><name><surname>Alt</surname> <given-names>J</given-names></name><name><surname>Rais</surname> <given-names>R</given-names></name><name><surname>Slusher</surname> <given-names>BS</given-names></name><name><surname>Powell</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion</article-title><source>Science</source><volume>366</volume><fpage>1013</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1126/science.aav2588</pub-id><pub-id pub-id-type="pmid">31699883</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lévesque</surname> <given-names>S</given-names></name><name><surname>Pol</surname> <given-names>JG</given-names></name><name><surname>Ferrere</surname> <given-names>G</given-names></name><name><surname>Galluzzi</surname> <given-names>L</given-names></name><name><surname>Zitvogel</surname> <given-names>L</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Trial watch: dietary interventions for Cancer therapy</article-title><source>OncoImmunology</source><volume>8</volume><elocation-id>e1591878</elocation-id><pub-id pub-id-type="doi">10.1080/2162402X.2019.1591878</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Yao</surname> <given-names>D</given-names></name><name><surname>Zeng</surname> <given-names>X</given-names></name><name><surname>Kasakovski</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Zha</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Age related human T cell subset evolution and senescence</article-title><source>Immunity &amp; Ageing</source><volume>16</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.1186/s12979-019-0165-8</pub-id><pub-id pub-id-type="pmid">31528179</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname> <given-names>MRL</given-names></name><name><surname>Nipp</surname> <given-names>RD</given-names></name><name><surname>Muzikansky</surname> <given-names>A</given-names></name><name><surname>Goodwin</surname> <given-names>K</given-names></name><name><surname>Anderson</surname> <given-names>D</given-names></name><name><surname>Newcomb</surname> <given-names>RA</given-names></name><name><surname>Gainor</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impact of age on outcomes with immunotherapy in patients with Non-Small cell lung Cancer</article-title><source>Journal of Thoracic Oncology</source><volume>14</volume><fpage>547</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1016/j.jtho.2018.11.011</pub-id><pub-id pub-id-type="pmid">30476576</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lien</surname> <given-names>EC</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A framework for examining how diet impacts tumour metabolism</article-title><source>Nature Reviews Cancer</source><volume>19</volume><fpage>651</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0198-5</pub-id><pub-id pub-id-type="pmid">31530936</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lighter</surname> <given-names>J</given-names></name><name><surname>Phillips</surname> <given-names>M</given-names></name><name><surname>Hochman</surname> <given-names>S</given-names></name><name><surname>Sterling</surname> <given-names>S</given-names></name><name><surname>Johnson</surname> <given-names>D</given-names></name><name><surname>Francois</surname> <given-names>F</given-names></name><name><surname>Stachel</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission</article-title><source>Clinical Infectious Diseases</source><volume>71</volume><fpage>896</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa415</pub-id><pub-id pub-id-type="pmid">32271368</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>AR</given-names></name><name><surname>Rathmell</surname> <given-names>WK</given-names></name><name><surname>Rathmell</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy</article-title><source>eLife</source><volume>9</volume><elocation-id>e55185</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.55185</pub-id><pub-id pub-id-type="pmid">32367803</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>GY</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>mTOR at the nexus of nutrition, growth, ageing and disease</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>21</volume><fpage>183</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0199-y</pub-id><pub-id pub-id-type="pmid">31937935</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Otín</surname> <given-names>C</given-names></name><name><surname>Blasco</surname> <given-names>MA</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Serrano</surname> <given-names>M</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The hallmarks of aging</article-title><source>Cell</source><volume>153</volume><fpage>1194</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id><pub-id pub-id-type="pmid">23746838</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Otín</surname> <given-names>C</given-names></name><name><surname>Galluzzi</surname> <given-names>L</given-names></name><name><surname>Freije</surname> <given-names>JMP</given-names></name><name><surname>Madeo</surname> <given-names>F</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic control of longevity</article-title><source>Cell</source><volume>166</volume><fpage>802</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.031</pub-id><pub-id pub-id-type="pmid">27518560</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname> <given-names>GM</given-names></name><name><surname>Matarese</surname> <given-names>G</given-names></name><name><surname>Howard</surname> <given-names>JK</given-names></name><name><surname>Baker</surname> <given-names>RJ</given-names></name><name><surname>Bloom</surname> <given-names>SR</given-names></name><name><surname>Lechler</surname> <given-names>RI</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression</article-title><source>Nature</source><volume>394</volume><fpage>897</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1038/29795</pub-id><pub-id pub-id-type="pmid">9732873</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lustgarten</surname> <given-names>J</given-names></name><name><surname>Dominguez</surname> <given-names>AL</given-names></name><name><surname>Thoman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Aged mice develop protective antitumor immune responses with appropriate costimulation</article-title><source>The Journal of Immunology</source><volume>173</volume><fpage>4510</fpage><lpage>4515</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.7.4510</pub-id><pub-id pub-id-type="pmid">15383582</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>EH</given-names></name><name><surname>Verway</surname> <given-names>MJ</given-names></name><name><surname>Johnson</surname> <given-names>RM</given-names></name><name><surname>Roy</surname> <given-names>DG</given-names></name><name><surname>Steadman</surname> <given-names>M</given-names></name><name><surname>Hayes</surname> <given-names>S</given-names></name><name><surname>Williams</surname> <given-names>KS</given-names></name><name><surname>Sheldon</surname> <given-names>RD</given-names></name><name><surname>Samborska</surname> <given-names>B</given-names></name><name><surname>Kosinski</surname> <given-names>PA</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Griss</surname> <given-names>T</given-names></name><name><surname>Faubert</surname> <given-names>B</given-names></name><name><surname>Condotta</surname> <given-names>SA</given-names></name><name><surname>Krawczyk</surname> <given-names>CM</given-names></name><name><surname>DeBerardinis</surname> <given-names>RJ</given-names></name><name><surname>Stewart</surname> <given-names>KM</given-names></name><name><surname>Richer</surname> <given-names>MJ</given-names></name><name><surname>Chubukov</surname> <given-names>V</given-names></name><name><surname>Roddy</surname> <given-names>TP</given-names></name><name><surname>Jones</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8+ T cells</article-title><source>Immunity</source><volume>51</volume><fpage>856</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.09.003</pub-id><pub-id pub-id-type="pmid">31747582</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddocks</surname> <given-names>ODK</given-names></name><name><surname>Athineos</surname> <given-names>D</given-names></name><name><surname>Cheung</surname> <given-names>EC</given-names></name><name><surname>Lee</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>van den Broek</surname> <given-names>NJF</given-names></name><name><surname>Mackay</surname> <given-names>GM</given-names></name><name><surname>Labuschagne</surname> <given-names>CF</given-names></name><name><surname>Gay</surname> <given-names>D</given-names></name><name><surname>Kruiswijk</surname> <given-names>F</given-names></name><name><surname>Blagih</surname> <given-names>J</given-names></name><name><surname>Vincent</surname> <given-names>DF</given-names></name><name><surname>Campbell</surname> <given-names>KJ</given-names></name><name><surname>Ceteci</surname> <given-names>F</given-names></name><name><surname>Sansom</surname> <given-names>OJ</given-names></name><name><surname>Blyth</surname> <given-names>K</given-names></name><name><surname>Vousden</surname> <given-names>KH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Modulating the therapeutic response of tumours to dietary serine and glycine starvation</article-title><source>Nature</source><volume>544</volume><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1038/nature22056</pub-id><pub-id pub-id-type="pmid">28425994</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannick</surname> <given-names>JB</given-names></name><name><surname>Del Giudice</surname> <given-names>G</given-names></name><name><surname>Lattanzi</surname> <given-names>M</given-names></name><name><surname>Valiante</surname> <given-names>NM</given-names></name><name><surname>Praestgaard</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Lonetto</surname> <given-names>MA</given-names></name><name><surname>Maecker</surname> <given-names>HT</given-names></name><name><surname>Kovarik</surname> <given-names>J</given-names></name><name><surname>Carson</surname> <given-names>S</given-names></name><name><surname>Glass</surname> <given-names>DJ</given-names></name><name><surname>Klickstein</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>mTOR inhibition improves immune function in the elderly</article-title><source>Science Translational Medicine</source><volume>6</volume><elocation-id>268ra179</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3009892</pub-id><pub-id pub-id-type="pmid">25540326</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannick</surname> <given-names>JB</given-names></name><name><surname>Morris</surname> <given-names>M</given-names></name><name><surname>Hockey</surname> <given-names>HP</given-names></name><name><surname>Roma</surname> <given-names>G</given-names></name><name><surname>Beibel</surname> <given-names>M</given-names></name><name><surname>Kulmatycki</surname> <given-names>K</given-names></name><name><surname>Watkins</surname> <given-names>M</given-names></name><name><surname>Shavlakadze</surname> <given-names>T</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Quinn</surname> <given-names>D</given-names></name><name><surname>Glass</surname> <given-names>DJ</given-names></name><name><surname>Klickstein</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TORC1 inhibition enhances immune function and reduces infections in the elderly</article-title><source>Science Translational Medicine</source><volume>10</volume><elocation-id>eaaq1564</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaq1564</pub-id><pub-id pub-id-type="pmid">29997249</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzo</surname> <given-names>T</given-names></name><name><surname>Prentice</surname> <given-names>BM</given-names></name><name><surname>Anderson</surname> <given-names>KG</given-names></name><name><surname>Raman</surname> <given-names>A</given-names></name><name><surname>Schalck</surname> <given-names>A</given-names></name><name><surname>Codreanu</surname> <given-names>GS</given-names></name><name><surname>Nava Lauson</surname> <given-names>CB</given-names></name><name><surname>Tiberti</surname> <given-names>S</given-names></name><name><surname>Raimondi</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>MA</given-names></name><name><surname>Reyzer</surname> <given-names>M</given-names></name><name><surname>Bates</surname> <given-names>BM</given-names></name><name><surname>Spraggins</surname> <given-names>JM</given-names></name><name><surname>Patterson</surname> <given-names>NH</given-names></name><name><surname>McLean</surname> <given-names>JA</given-names></name><name><surname>Rai</surname> <given-names>K</given-names></name><name><surname>Tacchetti</surname> <given-names>C</given-names></name><name><surname>Tucci</surname> <given-names>S</given-names></name><name><surname>Wargo</surname> <given-names>JA</given-names></name><name><surname>Rodighiero</surname> <given-names>S</given-names></name><name><surname>Clise-Dwyer</surname> <given-names>K</given-names></name><name><surname>Sherrod</surname> <given-names>SD</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Navin</surname> <given-names>NE</given-names></name><name><surname>Caprioli</surname> <given-names>RM</given-names></name><name><surname>Greenberg</surname> <given-names>PD</given-names></name><name><surname>Draetta</surname> <given-names>G</given-names></name><name><surname>Nezi</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells</article-title><source>Journal of Experimental Medicine</source><volume>217</volume><elocation-id>e20191920</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20191920</pub-id><pub-id pub-id-type="pmid">32491160</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Montalvo</surname> <given-names>A</given-names></name><name><surname>de Cabo</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitochondrial metabolic reprogramming induced by calorie restriction</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>19</volume><fpage>310</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1089/ars.2012.4866</pub-id><pub-id pub-id-type="pmid">22901095</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattison</surname> <given-names>JA</given-names></name><name><surname>Colman</surname> <given-names>RJ</given-names></name><name><surname>Beasley</surname> <given-names>TM</given-names></name><name><surname>Allison</surname> <given-names>DB</given-names></name><name><surname>Kemnitz</surname> <given-names>JW</given-names></name><name><surname>Roth</surname> <given-names>GS</given-names></name><name><surname>Ingram</surname> <given-names>DK</given-names></name><name><surname>Weindruch</surname> <given-names>R</given-names></name><name><surname>de Cabo</surname> <given-names>R</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Caloric restriction improves health and survival of rhesus monkeys</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14063</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14063</pub-id><pub-id pub-id-type="pmid">28094793</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauro</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>J</given-names></name><name><surname>Cucchi</surname> <given-names>D</given-names></name><name><surname>Coe</surname> <given-names>D</given-names></name><name><surname>Fu</surname> <given-names>H</given-names></name><name><surname>Bonacina</surname> <given-names>F</given-names></name><name><surname>Baragetti</surname> <given-names>A</given-names></name><name><surname>Cermenati</surname> <given-names>G</given-names></name><name><surname>Caruso</surname> <given-names>D</given-names></name><name><surname>Mitro</surname> <given-names>N</given-names></name><name><surname>Catapano</surname> <given-names>AL</given-names></name><name><surname>Ammirati</surname> <given-names>E</given-names></name><name><surname>Longhi</surname> <given-names>MP</given-names></name><name><surname>Okkenhaug</surname> <given-names>K</given-names></name><name><surname>Norata</surname> <given-names>GD</given-names></name><name><surname>Marelli-Berg</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Obesity-Induced metabolic stress leads to biased effector memory CD4<sup>+</sup>T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>593</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.01.008</pub-id><pub-id pub-id-type="pmid">28190771</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>EF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas</article-title><source>The Iowa Orthopaedic Journal</source><volume>26</volume><fpage>154</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">16789469</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCay</surname> <given-names>CM</given-names></name><name><surname>Crowell</surname> <given-names>MF</given-names></name><name><surname>Maynard</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="1935">1935</year><article-title>The effect of retarded growth upon the length of life span and upon the ultimate body size</article-title><source>The Journal of Nutrition</source><volume>10</volume><fpage>63</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1093/jn/10.1.63</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuade</surname> <given-names>JL</given-names></name><name><surname>Daniel</surname> <given-names>CR</given-names></name><name><surname>Hess</surname> <given-names>KR</given-names></name><name><surname>Mak</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>DY</given-names></name><name><surname>Rai</surname> <given-names>RR</given-names></name><name><surname>Park</surname> <given-names>JJ</given-names></name><name><surname>Haydu</surname> <given-names>LE</given-names></name><name><surname>Spencer</surname> <given-names>C</given-names></name><name><surname>Wongchenko</surname> <given-names>M</given-names></name><name><surname>Lane</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>DY</given-names></name><name><surname>Kaper</surname> <given-names>M</given-names></name><name><surname>McKean</surname> <given-names>M</given-names></name><name><surname>Beckermann</surname> <given-names>KE</given-names></name><name><surname>Rubinstein</surname> <given-names>SM</given-names></name><name><surname>Rooney</surname> <given-names>I</given-names></name><name><surname>Musib</surname> <given-names>L</given-names></name><name><surname>Budha</surname> <given-names>N</given-names></name><name><surname>Hsu</surname> <given-names>J</given-names></name><name><surname>Nowicki</surname> <given-names>TS</given-names></name><name><surname>Avila</surname> <given-names>A</given-names></name><name><surname>Haas</surname> <given-names>T</given-names></name><name><surname>Puligandla</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Fang</surname> <given-names>S</given-names></name><name><surname>Wargo</surname> <given-names>JA</given-names></name><name><surname>Gershenwald</surname> <given-names>JE</given-names></name><name><surname>Lee</surname> <given-names>JE</given-names></name><name><surname>Hwu</surname> <given-names>P</given-names></name><name><surname>Chapman</surname> <given-names>PB</given-names></name><name><surname>Sosman</surname> <given-names>JA</given-names></name><name><surname>Schadendorf</surname> <given-names>D</given-names></name><name><surname>Grob</surname> <given-names>JJ</given-names></name><name><surname>Flaherty</surname> <given-names>KT</given-names></name><name><surname>Walker</surname> <given-names>D</given-names></name><name><surname>Yan</surname> <given-names>Y</given-names></name><name><surname>McKenna</surname> <given-names>E</given-names></name><name><surname>Legos</surname> <given-names>JJ</given-names></name><name><surname>Carlino</surname> <given-names>MS</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name><name><surname>Kirkwood</surname> <given-names>JM</given-names></name><name><surname>Long</surname> <given-names>GV</given-names></name><name><surname>Johnson</surname> <given-names>DB</given-names></name><name><surname>Menzies</surname> <given-names>AM</given-names></name><name><surname>Davies</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis</article-title><source>The Lancet Oncology</source><volume>19</volume><fpage>310</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(18)30078-0</pub-id><pub-id pub-id-type="pmid">29449192</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messaoudi</surname> <given-names>I</given-names></name><name><surname>Warner</surname> <given-names>J</given-names></name><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Park</surname> <given-names>B</given-names></name><name><surname>Hill</surname> <given-names>B</given-names></name><name><surname>Mattison</surname> <given-names>J</given-names></name><name><surname>Lane</surname> <given-names>MA</given-names></name><name><surname>Roth</surname> <given-names>GS</given-names></name><name><surname>Ingram</surname> <given-names>DK</given-names></name><name><surname>Picker</surname> <given-names>LJ</given-names></name><name><surname>Douek</surname> <given-names>DC</given-names></name><name><surname>Mori</surname> <given-names>M</given-names></name><name><surname>Nikolich-Zugich</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates</article-title><source>PNAS</source><volume>103</volume><fpage>19448</fpage><lpage>19453</lpage><pub-id pub-id-type="doi">10.1073/pnas.0606661103</pub-id><pub-id pub-id-type="pmid">17159149</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalek</surname> <given-names>RD</given-names></name><name><surname>Gerriets</surname> <given-names>VA</given-names></name><name><surname>Jacobs</surname> <given-names>SR</given-names></name><name><surname>Macintyre</surname> <given-names>AN</given-names></name><name><surname>MacIver</surname> <given-names>NJ</given-names></name><name><surname>Mason</surname> <given-names>EF</given-names></name><name><surname>Sullivan</surname> <given-names>SA</given-names></name><name><surname>Nichols</surname> <given-names>AG</given-names></name><name><surname>Rathmell</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4<sup>+</sup>T cell subsets</article-title><source>The Journal of Immunology</source><volume>186</volume><fpage>3299</fpage><lpage>3303</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003613</pub-id><pub-id pub-id-type="pmid">21317389</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michelet</surname> <given-names>X</given-names></name><name><surname>Dyck</surname> <given-names>L</given-names></name><name><surname>Hogan</surname> <given-names>A</given-names></name><name><surname>Loftus</surname> <given-names>RM</given-names></name><name><surname>Duquette</surname> <given-names>D</given-names></name><name><surname>Wei</surname> <given-names>K</given-names></name><name><surname>Beyaz</surname> <given-names>S</given-names></name><name><surname>Tavakkoli</surname> <given-names>A</given-names></name><name><surname>Foley</surname> <given-names>C</given-names></name><name><surname>Donnelly</surname> <given-names>R</given-names></name><name><surname>O'Farrelly</surname> <given-names>C</given-names></name><name><surname>Raverdeau</surname> <given-names>M</given-names></name><name><surname>Vernon</surname> <given-names>A</given-names></name><name><surname>Pettee</surname> <given-names>W</given-names></name><name><surname>O'Shea</surname> <given-names>D</given-names></name><name><surname>Nikolajczyk</surname> <given-names>BS</given-names></name><name><surname>Mills</surname> <given-names>KHG</given-names></name><name><surname>Brenner</surname> <given-names>MB</given-names></name><name><surname>Finlay</surname> <given-names>D</given-names></name><name><surname>Lynch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metabolic reprogramming of natural killer cells in obesity limits antitumor responses</article-title><source>Nature Immunology</source><volume>19</volume><fpage>1330</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0251-7</pub-id><pub-id pub-id-type="pmid">30420624</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michels</surname> <given-names>KB</given-names></name><name><surname>Ekbom</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Caloric restriction and incidence of breast Cancer</article-title><source>Jama</source><volume>291</volume><fpage>1226</fpage><lpage>1230</lpage><pub-id pub-id-type="doi">10.1001/jama.291.10.1226</pub-id><pub-id pub-id-type="pmid">15010444</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>JF</given-names></name><name><surname>Mitchell</surname> <given-names>GF</given-names></name><name><surname>Weiss</surname> <given-names>NS</given-names></name></person-group><year iso-8601-date="1967">1967</year><article-title>Cellular basis of the immunological defects in thymectomized mice</article-title><source>Nature</source><volume>214</volume><fpage>992</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1038/214992a0</pub-id><pub-id pub-id-type="pmid">6055415</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>RA</given-names></name><name><surname>Buehner</surname> <given-names>G</given-names></name><name><surname>Chang</surname> <given-names>Y</given-names></name><name><surname>Harper</surname> <given-names>JM</given-names></name><name><surname>Sigler</surname> <given-names>R</given-names></name><name><surname>Smith-Wheelock</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance</article-title><source>Aging Cell</source><volume>4</volume><fpage>119</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2005.00152.x</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>BC</given-names></name><name><surname>Sen</surname> <given-names>DR</given-names></name><name><surname>Al Abosy</surname> <given-names>R</given-names></name><name><surname>Bi</surname> <given-names>K</given-names></name><name><surname>Virkud</surname> <given-names>YV</given-names></name><name><surname>LaFleur</surname> <given-names>MW</given-names></name><name><surname>Yates</surname> <given-names>KB</given-names></name><name><surname>Lako</surname> <given-names>A</given-names></name><name><surname>Felt</surname> <given-names>K</given-names></name><name><surname>Naik</surname> <given-names>GS</given-names></name><name><surname>Manos</surname> <given-names>M</given-names></name><name><surname>Gjini</surname> <given-names>E</given-names></name><name><surname>Kuchroo</surname> <given-names>JR</given-names></name><name><surname>Ishizuka</surname> <given-names>JJ</given-names></name><name><surname>Collier</surname> <given-names>JL</given-names></name><name><surname>Griffin</surname> <given-names>GK</given-names></name><name><surname>Maleri</surname> <given-names>S</given-names></name><name><surname>Comstock</surname> <given-names>DE</given-names></name><name><surname>Weiss</surname> <given-names>SA</given-names></name><name><surname>Brown</surname> <given-names>FD</given-names></name><name><surname>Panda</surname> <given-names>A</given-names></name><name><surname>Zimmer</surname> <given-names>MD</given-names></name><name><surname>Manguso</surname> <given-names>RT</given-names></name><name><surname>Hodi</surname> <given-names>FS</given-names></name><name><surname>Rodig</surname> <given-names>SJ</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Haining</surname> <given-names>WN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockade</article-title><source>Nature Immunology</source><volume>20</volume><fpage>326</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0312-6</pub-id><pub-id pub-id-type="pmid">30778252</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>JS</given-names></name><name><surname>Lanier</surname> <given-names>LL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Natural killer cells in Cancer immunotherapy</article-title><source>Annual Review of Cancer Biology</source><volume>3</volume><fpage>77</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1146/annurev-cancerbio-030518-055653</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirsoian</surname> <given-names>A</given-names></name><name><surname>Bouchlaka</surname> <given-names>MN</given-names></name><name><surname>Sckisel</surname> <given-names>GD</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Pai</surname> <given-names>CC</given-names></name><name><surname>Maverakis</surname> <given-names>E</given-names></name><name><surname>Spencer</surname> <given-names>RG</given-names></name><name><surname>Fishbein</surname> <given-names>KW</given-names></name><name><surname>Siddiqui</surname> <given-names>S</given-names></name><name><surname>Monjazeb</surname> <given-names>AM</given-names></name><name><surname>Martin</surname> <given-names>B</given-names></name><name><surname>Maudsley</surname> <given-names>S</given-names></name><name><surname>Hesdorffer</surname> <given-names>C</given-names></name><name><surname>Ferrucci</surname> <given-names>L</given-names></name><name><surname>Longo</surname> <given-names>DL</given-names></name><name><surname>Blazar</surname> <given-names>BR</given-names></name><name><surname>Wiltrout</surname> <given-names>RH</given-names></name><name><surname>Taub</surname> <given-names>DD</given-names></name><name><surname>Murphy</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice</article-title><source>Journal of Experimental Medicine</source><volume>211</volume><fpage>2373</fpage><lpage>2383</lpage><pub-id pub-id-type="doi">10.1084/jem.20140116</pub-id><pub-id pub-id-type="pmid">25366964</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirza</surname> <given-names>N</given-names></name><name><surname>Duque</surname> <given-names>MA</given-names></name><name><surname>Dominguez</surname> <given-names>AL</given-names></name><name><surname>Schrum</surname> <given-names>AG</given-names></name><name><surname>Dong</surname> <given-names>H</given-names></name><name><surname>Lustgarten</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>B7-H1 expression on old CD8<sup>+</sup> T cells negatively regulates the activation of immune responses in aged animals</article-title><source>The Journal of Immunology</source><volume>184</volume><fpage>5466</fpage><lpage>5474</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903561</pub-id><pub-id pub-id-type="pmid">20375308</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>EC</given-names></name><name><surname>Cash</surname> <given-names>HA</given-names></name><name><surname>Caruso</surname> <given-names>AM</given-names></name><name><surname>Uppaluri</surname> <given-names>R</given-names></name><name><surname>Hodge</surname> <given-names>JW</given-names></name><name><surname>Van Waes</surname> <given-names>C</given-names></name><name><surname>Allen</surname> <given-names>CT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Enhanced tumor control with combination mTOR and PD-L1 inhibition in syngeneic oral cavity cancers</article-title><source>Cancer Immunology Research</source><volume>4</volume><fpage>611</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-15-0252</pub-id><pub-id pub-id-type="pmid">27076449</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moskowitz</surname> <given-names>DM</given-names></name><name><surname>Zhang</surname> <given-names>DW</given-names></name><name><surname>Hu</surname> <given-names>B</given-names></name><name><surname>Le Saux</surname> <given-names>S</given-names></name><name><surname>Yanes</surname> <given-names>RE</given-names></name><name><surname>Ye</surname> <given-names>Z</given-names></name><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Weyand</surname> <given-names>CM</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Goronzy</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epigenomics of human CD8 T cell differentiation and aging</article-title><source>Science Immunology</source><volume>2</volume><elocation-id>eaag0192</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aag0192</pub-id><pub-id pub-id-type="pmid">28439570</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname> <given-names>KA</given-names></name><name><surname>James</surname> <given-names>BR</given-names></name><name><surname>Sjaastad</surname> <given-names>FV</given-names></name><name><surname>Kucaba</surname> <given-names>TA</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Brincks</surname> <given-names>EL</given-names></name><name><surname>Chua</surname> <given-names>SC</given-names></name><name><surname>Wilber</surname> <given-names>A</given-names></name><name><surname>Griffith</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cutting edge: elevated leptin during Diet-Induced obesity reduces the efficacy of tumor immunotherapy</article-title><source>The Journal of Immunology</source><volume>201</volume><fpage>1837</fpage><lpage>1841</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1701738</pub-id><pub-id pub-id-type="pmid">30135180</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Macrophage polarization</article-title><source>Annual Review of Physiology</source><volume>79</volume><fpage>541</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034339</pub-id><pub-id pub-id-type="pmid">27813830</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname> <given-names>GS</given-names></name><name><surname>Waikar</surname> <given-names>SS</given-names></name><name><surname>Johnson</surname> <given-names>AEW</given-names></name><name><surname>Buchbinder</surname> <given-names>EI</given-names></name><name><surname>Haq</surname> <given-names>R</given-names></name><name><surname>Hodi</surname> <given-names>FS</given-names></name><name><surname>Schoenfeld</surname> <given-names>JD</given-names></name><name><surname>Ott</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition</article-title><source>Journal for ImmunoTherapy of Cancer</source><volume>7</volume><elocation-id>89</elocation-id><pub-id pub-id-type="doi">10.1186/s40425-019-0512-5</pub-id><pub-id pub-id-type="pmid">30922394</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>K</given-names></name><name><surname>Smyth</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Myeloid immunosuppression and immune checkpoints in the tumor microenvironment</article-title><source>Cellular &amp; Molecular Immunology</source><volume>17</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41423-019-0306-1</pub-id><pub-id pub-id-type="pmid">31611651</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naveiras</surname> <given-names>O</given-names></name><name><surname>Nardi</surname> <given-names>V</given-names></name><name><surname>Wenzel</surname> <given-names>PL</given-names></name><name><surname>Hauschka</surname> <given-names>PV</given-names></name><name><surname>Fahey</surname> <given-names>F</given-names></name><name><surname>Daley</surname> <given-names>GQ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment</article-title><source>Nature</source><volume>460</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1038/nature08099</pub-id><pub-id pub-id-type="pmid">19516257</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname> <given-names>C</given-names></name><name><surname>Petri</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Leptin regulation of immune responses</article-title><source>Trends in Molecular Medicine</source><volume>22</volume><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2015.12.001</pub-id><pub-id pub-id-type="pmid">26776093</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolich-Žugich</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>G</given-names></name><name><surname>Uhrlaub</surname> <given-names>JL</given-names></name><name><surname>Renkema</surname> <given-names>KR</given-names></name><name><surname>Smithey</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Age-related changes in CD8 T cell homeostasis and immunity to infection</article-title><source>Seminars in Immunology</source><volume>24</volume><fpage>356</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2012.04.009</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname> <given-names>H</given-names></name><name><surname>Nose</surname> <given-names>M</given-names></name><name><surname>Hiai</surname> <given-names>H</given-names></name><name><surname>Minato</surname> <given-names>N</given-names></name><name><surname>Honjo</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor</article-title><source>Immunity</source><volume>11</volume><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80089-8</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname> <given-names>S</given-names></name><name><surname>Manabe</surname> <given-names>I</given-names></name><name><surname>Nagasaki</surname> <given-names>M</given-names></name><name><surname>Eto</surname> <given-names>K</given-names></name><name><surname>Yamashita</surname> <given-names>H</given-names></name><name><surname>Ohsugi</surname> <given-names>M</given-names></name><name><surname>Otsu</surname> <given-names>M</given-names></name><name><surname>Hara</surname> <given-names>K</given-names></name><name><surname>Ueki</surname> <given-names>K</given-names></name><name><surname>Sugiura</surname> <given-names>S</given-names></name><name><surname>Yoshimura</surname> <given-names>K</given-names></name><name><surname>Kadowaki</surname> <given-names>T</given-names></name><name><surname>Nagai</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity</article-title><source>Nature Medicine</source><volume>15</volume><fpage>914</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1038/nm.1964</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname> <given-names>LM</given-names></name><name><surname>Lavigne</surname> <given-names>JA</given-names></name><name><surname>Chandramouli</surname> <given-names>GV</given-names></name><name><surname>Lui</surname> <given-names>H</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Hursting</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1</article-title><source>Cancer Medicine</source><volume>1</volume><fpage>275</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1002/cam4.23</pub-id><pub-id pub-id-type="pmid">23342276</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norian</surname> <given-names>LA</given-names></name><name><surname>Rodriguez</surname> <given-names>PC</given-names></name><name><surname>O'Mara</surname> <given-names>LA</given-names></name><name><surname>Zabaleta</surname> <given-names>J</given-names></name><name><surname>Ochoa</surname> <given-names>AC</given-names></name><name><surname>Cella</surname> <given-names>M</given-names></name><name><surname>Allen</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via L-Arginine Metabolism</article-title><source>Cancer Research</source><volume>69</volume><fpage>3086</fpage><lpage>3094</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-2826</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Flanagan</surname> <given-names>CH</given-names></name><name><surname>Smith</surname> <given-names>LA</given-names></name><name><surname>McDonell</surname> <given-names>SB</given-names></name><name><surname>Hursting</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>When less may be more: calorie restriction and response to Cancer therapy</article-title><source>BMC Medicine</source><volume>15</volume><elocation-id>106</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-017-0873-x</pub-id><pub-id pub-id-type="pmid">28539118</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Neill</surname> <given-names>LA</given-names></name><name><surname>Hardie</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabolism of inflammation limited by AMPK and pseudo-starvation</article-title><source>Nature</source><volume>493</volume><fpage>346</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1038/nature11862</pub-id><pub-id pub-id-type="pmid">23325217</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Sullivan</surname> <given-names>D</given-names></name><name><surname>Sanin</surname> <given-names>DE</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolic interventions in the immune response to Cancer</article-title><source>Nature Reviews Immunology</source><volume>19</volume><fpage>324</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0140-9</pub-id><pub-id pub-id-type="pmid">30820043</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname> <given-names>J</given-names></name><name><surname>Magnuson</surname> <given-names>A</given-names></name><name><surname>Benoist</surname> <given-names>C</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name><name><surname>Weissleder</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Age-related tumor growth in mice is related to integrin α 4 in CD8+ T cells</article-title><source>JCI Insight</source><volume>3</volume><elocation-id>122961</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.122961</pub-id><pub-id pub-id-type="pmid">30385729</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orillion</surname> <given-names>A</given-names></name><name><surname>Damayanti</surname> <given-names>NP</given-names></name><name><surname>Shen</surname> <given-names>L</given-names></name><name><surname>Adelaiye-Ogala</surname> <given-names>R</given-names></name><name><surname>Affronti</surname> <given-names>H</given-names></name><name><surname>Elbanna</surname> <given-names>M</given-names></name><name><surname>Chintala</surname> <given-names>S</given-names></name><name><surname>Ciesielski</surname> <given-names>M</given-names></name><name><surname>Fontana</surname> <given-names>L</given-names></name><name><surname>Kao</surname> <given-names>C</given-names></name><name><surname>Elzey</surname> <given-names>BD</given-names></name><name><surname>Ratliff</surname> <given-names>TL</given-names></name><name><surname>Nelson</surname> <given-names>DE</given-names></name><name><surname>Smiraglia</surname> <given-names>D</given-names></name><name><surname>Abrams</surname> <given-names>SI</given-names></name><name><surname>Pili</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dietary protein restriction reprograms Tumor-Associated macrophages and enhances immunotherapy</article-title><source>Clinical Cancer Research</source><volume>24</volume><fpage>6383</fpage><lpage>6395</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-0980</pub-id><pub-id pub-id-type="pmid">30190370</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padrón</surname> <given-names>Á</given-names></name><name><surname>Hurez</surname> <given-names>V</given-names></name><name><surname>Gupta</surname> <given-names>HB</given-names></name><name><surname>Clark</surname> <given-names>CA</given-names></name><name><surname>Pandeswara</surname> <given-names>SL</given-names></name><name><surname>Yuan</surname> <given-names>B</given-names></name><name><surname>Svatek</surname> <given-names>RS</given-names></name><name><surname>Turk</surname> <given-names>MJ</given-names></name><name><surname>Drerup</surname> <given-names>JM</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Curiel</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model</article-title><source>Experimental Gerontology</source><volume>105</volume><fpage>146</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2017.12.025</pub-id><pub-id pub-id-type="pmid">29326088</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname> <given-names>SD</given-names></name><name><surname>Ovsyannikova</surname> <given-names>IG</given-names></name><name><surname>Poland</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The weight of obesity on the human immune response to vaccination</article-title><source>Vaccine</source><volume>33</volume><fpage>4422</fpage><lpage>4429</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2015.06.101</pub-id><pub-id pub-id-type="pmid">26163925</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>YJ</given-names></name><name><surname>Kuen</surname> <given-names>DS</given-names></name><name><surname>Chung</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Future prospects of immune checkpoint blockade in Cancer: from response prediction to overcoming resistance</article-title><source>Experimental &amp; Molecular Medicine</source><volume>50</volume><elocation-id>109</elocation-id><pub-id pub-id-type="doi">10.1038/s12276-018-0130-1</pub-id><pub-id pub-id-type="pmid">30135516</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawelec</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Does patient age influence anti-cancer immunity?</article-title><source>Seminars in Immunopathology</source><volume>41</volume><fpage>125</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1007/s00281-018-0697-6</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname> <given-names>EL</given-names></name><name><surname>Walsh</surname> <given-names>MC</given-names></name><name><surname>Cejas</surname> <given-names>PJ</given-names></name><name><surname>Harms</surname> <given-names>GM</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>LS</given-names></name><name><surname>Jones</surname> <given-names>RG</given-names></name><name><surname>Choi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Enhancing CD8 T-cell memory by modulating fatty acid metabolism</article-title><source>Nature</source><volume>460</volume><fpage>103</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1038/nature08097</pub-id><pub-id pub-id-type="pmid">19494812</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>M</given-names></name><name><surname>Yin</surname> <given-names>N</given-names></name><name><surname>Chhangawala</surname> <given-names>S</given-names></name><name><surname>Xu</surname> <given-names>K</given-names></name><name><surname>Leslie</surname> <given-names>CS</given-names></name><name><surname>Li</surname> <given-names>MO</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism</article-title><source>Science</source><volume>354</volume><fpage>481</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1126/science.aaf6284</pub-id><pub-id pub-id-type="pmid">27708054</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennock</surname> <given-names>ND</given-names></name><name><surname>White</surname> <given-names>JT</given-names></name><name><surname>Cross</surname> <given-names>EW</given-names></name><name><surname>Cheney</surname> <given-names>EE</given-names></name><name><surname>Tamburini</surname> <given-names>BA</given-names></name><name><surname>Kedl</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>T cell responses: naïve to memory and everything in between</article-title><source>Advances in Physiology Education</source><volume>37</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1152/advan.00066.2013</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrocola</surname> <given-names>F</given-names></name><name><surname>Pol</surname> <given-names>J</given-names></name><name><surname>Vacchelli</surname> <given-names>E</given-names></name><name><surname>Rao</surname> <given-names>S</given-names></name><name><surname>Enot</surname> <given-names>DP</given-names></name><name><surname>Baracco</surname> <given-names>EE</given-names></name><name><surname>Levesque</surname> <given-names>S</given-names></name><name><surname>Castoldi</surname> <given-names>F</given-names></name><name><surname>Jacquelot</surname> <given-names>N</given-names></name><name><surname>Yamazaki</surname> <given-names>T</given-names></name><name><surname>Senovilla</surname> <given-names>L</given-names></name><name><surname>Marino</surname> <given-names>G</given-names></name><name><surname>Aranda</surname> <given-names>F</given-names></name><name><surname>Durand</surname> <given-names>S</given-names></name><name><surname>Sica</surname> <given-names>V</given-names></name><name><surname>Chery</surname> <given-names>A</given-names></name><name><surname>Lachkar</surname> <given-names>S</given-names></name><name><surname>Sigl</surname> <given-names>V</given-names></name><name><surname>Bloy</surname> <given-names>N</given-names></name><name><surname>Buque</surname> <given-names>A</given-names></name><name><surname>Falzoni</surname> <given-names>S</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name><name><surname>Apetoh</surname> <given-names>L</given-names></name><name><surname>Di Virgilio</surname> <given-names>F</given-names></name><name><surname>Madeo</surname> <given-names>F</given-names></name><name><surname>Maiuri</surname> <given-names>MC</given-names></name><name><surname>Zitvogel</surname> <given-names>L</given-names></name><name><surname>Levine</surname> <given-names>B</given-names></name><name><surname>Penninger</surname> <given-names>JM</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Caloric restriction mimetics enhance anticancer immunosurveillance</article-title><source>Cancer Cell</source><volume>30</volume><fpage>147</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.05.016</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollizzi</surname> <given-names>KN</given-names></name><name><surname>Patel</surname> <given-names>CH</given-names></name><name><surname>Sun</surname> <given-names>IH</given-names></name><name><surname>Oh</surname> <given-names>MH</given-names></name><name><surname>Waickman</surname> <given-names>AT</given-names></name><name><surname>Wen</surname> <given-names>J</given-names></name><name><surname>Delgoffe</surname> <given-names>GM</given-names></name><name><surname>Powell</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation</article-title><source>Journal of Clinical Investigation</source><volume>125</volume><fpage>2090</fpage><lpage>2108</lpage><pub-id pub-id-type="doi">10.1172/JCI77746</pub-id><pub-id pub-id-type="pmid">25893604</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollizzi</surname> <given-names>KN</given-names></name><name><surname>Sun</surname> <given-names>I-H</given-names></name><name><surname>Patel</surname> <given-names>CH</given-names></name><name><surname>Lo</surname> <given-names>Y-C</given-names></name><name><surname>Oh</surname> <given-names>M-H</given-names></name><name><surname>Waickman</surname> <given-names>AT</given-names></name><name><surname>Tam</surname> <given-names>AJ</given-names></name><name><surname>Blosser</surname> <given-names>RL</given-names></name><name><surname>Wen</surname> <given-names>J</given-names></name><name><surname>Delgoffe</surname> <given-names>GM</given-names></name><name><surname>Powell</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation</article-title><source>Nature Immunology</source><volume>17</volume><fpage>704</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1038/ni.3438</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollizzi</surname> <given-names>KN</given-names></name><name><surname>Powell</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Integrating canonical and metabolic signalling programmes in the regulation of T cell responses</article-title><source>Nature Reviews Immunology</source><volume>14</volume><fpage>435</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1038/nri3701</pub-id><pub-id pub-id-type="pmid">24962260</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poropatich</surname> <given-names>K</given-names></name><name><surname>Fontanarosa</surname> <given-names>J</given-names></name><name><surname>Samant</surname> <given-names>S</given-names></name><name><surname>Sosman</surname> <given-names>JA</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cancer immunotherapies: are they as effective in the elderly?</article-title><source>Drugs &amp; Aging</source><volume>34</volume><fpage>567</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1007/s40266-017-0479-1</pub-id><pub-id pub-id-type="pmid">28707274</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Provinciali</surname> <given-names>M</given-names></name><name><surname>Argentati</surname> <given-names>K</given-names></name><name><surname>Tibaldi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Efficacy of Cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice</article-title><source>Gene Therapy</source><volume>7</volume><fpage>624</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1038/sj.gt.3301131</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Provinciali</surname> <given-names>M</given-names></name><name><surname>Smorlesi</surname> <given-names>A</given-names></name><name><surname>Donnini</surname> <given-names>A</given-names></name><name><surname>Bartozzi</surname> <given-names>B</given-names></name><name><surname>Amici</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Low effectiveness of DNA vaccination against HER-2/neu in ageing</article-title><source>Vaccine</source><volume>21</volume><fpage>843</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(02)00530-3</pub-id><pub-id pub-id-type="pmid">12547592</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quail</surname> <given-names>DF</given-names></name><name><surname>Olson</surname> <given-names>OC</given-names></name><name><surname>Bhardwaj</surname> <given-names>P</given-names></name><name><surname>Walsh</surname> <given-names>LA</given-names></name><name><surname>Akkari</surname> <given-names>L</given-names></name><name><surname>Quick</surname> <given-names>ML</given-names></name><name><surname>Chen</surname> <given-names>I-C</given-names></name><name><surname>Wendel</surname> <given-names>N</given-names></name><name><surname>Ben-Chetrit</surname> <given-names>N</given-names></name><name><surname>Walker</surname> <given-names>J</given-names></name><name><surname>Holt</surname> <given-names>PR</given-names></name><name><surname>Dannenberg</surname> <given-names>AJ</given-names></name><name><surname>Joyce</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Obesity alters the lung myeloid cell landscape to enhance breast Cancer metastasis through IL5 and GM-CSF</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>974</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1038/ncb3578</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname> <given-names>KM</given-names></name><name><surname>Fox</surname> <given-names>A</given-names></name><name><surname>Harland</surname> <given-names>KL</given-names></name><name><surname>Russ</surname> <given-names>BE</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Nguyen</surname> <given-names>THO</given-names></name><name><surname>Loh</surname> <given-names>L</given-names></name><name><surname>Olshanksy</surname> <given-names>M</given-names></name><name><surname>Naeem</surname> <given-names>H</given-names></name><name><surname>Tsyganov</surname> <given-names>K</given-names></name><name><surname>Wiede</surname> <given-names>F</given-names></name><name><surname>Webster</surname> <given-names>R</given-names></name><name><surname>Blyth</surname> <given-names>C</given-names></name><name><surname>Sng</surname> <given-names>XYX</given-names></name><name><surname>Tiganis</surname> <given-names>T</given-names></name><name><surname>Powell</surname> <given-names>D</given-names></name><name><surname>Doherty</surname> <given-names>PC</given-names></name><name><surname>Turner</surname> <given-names>SJ</given-names></name><name><surname>Kedzierska</surname> <given-names>K</given-names></name><name><surname>La Gruta</surname> <given-names>NL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Age-Related decline in primary CD8<sup>+</sup>T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8<sup>+</sup> T Cells</article-title><source>Cell Reports</source><volume>23</volume><fpage>3512</fpage><lpage>3524</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.05.057</pub-id><pub-id pub-id-type="pmid">29924995</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname> <given-names>KM</given-names></name><name><surname>Palchaudhuri</surname> <given-names>R</given-names></name><name><surname>Palmer</surname> <given-names>CS</given-names></name><name><surname>La Gruta</surname> <given-names>NL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The clock is ticking: the impact of ageing on T cell metabolism</article-title><source>Clinical &amp; Translational Immunology</source><volume>8</volume><elocation-id>1091</elocation-id><pub-id pub-id-type="doi">10.1002/cti2.1091</pub-id></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname> <given-names>KM</given-names></name><name><surname>Hussain</surname> <given-names>T</given-names></name><name><surname>Kraus</surname> <given-names>F</given-names></name><name><surname>Formosa</surname> <given-names>LE</given-names></name><name><surname>Lam</surname> <given-names>WK</given-names></name><name><surname>Dagley</surname> <given-names>MJ</given-names></name><name><surname>Saunders</surname> <given-names>EC</given-names></name><name><surname>Assmus</surname> <given-names>LM</given-names></name><name><surname>Wynne-Jones</surname> <given-names>E</given-names></name><name><surname>Loh</surname> <given-names>L</given-names></name><name><surname>van de Sandt</surname> <given-names>CE</given-names></name><name><surname>Cooper</surname> <given-names>L</given-names></name><name><surname>Good-Jacobson</surname> <given-names>KL</given-names></name><name><surname>Kedzierska</surname> <given-names>K</given-names></name><name><surname>Mackay</surname> <given-names>LK</given-names></name><name><surname>McConville</surname> <given-names>MJ</given-names></name><name><surname>Ramm</surname> <given-names>G</given-names></name><name><surname>Ryan</surname> <given-names>MT</given-names></name><name><surname>La Gruta</surname> <given-names>NL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Metabolic characteristics of CD8<sup>+</sup>T cell subsets in young and aged individuals are not predictive of functionality</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2857</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16633-7</pub-id><pub-id pub-id-type="pmid">32504069</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname> <given-names>E</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>G</given-names></name><name><surname>Hao</surname> <given-names>J</given-names></name><name><surname>Persson</surname> <given-names>XM</given-names></name><name><surname>Egilmez</surname> <given-names>NK</given-names></name><name><surname>Suttles</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death</article-title><source>Oncotarget</source><volume>6</volume><fpage>7944</fpage><lpage>7958</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.3501</pub-id><pub-id pub-id-type="pmid">25760243</pub-id></element-citation></ref><ref id="bib184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebeles</surname> <given-names>J</given-names></name><name><surname>Green</surname> <given-names>WD</given-names></name><name><surname>Alwarawrah</surname> <given-names>Y</given-names></name><name><surname>Nichols</surname> <given-names>AG</given-names></name><name><surname>Eisner</surname> <given-names>W</given-names></name><name><surname>Danzaki</surname> <given-names>K</given-names></name><name><surname>MacIver</surname> <given-names>NJ</given-names></name><name><surname>Beck</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Obesity-Induced changes in T-Cell metabolism are associated with impaired memory T-Cell response to influenza and are not reversed with weight loss</article-title><source>The Journal of Infectious Diseases</source><volume>219</volume><fpage>1652</fpage><lpage>1661</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiy700</pub-id><pub-id pub-id-type="pmid">30535161</pub-id></element-citation></ref><ref id="bib185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recino</surname> <given-names>A</given-names></name><name><surname>Barkan</surname> <given-names>K</given-names></name><name><surname>Wong</surname> <given-names>FS</given-names></name><name><surname>Ladds</surname> <given-names>G</given-names></name><name><surname>Cooke</surname> <given-names>A</given-names></name><name><surname>Wallberg</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hyperglycaemia does not affect antigen-specific activation and cytolytic killing by CD8<sup>+</sup> T cells <italic>in vivo</italic></article-title><source>Bioscience Reports</source><volume>37</volume><elocation-id>BSR20171079</elocation-id><pub-id pub-id-type="doi">10.1042/BSR20171079</pub-id><pub-id pub-id-type="pmid">28798194</pub-id></element-citation></ref><ref id="bib186"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renkema</surname> <given-names>KR</given-names></name><name><surname>Li</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>A</given-names></name><name><surname>Smithey</surname> <given-names>MJ</given-names></name><name><surname>Nikolich-Žugich</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Two separate defects affecting true naive or virtual memory T cell precursors combine to reduce naive T cell responses with aging</article-title><source>The Journal of Immunology</source><volume>192</volume><fpage>151</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301453</pub-id><pub-id pub-id-type="pmid">24293630</pub-id></element-citation></ref><ref id="bib187"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivadeneira</surname> <given-names>DB</given-names></name><name><surname>DePeaux</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Kulkarni</surname> <given-names>A</given-names></name><name><surname>Tabib</surname> <given-names>T</given-names></name><name><surname>Menk</surname> <given-names>AV</given-names></name><name><surname>Sampath</surname> <given-names>P</given-names></name><name><surname>Lafyatis</surname> <given-names>R</given-names></name><name><surname>Ferris</surname> <given-names>RL</given-names></name><name><surname>Sarkar</surname> <given-names>SN</given-names></name><name><surname>Thorne</surname> <given-names>SH</given-names></name><name><surname>Delgoffe</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Oncolytic viruses engineered to enforce leptin expression reprogram Tumor-Infiltrating T cell metabolism and promote tumor clearance</article-title><source>Immunity</source><volume>51</volume><fpage>548</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.07.003</pub-id><pub-id pub-id-type="pmid">31471106</pub-id></element-citation></ref><ref id="bib188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname> <given-names>PC</given-names></name><name><surname>Quiceno</surname> <given-names>DG</given-names></name><name><surname>Zabaleta</surname> <given-names>J</given-names></name><name><surname>Ortiz</surname> <given-names>B</given-names></name><name><surname>Zea</surname> <given-names>AH</given-names></name><name><surname>Piazuelo</surname> <given-names>MB</given-names></name><name><surname>Delgado</surname> <given-names>A</given-names></name><name><surname>Correa</surname> <given-names>P</given-names></name><name><surname>Brayer</surname> <given-names>J</given-names></name><name><surname>Sotomayor</surname> <given-names>EM</given-names></name><name><surname>Antonia</surname> <given-names>S</given-names></name><name><surname>Ochoa</surname> <given-names>JB</given-names></name><name><surname>Ochoa</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses</article-title><source>Cancer Research</source><volume>64</volume><fpage>5839</fpage><lpage>5849</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-0465</pub-id><pub-id pub-id-type="pmid">15313928</pub-id></element-citation></ref><ref id="bib189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron-Harel</surname> <given-names>N</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Haigis</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial metabolism in T cell activation and senescence: a mini-review</article-title><source>Gerontology</source><volume>61</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1159/000362502</pub-id><pub-id pub-id-type="pmid">25402204</pub-id></element-citation></ref><ref id="bib190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron-Harel</surname> <given-names>N</given-names></name><name><surname>Santos</surname> <given-names>D</given-names></name><name><surname>Ghergurovich</surname> <given-names>JM</given-names></name><name><surname>Sage</surname> <given-names>PT</given-names></name><name><surname>Reddy</surname> <given-names>A</given-names></name><name><surname>Lovitch</surname> <given-names>SB</given-names></name><name><surname>Dephoure</surname> <given-names>N</given-names></name><name><surname>Satterstrom</surname> <given-names>FK</given-names></name><name><surname>Sheffer</surname> <given-names>M</given-names></name><name><surname>Spinelli</surname> <given-names>JB</given-names></name><name><surname>Gygi</surname> <given-names>S</given-names></name><name><surname>Rabinowitz</surname> <given-names>JD</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Haigis</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial biogenesis and proteome remodeling promote One-Carbon metabolism for T cell activation</article-title><source>Cell Metabolism</source><volume>24</volume><fpage>104</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.06.007</pub-id><pub-id pub-id-type="pmid">27411012</pub-id></element-citation></ref><ref id="bib191"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron-Harel</surname> <given-names>N</given-names></name><name><surname>Notarangelo</surname> <given-names>G</given-names></name><name><surname>Ghergurovich</surname> <given-names>JM</given-names></name><name><surname>Paulo</surname> <given-names>JA</given-names></name><name><surname>Sage</surname> <given-names>PT</given-names></name><name><surname>Santos</surname> <given-names>D</given-names></name><name><surname>Satterstrom</surname> <given-names>FK</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Rabinowitz</surname> <given-names>JD</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Haigis</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice</article-title><source>PNAS</source><volume>115</volume><fpage>13347</fpage><lpage>13352</lpage><pub-id pub-id-type="doi">10.1073/pnas.1804149115</pub-id><pub-id pub-id-type="pmid">30530686</pub-id></element-citation></ref><ref id="bib192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname> <given-names>SA</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adoptive cell transfer as personalized immunotherapy for human Cancer</article-title><source>Science</source><volume>348</volume><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1126/science.aaa4967</pub-id><pub-id pub-id-type="pmid">25838374</pub-id></element-citation></ref><ref id="bib193"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname> <given-names>MH</given-names></name><name><surname>Bras</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Tumor Incidence Patterns and Nutrition in the Rat</article-title><source>The Journal of Nutrition</source><volume>87</volume><fpage>245</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1093/jn/87.3.245</pub-id></element-citation></ref><ref id="bib194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossjohn</surname> <given-names>J</given-names></name><name><surname>Gras</surname> <given-names>S</given-names></name><name><surname>Miles</surname> <given-names>JJ</given-names></name><name><surname>Turner</surname> <given-names>SJ</given-names></name><name><surname>Godfrey</surname> <given-names>DI</given-names></name><name><surname>McCluskey</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>T cell antigen receptor recognition of antigen-presenting molecules</article-title><source>Annual Review of Immunology</source><volume>33</volume><fpage>169</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112334</pub-id><pub-id pub-id-type="pmid">25493333</pub-id></element-citation></ref><ref id="bib195"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rous</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1914">1914</year><article-title>The influence of diet on transplanted and spontaneous mouse tumors</article-title><source>Journal of Experimental Medicine</source><volume>20</volume><fpage>433</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1084/jem.20.5.433</pub-id><pub-id pub-id-type="pmid">19867833</pub-id></element-citation></ref><ref id="bib196"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio-Patiño</surname> <given-names>C</given-names></name><name><surname>Bossowski</surname> <given-names>JP</given-names></name><name><surname>De Donatis</surname> <given-names>GM</given-names></name><name><surname>Mondragón</surname> <given-names>L</given-names></name><name><surname>Villa</surname> <given-names>E</given-names></name><name><surname>Aira</surname> <given-names>LE</given-names></name><name><surname>Chiche</surname> <given-names>J</given-names></name><name><surname>Mhaidly</surname> <given-names>R</given-names></name><name><surname>Lebeaupin</surname> <given-names>C</given-names></name><name><surname>Marchetti</surname> <given-names>S</given-names></name><name><surname>Voutetakis</surname> <given-names>K</given-names></name><name><surname>Chatziioannou</surname> <given-names>A</given-names></name><name><surname>Castelli</surname> <given-names>FA</given-names></name><name><surname>Lamourette</surname> <given-names>P</given-names></name><name><surname>Chu-Van</surname> <given-names>E</given-names></name><name><surname>Fenaille</surname> <given-names>F</given-names></name><name><surname>Avril</surname> <given-names>T</given-names></name><name><surname>Passeron</surname> <given-names>T</given-names></name><name><surname>Patterson</surname> <given-names>JB</given-names></name><name><surname>Verhoeyen</surname> <given-names>E</given-names></name><name><surname>Bailly-Maitre</surname> <given-names>B</given-names></name><name><surname>Chevet</surname> <given-names>E</given-names></name><name><surname>Ricci</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Low-Protein diet induces IRE1α-Dependent anticancer immunosurveillance</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>828</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.02.009</pub-id><pub-id pub-id-type="pmid">29551590</pub-id></element-citation></ref><ref id="bib197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruby</surname> <given-names>CE</given-names></name><name><surname>Weinberg</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>OX40-enhanced tumor rejection and effector T cell differentiation decreases with age</article-title><source>The Journal of Immunology</source><volume>182</volume><fpage>1481</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.182.3.1481</pub-id><pub-id pub-id-type="pmid">19155495</pub-id></element-citation></ref><ref id="bib198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruhland</surname> <given-names>MK</given-names></name><name><surname>Loza</surname> <given-names>AJ</given-names></name><name><surname>Capietto</surname> <given-names>AH</given-names></name><name><surname>Luo</surname> <given-names>X</given-names></name><name><surname>Knolhoff</surname> <given-names>BL</given-names></name><name><surname>Flanagan</surname> <given-names>KC</given-names></name><name><surname>Belt</surname> <given-names>BA</given-names></name><name><surname>Alspach</surname> <given-names>E</given-names></name><name><surname>Leahy</surname> <given-names>K</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Schaffer</surname> <given-names>A</given-names></name><name><surname>Edwards</surname> <given-names>JR</given-names></name><name><surname>Longmore</surname> <given-names>G</given-names></name><name><surname>Faccio</surname> <given-names>R</given-names></name><name><surname>DeNardo</surname> <given-names>DG</given-names></name><name><surname>Stewart</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11762</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11762</pub-id><pub-id pub-id-type="pmid">27272654</pub-id></element-citation></ref><ref id="bib199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rytter</surname> <given-names>MJ</given-names></name><name><surname>Kolte</surname> <given-names>L</given-names></name><name><surname>Briend</surname> <given-names>A</given-names></name><name><surname>Friis</surname> <given-names>H</given-names></name><name><surname>Christensen</surname> <given-names>VB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The immune system in children with malnutrition--a systematic review</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e105017</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0105017</pub-id><pub-id pub-id-type="pmid">25153531</pub-id></element-citation></ref><ref id="bib200"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salminen</surname> <given-names>A</given-names></name><name><surname>Kauppinen</surname> <given-names>A</given-names></name><name><surname>Kaarniranta</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on Cancer and aging</article-title><source>Journal of Molecular Medicine</source><volume>97</volume><fpage>1049</fpage><lpage>1064</lpage><pub-id pub-id-type="doi">10.1007/s00109-019-01795-9</pub-id><pub-id pub-id-type="pmid">31129755</pub-id></element-citation></ref><ref id="bib201"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saucillo</surname> <given-names>DC</given-names></name><name><surname>Gerriets</surname> <given-names>VA</given-names></name><name><surname>Sheng</surname> <given-names>J</given-names></name><name><surname>Rathmell</surname> <given-names>JC</given-names></name><name><surname>Maciver</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Leptin metabolically licenses T cells for activation to link nutrition and immunity</article-title><source>The Journal of Immunology</source><volume>192</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301158</pub-id><pub-id pub-id-type="pmid">24273001</pub-id></element-citation></ref><ref id="bib202"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sceneay</surname> <given-names>J</given-names></name><name><surname>Goreczny</surname> <given-names>GJ</given-names></name><name><surname>Wilson</surname> <given-names>K</given-names></name><name><surname>Morrow</surname> <given-names>S</given-names></name><name><surname>DeCristo</surname> <given-names>MJ</given-names></name><name><surname>Ubellacker</surname> <given-names>JM</given-names></name><name><surname>Qin</surname> <given-names>Y</given-names></name><name><surname>Laszewski</surname> <given-names>T</given-names></name><name><surname>Stover</surname> <given-names>DG</given-names></name><name><surname>Barrera</surname> <given-names>V</given-names></name><name><surname>Hutchinson</surname> <given-names>JN</given-names></name><name><surname>Freedman</surname> <given-names>RA</given-names></name><name><surname>Mittendorf</surname> <given-names>EA</given-names></name><name><surname>McAllister</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in Triple-Negative breast Cancer</article-title><source>Cancer Discovery</source><volume>9</volume><fpage>1208</fpage><lpage>1227</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-18-1454</pub-id><pub-id pub-id-type="pmid">31217296</pub-id></element-citation></ref><ref id="bib203"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharping</surname> <given-names>NE</given-names></name><name><surname>Menk</surname> <given-names>AV</given-names></name><name><surname>Moreci</surname> <given-names>RS</given-names></name><name><surname>Whetstone</surname> <given-names>RD</given-names></name><name><surname>Dadey</surname> <given-names>RE</given-names></name><name><surname>Watkins</surname> <given-names>SC</given-names></name><name><surname>Ferris</surname> <given-names>RL</given-names></name><name><surname>Delgoffe</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction</article-title><source>Immunity</source><volume>45</volume><fpage>374</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.07.009</pub-id><pub-id pub-id-type="pmid">27496732</pub-id></element-citation></ref><ref id="bib204"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharping</surname> <given-names>NE</given-names></name><name><surname>Menk</surname> <given-names>AV</given-names></name><name><surname>Whetstone</surname> <given-names>RD</given-names></name><name><surname>Zeng</surname> <given-names>X</given-names></name><name><surname>Delgoffe</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Efficacy of PD-1 blockade is potentiated by Metformin-Induced reduction of tumor hypoxia</article-title><source>Cancer Immunology Research</source><volume>5</volume><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-16-0103</pub-id><pub-id pub-id-type="pmid">27941003</pub-id></element-citation></ref><ref id="bib205"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekido</surname> <given-names>K</given-names></name><name><surname>Tomihara</surname> <given-names>K</given-names></name><name><surname>Tachinami</surname> <given-names>H</given-names></name><name><surname>Heshiki</surname> <given-names>W</given-names></name><name><surname>Sakurai</surname> <given-names>K</given-names></name><name><surname>Moniruzzaman</surname> <given-names>R</given-names></name><name><surname>Imaue</surname> <given-names>S</given-names></name><name><surname>Fujiwara</surname> <given-names>K</given-names></name><name><surname>Noguchi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Alterations in composition of immune cells and impairment of anti-tumor immune response in aged oral cancer-bearing mice</article-title><source>Oral Oncology</source><volume>99</volume><elocation-id>104462</elocation-id><pub-id pub-id-type="doi">10.1016/j.oraloncology.2019.104462</pub-id><pub-id pub-id-type="pmid">31683168</pub-id></element-citation></ref><ref id="bib206"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankaran</surname> <given-names>V</given-names></name><name><surname>Ikeda</surname> <given-names>H</given-names></name><name><surname>Bruce</surname> <given-names>AT</given-names></name><name><surname>White</surname> <given-names>JM</given-names></name><name><surname>Swanson</surname> <given-names>PE</given-names></name><name><surname>Old</surname> <given-names>LJ</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity</article-title><source>Nature</source><volume>410</volume><fpage>1107</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1038/35074122</pub-id><pub-id pub-id-type="pmid">11323675</pub-id></element-citation></ref><ref id="bib207"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>S</given-names></name><name><surname>Dominguez</surname> <given-names>AL</given-names></name><name><surname>Lustgarten</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>High accumulation of T regulatory cells prevents the activation of immune responses in aged animals</article-title><source>The Journal of Immunology</source><volume>177</volume><fpage>8348</fpage><lpage>8355</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.12.8348</pub-id><pub-id pub-id-type="pmid">17142731</pub-id></element-citation></ref><ref id="bib208"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname> <given-names>PA</given-names></name><name><surname>Paich</surname> <given-names>HA</given-names></name><name><surname>Handy</surname> <given-names>J</given-names></name><name><surname>Karlsson</surname> <given-names>EA</given-names></name><name><surname>Hudgens</surname> <given-names>MG</given-names></name><name><surname>Sammon</surname> <given-names>AB</given-names></name><name><surname>Holland</surname> <given-names>LA</given-names></name><name><surname>Weir</surname> <given-names>S</given-names></name><name><surname>Noah</surname> <given-names>TL</given-names></name><name><surname>Beck</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Obesity is associated with impaired immune response to influenza vaccination in humans</article-title><source>International Journal of Obesity</source><volume>36</volume><fpage>1072</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1038/ijo.2011.208</pub-id></element-citation></ref><ref id="bib209"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirakawa</surname> <given-names>K</given-names></name><name><surname>Yan</surname> <given-names>X</given-names></name><name><surname>Shinmura</surname> <given-names>K</given-names></name><name><surname>Endo</surname> <given-names>J</given-names></name><name><surname>Kataoka</surname> <given-names>M</given-names></name><name><surname>Katsumata</surname> <given-names>Y</given-names></name><name><surname>Yamamoto</surname> <given-names>T</given-names></name><name><surname>Anzai</surname> <given-names>A</given-names></name><name><surname>Isobe</surname> <given-names>S</given-names></name><name><surname>Yoshida</surname> <given-names>N</given-names></name><name><surname>Itoh</surname> <given-names>H</given-names></name><name><surname>Manabe</surname> <given-names>I</given-names></name><name><surname>Sekai</surname> <given-names>M</given-names></name><name><surname>Hamazaki</surname> <given-names>Y</given-names></name><name><surname>Fukuda</surname> <given-names>K</given-names></name><name><surname>Minato</surname> <given-names>N</given-names></name><name><surname>Sano</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Obesity accelerates T cell senescence in murine visceral adipose tissue</article-title><source>Journal of Clinical Investigation</source><volume>126</volume><fpage>4626</fpage><lpage>4639</lpage><pub-id pub-id-type="doi">10.1172/JCI88606</pub-id></element-citation></ref><ref id="bib210"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname> <given-names>RL</given-names></name><name><surname>Miller</surname> <given-names>KD</given-names></name><name><surname>Jemal</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cancer statistics, 2019</article-title><source>CA: A Cancer Journal for Clinicians</source><volume>69</volume><fpage>7</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.3322/caac.21551</pub-id><pub-id pub-id-type="pmid">30620402</pub-id></element-citation></ref><ref id="bib211"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith-Garvin</surname> <given-names>JE</given-names></name><name><surname>Koretzky</surname> <given-names>GA</given-names></name><name><surname>Jordan</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>T cell activation</article-title><source>Annual Review of Immunology</source><volume>27</volume><fpage>591</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132706</pub-id></element-citation></ref><ref id="bib212"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spielmann</surname> <given-names>G</given-names></name><name><surname>Johnston</surname> <given-names>CA</given-names></name><name><surname>O'Connor</surname> <given-names>DP</given-names></name><name><surname>Foreyt</surname> <given-names>JP</given-names></name><name><surname>Simpson</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Excess body mass is associated with T cell differentiation indicative of immune ageing in children</article-title><source>Clinical &amp; Experimental Immunology</source><volume>176</volume><fpage>246</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1111/cei.12267</pub-id><pub-id pub-id-type="pmid">24401077</pub-id></element-citation></ref><ref id="bib213"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spranger</surname> <given-names>S</given-names></name><name><surname>Bao</surname> <given-names>R</given-names></name><name><surname>Gajewski</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity</article-title><source>Nature</source><volume>523</volume><fpage>231</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1038/nature14404</pub-id><pub-id pub-id-type="pmid">25970248</pub-id></element-citation></ref><ref id="bib214"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname> <given-names>NL</given-names></name><name><surname>Iyengar</surname> <given-names>NM</given-names></name><name><surname>Bareja</surname> <given-names>R</given-names></name><name><surname>Verma</surname> <given-names>A</given-names></name><name><surname>Jochelson</surname> <given-names>MS</given-names></name><name><surname>Giri</surname> <given-names>DD</given-names></name><name><surname>Zhou</surname> <given-names>XK</given-names></name><name><surname>Elemento</surname> <given-names>O</given-names></name><name><surname>Dannenberg</surname> <given-names>AJ</given-names></name><name><surname>Fischbach</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Obesity-Associated extracellular matrix remodeling promotes a macrophage phenotype similar to Tumor-Associated macrophages</article-title><source>The American Journal of Pathology</source><volume>189</volume><fpage>2019</fpage><lpage>2035</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2019.06.005</pub-id><pub-id pub-id-type="pmid">31323189</pub-id></element-citation></ref><ref id="bib215"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>MR</given-names></name><name><surname>Danai</surname> <given-names>LV</given-names></name><name><surname>Lewis</surname> <given-names>CA</given-names></name><name><surname>Chan</surname> <given-names>SH</given-names></name><name><surname>Gui</surname> <given-names>DY</given-names></name><name><surname>Kunchok</surname> <given-names>T</given-names></name><name><surname>Dennstedt</surname> <given-names>EA</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name><name><surname>Muir</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability</article-title><source>eLife</source><volume>8</volume><elocation-id>e44235</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44235</pub-id><pub-id pub-id-type="pmid">30990168</pub-id></element-citation></ref><ref id="bib216"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>AK</given-names></name><name><surname>Cao</surname> <given-names>W</given-names></name><name><surname>Vora</surname> <given-names>KP</given-names></name><name><surname>De La Cruz</surname> <given-names>J</given-names></name><name><surname>Shieh</surname> <given-names>WJ</given-names></name><name><surname>Zaki</surname> <given-names>SR</given-names></name><name><surname>Katz</surname> <given-names>JM</given-names></name><name><surname>Sambhara</surname> <given-names>S</given-names></name><name><surname>Gangappa</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice</article-title><source>The Journal of Infectious Diseases</source><volume>207</volume><fpage>501</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis527</pub-id><pub-id pub-id-type="pmid">22949306</pub-id></element-citation></ref><ref id="bib217"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilstra</surname> <given-names>JS</given-names></name><name><surname>Robinson</surname> <given-names>AR</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Gregg</surname> <given-names>SQ</given-names></name><name><surname>Clauson</surname> <given-names>CL</given-names></name><name><surname>Reay</surname> <given-names>DP</given-names></name><name><surname>Nasto</surname> <given-names>LA</given-names></name><name><surname>St Croix</surname> <given-names>CM</given-names></name><name><surname>Usas</surname> <given-names>A</given-names></name><name><surname>Vo</surname> <given-names>N</given-names></name><name><surname>Huard</surname> <given-names>J</given-names></name><name><surname>Clemens</surname> <given-names>PR</given-names></name><name><surname>Stolz</surname> <given-names>DB</given-names></name><name><surname>Guttridge</surname> <given-names>DC</given-names></name><name><surname>Watkins</surname> <given-names>SC</given-names></name><name><surname>Garinis</surname> <given-names>GA</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Niedernhofer</surname> <given-names>LJ</given-names></name><name><surname>Robbins</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NF-κB inhibition delays DNA damage-induced senescence and aging in mice</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>2601</fpage><lpage>2612</lpage><pub-id pub-id-type="doi">10.1172/JCI45785</pub-id><pub-id pub-id-type="pmid">22706308</pub-id></element-citation></ref><ref id="bib218"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tivol</surname> <given-names>EA</given-names></name><name><surname>Borriello</surname> <given-names>F</given-names></name><name><surname>Schweitzer</surname> <given-names>AN</given-names></name><name><surname>Lynch</surname> <given-names>WP</given-names></name><name><surname>Bluestone</surname> <given-names>JA</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4</article-title><source>Immunity</source><volume>3</volume><fpage>541</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1016/1074-7613(95)90125-6</pub-id><pub-id pub-id-type="pmid">7584144</pub-id></element-citation></ref><ref id="bib219"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname> <given-names>S</given-names></name><name><surname>Clemente-Casares</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>AC</given-names></name><name><surname>Lei</surname> <given-names>H</given-names></name><name><surname>Ahn</surname> <given-names>JJ</given-names></name><name><surname>Chan</surname> <given-names>YT</given-names></name><name><surname>Choi</surname> <given-names>O</given-names></name><name><surname>Luck</surname> <given-names>H</given-names></name><name><surname>Woo</surname> <given-names>M</given-names></name><name><surname>Dunn</surname> <given-names>SE</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name><name><surname>Watts</surname> <given-names>TH</given-names></name><name><surname>Winer</surname> <given-names>S</given-names></name><name><surname>Winer</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Insulin Receptor-Mediated stimulation boosts T cell immunity during inflammation and infection</article-title><source>Cell Metabolism</source><volume>28</volume><fpage>922</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.08.003</pub-id><pub-id pub-id-type="pmid">30174303</pub-id></element-citation></ref><ref id="bib220"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turbitt</surname> <given-names>WJ</given-names></name><name><surname>Collins</surname> <given-names>SD</given-names></name><name><surname>Meng</surname> <given-names>H</given-names></name><name><surname>Rogers</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Increased Adiposity Enhances the Accumulation of MDSCs in the Tumor Microenvironment and Adipose Tissue of Pancreatic Tumor-Bearing Mice and in Immune Organs of Tumor-Free Hosts</article-title><source>Nutrients</source><volume>11</volume><elocation-id>3012</elocation-id><pub-id pub-id-type="doi">10.3390/nu11123012</pub-id></element-citation></ref><ref id="bib221"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turbitt</surname> <given-names>WJ</given-names></name><name><surname>Buchta Rosean</surname> <given-names>C</given-names></name><name><surname>Weber</surname> <given-names>KS</given-names></name><name><surname>Norian</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Obesity and CD8 T cell metabolism: implications for anti-tumor immunity and Cancer immunotherapy outcomes</article-title><source>Immunological Reviews</source><volume>295</volume><fpage>203</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1111/imr.12849</pub-id><pub-id pub-id-type="pmid">32157710</pub-id></element-citation></ref><ref id="bib222"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uyttenhove</surname> <given-names>C</given-names></name><name><surname>Pilotte</surname> <given-names>L</given-names></name><name><surname>Théate</surname> <given-names>I</given-names></name><name><surname>Stroobant</surname> <given-names>V</given-names></name><name><surname>Colau</surname> <given-names>D</given-names></name><name><surname>Parmentier</surname> <given-names>N</given-names></name><name><surname>Boon</surname> <given-names>T</given-names></name><name><surname>Van den Eynde</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase</article-title><source>Nature Medicine</source><volume>9</volume><fpage>1269</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1038/nm934</pub-id><pub-id pub-id-type="pmid">14502282</pub-id></element-citation></ref><ref id="bib223"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vabret</surname> <given-names>N</given-names></name><name><surname>Britton</surname> <given-names>GJ</given-names></name><name><surname>Gruber</surname> <given-names>C</given-names></name><name><surname>Hegde</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Kuksin</surname> <given-names>M</given-names></name><name><surname>Levantovsky</surname> <given-names>R</given-names></name><name><surname>Malle</surname> <given-names>L</given-names></name><name><surname>Moreira</surname> <given-names>A</given-names></name><name><surname>Park</surname> <given-names>MD</given-names></name><name><surname>Pia</surname> <given-names>L</given-names></name><name><surname>Risson</surname> <given-names>E</given-names></name><name><surname>Saffern</surname> <given-names>M</given-names></name><name><surname>Salomé</surname> <given-names>B</given-names></name><name><surname>Esai Selvan</surname> <given-names>M</given-names></name><name><surname>Spindler</surname> <given-names>MP</given-names></name><name><surname>Tan</surname> <given-names>J</given-names></name><name><surname>van der Heide</surname> <given-names>V</given-names></name><name><surname>Gregory</surname> <given-names>JK</given-names></name><name><surname>Alexandropoulos</surname> <given-names>K</given-names></name><name><surname>Bhardwaj</surname> <given-names>N</given-names></name><name><surname>Brown</surname> <given-names>BD</given-names></name><name><surname>Greenbaum</surname> <given-names>B</given-names></name><name><surname>Gümüş</surname> <given-names>ZH</given-names></name><name><surname>Homann</surname> <given-names>D</given-names></name><name><surname>Horowitz</surname> <given-names>A</given-names></name><name><surname>Kamphorst</surname> <given-names>AO</given-names></name><name><surname>Curotto de Lafaille</surname> <given-names>MA</given-names></name><name><surname>Mehandru</surname> <given-names>S</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Samstein</surname> <given-names>RM</given-names></name><collab>Sinai Immunology Review Project</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Immunology of COVID-19: current state of the science</article-title><source>Immunity</source><volume>52</volume><fpage>910</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.05.002</pub-id><pub-id pub-id-type="pmid">32505227</pub-id></element-citation></ref><ref id="bib224"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vliet</surname> <given-names>HJJ</given-names></name><name><surname>Nieuwenhuis</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>IPEX as a result of mutations in FOXP3</article-title><source>Clinical and Developmental Immunology</source><volume>2007</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1155/2007/89017</pub-id></element-citation></ref><ref id="bib225"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Windt</surname> <given-names>GJ</given-names></name><name><surname>Everts</surname> <given-names>B</given-names></name><name><surname>Chang</surname> <given-names>CH</given-names></name><name><surname>Curtis</surname> <given-names>JD</given-names></name><name><surname>Freitas</surname> <given-names>TC</given-names></name><name><surname>Amiel</surname> <given-names>E</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development</article-title><source>Immunity</source><volume>36</volume><fpage>68</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.007</pub-id><pub-id pub-id-type="pmid">22206904</pub-id></element-citation></ref><ref id="bib226"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbist</surname> <given-names>KC</given-names></name><name><surname>Guy</surname> <given-names>CS</given-names></name><name><surname>Milasta</surname> <given-names>S</given-names></name><name><surname>Liedmann</surname> <given-names>S</given-names></name><name><surname>Kamiński</surname> <given-names>MM</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Green</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic maintenance of cell asymmetry following division in activated T lymphocytes</article-title><source>Nature</source><volume>532</volume><fpage>389</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1038/nature17442</pub-id><pub-id pub-id-type="pmid">27064903</pub-id></element-citation></ref><ref id="bib227"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldman</surname> <given-names>AD</given-names></name><name><surname>Fritz</surname> <given-names>JM</given-names></name><name><surname>Lenardo</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A guide to Cancer immunotherapy: from T cell basic science to clinical practice</article-title><source>Nature Reviews Immunology</source><volume>20</volume><fpage>651</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0306-5</pub-id><pub-id pub-id-type="pmid">32433532</pub-id></element-citation></ref><ref id="bib228"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanders</surname> <given-names>D</given-names></name><name><surname>Hobson</surname> <given-names>K</given-names></name><name><surname>Ji</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Methionine restriction and Cancer biology</article-title><source>Nutrients</source><volume>12</volume><elocation-id>684</elocation-id><pub-id pub-id-type="doi">10.3390/nu12030684</pub-id></element-citation></ref><ref id="bib229"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Dillon</surname> <given-names>CP</given-names></name><name><surname>Shi</surname> <given-names>LZ</given-names></name><name><surname>Milasta</surname> <given-names>S</given-names></name><name><surname>Carter</surname> <given-names>R</given-names></name><name><surname>Finkelstein</surname> <given-names>D</given-names></name><name><surname>McCormick</surname> <given-names>LL</given-names></name><name><surname>Fitzgerald</surname> <given-names>P</given-names></name><name><surname>Chi</surname> <given-names>H</given-names></name><name><surname>Munger</surname> <given-names>J</given-names></name><name><surname>Green</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The transcription factor myc controls metabolic reprogramming upon T lymphocyte activation</article-title><source>Immunity</source><volume>35</volume><fpage>871</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.09.021</pub-id><pub-id pub-id-type="pmid">22195744</pub-id></element-citation></ref><ref id="bib230"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Aguilar</surname> <given-names>EG</given-names></name><name><surname>Luna</surname> <given-names>JI</given-names></name><name><surname>Dunai</surname> <given-names>C</given-names></name><name><surname>Khuat</surname> <given-names>LT</given-names></name><name><surname>Le</surname> <given-names>CT</given-names></name><name><surname>Mirsoian</surname> <given-names>A</given-names></name><name><surname>Minnar</surname> <given-names>CM</given-names></name><name><surname>Stoffel</surname> <given-names>KM</given-names></name><name><surname>Sturgill</surname> <given-names>IR</given-names></name><name><surname>Grossenbacher</surname> <given-names>SK</given-names></name><name><surname>Withers</surname> <given-names>SS</given-names></name><name><surname>Rebhun</surname> <given-names>RB</given-names></name><name><surname>Hartigan-O'Connor</surname> <given-names>DJ</given-names></name><name><surname>Méndez-Lagares</surname> <given-names>G</given-names></name><name><surname>Tarantal</surname> <given-names>AF</given-names></name><name><surname>Isseroff</surname> <given-names>RR</given-names></name><name><surname>Griffith</surname> <given-names>TS</given-names></name><name><surname>Schalper</surname> <given-names>KA</given-names></name><name><surname>Merleev</surname> <given-names>A</given-names></name><name><surname>Saha</surname> <given-names>A</given-names></name><name><surname>Maverakis</surname> <given-names>E</given-names></name><name><surname>Kelly</surname> <given-names>K</given-names></name><name><surname>Aljumaily</surname> <given-names>R</given-names></name><name><surname>Ibrahimi</surname> <given-names>S</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Machiorlatti</surname> <given-names>M</given-names></name><name><surname>Vesely</surname> <given-names>SK</given-names></name><name><surname>Longo</surname> <given-names>DL</given-names></name><name><surname>Blazar</surname> <given-names>BR</given-names></name><name><surname>Canter</surname> <given-names>RJ</given-names></name><name><surname>Murphy</surname> <given-names>WJ</given-names></name><name><surname>Monjazeb</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade</article-title><source>Nature Medicine</source><volume>25</volume><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0221-5</pub-id><pub-id pub-id-type="pmid">30420753</pub-id></element-citation></ref><ref id="bib231"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Franco</surname> <given-names>F</given-names></name><name><surname>Tsui</surname> <given-names>YC</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name><name><surname>Trefny</surname> <given-names>MP</given-names></name><name><surname>Zappasodi</surname> <given-names>R</given-names></name><name><surname>Mohmood</surname> <given-names>SR</given-names></name><name><surname>Fernández-García</surname> <given-names>J</given-names></name><name><surname>Tsai</surname> <given-names>CH</given-names></name><name><surname>Schulze</surname> <given-names>I</given-names></name><name><surname>Picard</surname> <given-names>F</given-names></name><name><surname>Meylan</surname> <given-names>E</given-names></name><name><surname>Silverstein</surname> <given-names>R</given-names></name><name><surname>Goldberg</surname> <given-names>I</given-names></name><name><surname>Fendt</surname> <given-names>SM</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Jandus</surname> <given-names>C</given-names></name><name><surname>Zippelius</surname> <given-names>A</given-names></name><name><surname>Ho</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors</article-title><source>Nature Immunology</source><volume>21</volume><fpage>298</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0589-5</pub-id><pub-id pub-id-type="pmid">32066953</pub-id></element-citation></ref><ref id="bib232"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weindruch</surname> <given-names>R</given-names></name><name><surname>Walford</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous Cancer incidence</article-title><source>Science</source><volume>215</volume><fpage>1415</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1126/science.7063854</pub-id><pub-id pub-id-type="pmid">7063854</pub-id></element-citation></ref><ref id="bib233"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weitman</surname> <given-names>ES</given-names></name><name><surname>Aschen</surname> <given-names>SZ</given-names></name><name><surname>Farias-Eisner</surname> <given-names>G</given-names></name><name><surname>Albano</surname> <given-names>N</given-names></name><name><surname>Cuzzone</surname> <given-names>DA</given-names></name><name><surname>Ghanta</surname> <given-names>S</given-names></name><name><surname>Zampell</surname> <given-names>JC</given-names></name><name><surname>Thorek</surname> <given-names>D</given-names></name><name><surname>Mehrara</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e70703</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0070703</pub-id><pub-id pub-id-type="pmid">23950984</pub-id></element-citation></ref><ref id="bib234"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winer</surname> <given-names>S</given-names></name><name><surname>Chan</surname> <given-names>Y</given-names></name><name><surname>Paltser</surname> <given-names>G</given-names></name><name><surname>Truong</surname> <given-names>D</given-names></name><name><surname>Tsui</surname> <given-names>H</given-names></name><name><surname>Bahrami</surname> <given-names>J</given-names></name><name><surname>Dorfman</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Zielenski</surname> <given-names>J</given-names></name><name><surname>Mastronardi</surname> <given-names>F</given-names></name><name><surname>Maezawa</surname> <given-names>Y</given-names></name><name><surname>Drucker</surname> <given-names>DJ</given-names></name><name><surname>Engleman</surname> <given-names>E</given-names></name><name><surname>Winer</surname> <given-names>D</given-names></name><name><surname>Dosch</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Normalization of obesity-associated insulin resistance through immunotherapy</article-title><source>Nature Medicine</source><volume>15</volume><fpage>921</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1038/nm.2001</pub-id><pub-id pub-id-type="pmid">19633657</pub-id></element-citation></ref><ref id="bib235"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>McGoogan</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China</article-title><source>Jama</source><volume>323</volume><elocation-id>1239</elocation-id><pub-id pub-id-type="doi">10.1001/jama.2020.2648</pub-id></element-citation></ref><ref id="bib236"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Cao</surname> <given-names>D</given-names></name><name><surname>He</surname> <given-names>A</given-names></name><name><surname>Ge</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The prognostic role of obesity is independent of sex in Cancer patients treated with immune checkpoint inhibitors: a pooled analysis of 4090 Cancer patients</article-title><source>International Immunopharmacology</source><volume>74</volume><elocation-id>105745</elocation-id><pub-id pub-id-type="doi">10.1016/j.intimp.2019.105745</pub-id><pub-id pub-id-type="pmid">31302449</pub-id></element-citation></ref><ref id="bib237"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Youm</surname> <given-names>YH</given-names></name><name><surname>Dixit</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution</article-title><source>The Journal of Immunology</source><volume>183</volume><fpage>3040</fpage><lpage>3052</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900562</pub-id><pub-id pub-id-type="pmid">19648267</pub-id></element-citation></ref><ref id="bib238"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Youm</surname> <given-names>YH</given-names></name><name><surname>Vandanmagsar</surname> <given-names>B</given-names></name><name><surname>Rood</surname> <given-names>J</given-names></name><name><surname>Kumar</surname> <given-names>KG</given-names></name><name><surname>Butler</surname> <given-names>AA</given-names></name><name><surname>Dixit</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Obesity accelerates thymic aging</article-title><source>Blood</source><volume>114</volume><fpage>3803</fpage><lpage>3812</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-03-213595</pub-id><pub-id pub-id-type="pmid">19721009</pub-id></element-citation></ref><ref id="bib239"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>W</given-names></name><name><surname>Bai</surname> <given-names>Y</given-names></name><name><surname>Xiong</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Meng</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Yan</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Chang</surname> <given-names>CC</given-names></name><name><surname>Chang</surname> <given-names>TY</given-names></name><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>Zhou</surname> <given-names>P</given-names></name><name><surname>Song</surname> <given-names>BL</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Sun</surname> <given-names>SC</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>BL</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism</article-title><source>Nature</source><volume>531</volume><fpage>651</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1038/nature17412</pub-id><pub-id pub-id-type="pmid">26982734</pub-id></element-citation></ref><ref id="bib240"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Kurupati</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Zhou</surname> <given-names>XY</given-names></name><name><surname>Zhang</surname> <given-names>G</given-names></name><name><surname>Hudaihed</surname> <given-names>A</given-names></name><name><surname>Filisio</surname> <given-names>F</given-names></name><name><surname>Giles-Davis</surname> <given-names>W</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Karakousis</surname> <given-names>GC</given-names></name><name><surname>Schuchter</surname> <given-names>LM</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Amaravadi</surname> <given-names>R</given-names></name><name><surname>Xiao</surname> <given-names>M</given-names></name><name><surname>Sadek</surname> <given-names>N</given-names></name><name><surname>Krepler</surname> <given-names>C</given-names></name><name><surname>Herlyn</surname> <given-names>M</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Rabinowitz</surname> <given-names>JD</given-names></name><name><surname>Ertl</surname> <given-names>HCJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Enhancing CD8<sup>+</sup>T cell fatty acid catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy</article-title><source>Cancer Cell</source><volume>32</volume><fpage>377</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2017.08.004</pub-id><pub-id pub-id-type="pmid">28898698</pub-id></element-citation></ref><ref id="bib241"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Yue</surname> <given-names>C</given-names></name><name><surname>Herrmann</surname> <given-names>A</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Egelston</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Aftabizadeh</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>YJ</given-names></name><name><surname>Lee</surname> <given-names>PP</given-names></name><name><surname>Forman</surname> <given-names>S</given-names></name><name><surname>Somlo</surname> <given-names>G</given-names></name><name><surname>Chu</surname> <given-names>P</given-names></name><name><surname>Kruper</surname> <given-names>L</given-names></name><name><surname>Mortimer</surname> <given-names>J</given-names></name><name><surname>Hoon</surname> <given-names>DSB</given-names></name><name><surname>Huang</surname> <given-names>W</given-names></name><name><surname>Priceman</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>STAT3 Activation-Induced fatty acid oxidation in CD8<sup>+</sup> T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth</article-title><source>Cell Metabolism</source><volume>31</volume><fpage>148</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2019.10.013</pub-id><pub-id pub-id-type="pmid">31761565</pub-id></element-citation></ref><ref id="bib242"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Tang</surname> <given-names>Z</given-names></name><name><surname>Gao</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tumor-Associated macrophages: recent insights and therapies</article-title><source>Frontiers in Oncology</source><volume>10</volume><elocation-id>188</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2020.00188</pub-id><pub-id pub-id-type="pmid">32161718</pub-id></element-citation></ref><ref id="bib243"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinkernagel</surname> <given-names>RM</given-names></name><name><surname>Doherty</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system</article-title><source>Nature</source><volume>248</volume><fpage>701</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1038/248701a0</pub-id><pub-id pub-id-type="pmid">4133807</pub-id></element-citation></ref></ref-list></back></article>